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ABSTRACT 
Four thiosemicarbazones ligands (1-4) have been prepared with good yield by refluxing 
2,4-dihydroxybenzaldehyde with thiosemicarbazide or N(4)-substituted thiosemicarbazide 
in ethanol or methanol. From these four ligands, 16 new ternary metal complexes (5-20) 
with the general formulation of M(B)L have been prepared from the reactions of metal 
acetates  with 2,4-dihydroxybenzaldehyde N(4)-substituted thiosemicarbazone in the 
presence of N,N-heterocyclic base (M2+ = Zn2+ or Cu2+; B = 2,2'-bipyridine, (bpy); 1,10-
phenanthroline, (phen); L2- = doubly deprotonated thiosemicarbazones =                          
2,4-dihydroxybenzaldehyde thiosemicarbazonato, (HT); 2,4-dihydroxybenzaldehyde                
4-methylthiosemicarbazonato, (HM); 2,4-dihydroxybenzaldehyde 4-
ethylthiosemicarbazonato, (HE) and 2,4-dihydroxybenzaldehyde 4-
phenylthiosemicarbazonato, (HP))  These compounds have been characterized by elemental 
analyses, IR, UV-Vis, NMR and magnetic susceptibility. The structures for ligands (2, 3, 5) 
and complexes (8, 9, 11, 13 and 18) have been solved by single crystal X-ray 
crystallography. Results from spectroscopic data and crystal structure analysis show that all 
the free ligands exist in the thione form. The complexes are mononuclear and five 
coordinated with the doubly deprotonated thiosemicarbazone as a tridentate ligand 
coordinating through the phenolic oxygen, azomethine nitrogen and thiolate sulfur while 
2,2'-bipyridine or 1,10-phenanthroline as the N,N’-bidentate ligand. The coordination 
geometries vary from distorted square pyramidal to distorted trigonal bipyramidal. The 
effect of varying the N(4) substituent from methyl, ethyl to phenyl, metal ions and 
polpyridyl ligand towards the chemical and biological properties of these compounds 
(DNA duplex and G-quadruplex binding, nucleolytic, topoisomerase I inhibition and 
antimicrobial) have been studied. Results from our biological studies show that compounds 
with more hydrophobic ligands generally have better biological properties. The nucleolytic 
efficiency of the copper(II) complexes are better than their zinc analogs. Interestingly, 
complexes Cu(phen)(HM) 18 and Cu(phen)(HE) 19   can induce oxidative DNA cleavage 
in the absence of exogenous agent. 
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ABSTRAK 
Empat ligan tiosemikarbazon (1-4) telah berjaya disediakan dengan hasil yang baik dengan 
kaedah refluks campuran 2,4-dihidroksibenzaldehid dengan tiosemikarbazida atau dengan 
tiosemikarbazida N(4)-tertukarganti dalam metanol atau etanol. Daripada empat ligan ini, 
16 kompleks logam ternari (5-20) dengan formula umum, M(B)(L) telah disediakan melalui 
tindak balas antara asetat logam dan 2,4-dihidroksibenzaldehid tiosemikarbazon N(4)-
tertukarganti dengan kehadiran bes N,N’-heterosiklik (M2+ = Zn2+ atau Cu2+; B = 2,2'-
bipiridina, (bpy); 1,10'-phenantrolin, (phen); L2- = tiosemikarbazon ternyahproton =                          
2,4-dihidroksibenzaldehid tiosemikarbazonato, (HT); 2,4-dihidroksibenzaldehid               4-
metiltiosemikarbazonato, (HM); 2,4-dihidroksibenzaldehid4-etiltiosemikarbazonato, (HE) 
and 2,4-dihidroksibenzaldehid 4-feniltiosemikarbazonato, (HP)).  Sebatian yang terhasil 
telah dicirikan dengan kaedah analisis unsur, spektroskopi seperti infra merah, ultra-
lembayung nampak, resonans magnet nukleus dan kerentanan magnet. Struktur untuk ligan-
ligan (2, 3 dan 5) dan kompleks (8, 9, 11, 13 and 18) telah ditentukan dengan kaedah 
kristalografi sinar-X. Data spektroskopi dan analisis struktur hablur menunjukkan bahawa 
semua ligan bebas wujud dalam bentuk tion. Kompleks yang terhasil adalah mononuklear 
dan terkoordinat lima. Tiosemikarbazon yang ternyahproton bertindak sebagai ligan 
tridentat yang mengkoordinat melalui oksigen fenolik, nitrogen azometina dan sulfur tiolat 
manakala 2,2’-bipiridina atau 1,10-phenantrolin bertindak sebagai ligan bidentat-N,N’. 
Kompleks yang terhasil mempunyai geometri piramid segiempat terherot atau trigonal 
bipiramid terherot. Kesan mengubah kumpulan penukarganti N(4) dari metil, etil ke fenil 
serta ion logam dan ligan polipiridil terhadap sifat kimia dan aktiviti biologi (pertambatan 
DNA, nukleolitik, perencatan toposiomerase I dan antimikrob) sebatian-sebatian ini telah 
dikaji. Kajian aktiviti biologi menunjukkan bahawa secara kebiasaannya, sebatian yang 
mengandungi ligan yang lebih hidrofobik memiliki aktiviti biologi yang lebih baik. Aktiviti 
nukleolitik kompleks kuprum(II) adalah lebih baik berbanding dengan analog zink. 
Kompleks Cu(phen)(HM) 18 dan Cu(phen)(HE) 19 boleh mengaruhkan pembelahan DNA 
oksidatif tanpa kehadiran agen eksogenus. 
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Chapter 1 
Introduction 
1.1 Metal ions in biological system 
Metal ions and their coordination compounds can be found in various biological systems.  
Iron for example, can be found in hemoglobin, a molecule responsible for carrying oxygen 
to the cells in animals (Orvig and Abrams, 1999). In addition, iron is also found in 
ribonucleotide reductase, an enzyme involved in the rate limiting step of DNA synthesis 
(Reichard, 1988; Fan et al. 1998). Metal ions such as zinc provide the structural framework 
for the zinc fingers that regulate the functions of genes in the nuclei of cells. Zinc is also a 
natural component of insulin, a substance that regulates sugar metabolism. Metal ions such 
as copper, zinc, iron, nickel and manganese are incorporated into various metalloenzymes, 
catalytic proteins which promotes a multitude of chemical reactions crucial for life (Orvig 
and Abrams, 1999). Meanwhile, the chlorophyll essential for photosynthesis in plants is 
actually a coordination compound of magnesium and porphyrin (Fleming, 1967). These 
metal cations or metal-containing complex species function by interacting with various 
inorganic molecules or biomolecules, such as protein, DNA and RNA, through electrostatic 
interaction, covalent bonding, hydrogen bonding, and van der Waals forces. 
 
Since metal ions play many important roles in biological system, it is essential to 
maintain adequate concentration of metal ions in the system for the organism to function 
healthily. There are many complications that can arise due to deficiency of metal ions. 
Anemia in mammals is due to the deficiency of iron (Lozoff et al. 1987; Guyatt et al. 
1992), while the lack of calcium could lead to osteoporosis (Tilyard et al. 1992; Nordin, 
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1997; Heaney, 2000). Although metal ions are essential to animals, it can also induce 
toxicity if present in excess. Iron overload can lead to thalassemia and Friedrich’s ataxia 
(Galanello et al. 2003; Wagner et al. 2003; Neufeld, 2006) while copper(II) has been 
implicated in diseases such as Wilson’s, Menkes, Alzheimer’s, Parkinson’s and other 
neurodegenerative diseaseS (Linder and Hazegh, 1996; Sarkar, 1999; Lyons et al, 1999; 
Gaggelli et al. 2006). Excess free metal ions can participate in Fenton chemistry and 
produce reactive oxygen species (ROS) such as hydroxyl radical, resulting in oxidative 
insults to critical biomolecules like protein, DNA and lipids that will cause impaired 
cellular functions (Valko et al. 2006; Kozlowski  et al. 2009). 
 
Given the wide importance of metal ions and their coordination compound in living 
system, it is understandable why the field of inorganic biochemistry and medicinal 
inorganic chemistry are growing in prominence. Synthesis of new metal complexes of 
biological importance and elucidation of their properties are increasingly attracting 
attention because adequate knowledge in these fields is vital in the search of treatments for 
metal related disease, metal-based drugs and to gain a better understanding on how nature 
works. 
 
1.2 Metal complexes with anticancer properties: Designs and improvements 
The usage of metal ions in medicinal chemistry has a history of about 5000 years (Orvig, 
and Abrams, 1999). However, the true potential of metal ions in medicinal chemistry was 
only fully acknowledged and explored with the serendipitous discovery of the antitumor 
activity of cisplatin (Rosenberg et al. 1969). Cisplatin still remains as one of the leading 
metal-based anticancer drug, being especially effective in treatments of genitourinary 
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tumors such as testicular cancer. However, the clinical use of cisplatin is severely limited 
by dose limiting side effects such as neuro-, hepato- and nephrotoxicity (Zhang and 
Lippard, 2003; Zutphen and Reedjik, 2005). Besides high systemic toxicity, the second 
problem seems to be the acquired resistance of cancer cell towards platinum-based drugs. 
In order to develop metal-based anticancer drugs with higher specificity and reduced side 
effectS, a departure from the cisplatin paradigm of activity is necessary. Much effort has 
been put into overcoming toxicity and drug resistance. The alternative strategies include 
development of more selective delivery or activation of cisplatin related prodrugs, 
development of non-platinum metal-based drugs, discovery of new non-covalent 
interactions with DNA (intercalator or groove binder) and looking at other molecular target 
besides DNA (Bruijnincx and Sadler, 2008). 
 
1.2.1 Improving platinum-based anticancer agents 
Problems like toxic side effects and acquired drug resistance do not dampen the interest of 
scientist towards developing platinum complexes as potential anticancer agents, owing to 
the huge success of cisplatin. Instead, numerous effort have been reported on designing 
drug delivery system capable of delivering platinum to tumor cells only and preventing  
binding to non-pharmacological targets. In addition, platinum complexes with different 
binding modes from that of cisplatin are of current interest and may provide higher 
antitumor activity against cisplatin-resistant cancer cells (Zhang and Lippard, 2003). 
 
Recently, Yang et al. (2007) have developed a method of delivering platinum drugs 
to the tumor cells only by encapsulating cisplatin and carboplatin in the hollow protein cage 
of the iron storage protein ferritin, which can be internalized by some tumor tissues. The 
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drug-loaded protein showed cytotoxic activity against the rat pheochromocytoma cell line 
(PC12). Meanwhile, MacDiamird et al. (2007) have utilized some bacterially derived 400 
nm particles for encapsulation and cancer cell targeting of chemotherapeutics.  
Chemotherapeutics such as cisplatin were packed in the minicells and labeled with 
bispecific antibodies. These bispecific antibodies (BsAb) have two arms with different 
functions. One of these arms recognizes the O-antigen component of the minicell surface 
LPS whereas the other arm is a cell-surface receptor specific for the mammalian cell to be 
targeted. For example, EGFR or HER2/neu receptor targets breast and ovarian cancer cells, 
respectively. These minicells specifically target the tumor cell-surface receptors via its 
bispecific antibody coating. Receptor engagement results in minicell endocytosis, 
intracellular degradation, and ultimately drug release in cancer cells. 
 
Previously, in an attempt to improve the delivery of platinum(IV) prodrugs,  
Lippard’s group synthesized  an estrogen tethered platinum(IV) complex based on the 
observation that estrogen receptor-positive, ER(+), breast cancer cells treated with estrogen 
are sensitized to cisplatin. This approach is successful in inducing up regulation of high 
mobility group (HMG) domain protein upon intracellular reduction of the prodrug. The 
domain protein, HMGB1 shields platinated DNA from nucleotide excision repair (Barnes et 
al., 2004). 
 
 In another approach, Lippard et al. have circumvented the problem of drug delivery 
by attaching a Pt(IV) prodrug to a functionalized water soluble single-walled carbon 
nanotubes (SWNT), highly effective carriers that can transport various cargos across the 
cell membrane through clathrin-dependent endocytosis. The platinum(IV) complex  has 
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two different axial ligands, Fig. 1.1 and binds non-covalently to the nanotube surface and 
one SWNT longboat carries on average 65 platinum complexes. The conjugate shows 
increased cellular uptake and substantial increase in cytotoxicity compared to the 
untethered complex and to cisplatin (Feazell et al., 2007). Along a similar vein, Dhar et al. 
(2008) have further improved this approach by attaching a folic acid derivative to the 
second axial ligand of the platinum(IV) complex as a homing device. This complex 
specifically targets folate receptor-enriched tumor cells and has enhanced cell killing 
properties when conjugated to SWNT. This compound is more active than cisplatin by a 
factor of 8.6. 
 
Fig. 1.1 Platinum(IV) complex bound to SWNT (Feazell et al., 2007). 
 
Attempt to overcome cancer cells resistant to cisplatin led to development of 
platinum complexes with distinctively different DNA binding mode such as trans-platin 
and multinuclear platinum complexes. Reports of trans-platinum complexes showing 
favorable cytotoxicity against cancer cells, especially cisplatin-resistant cells have been 
reviewed by Natile and Coluccia (2001). A series of trans-Pt(II)-piperazine compounds 
were reported by Najajreh et al. (2002). These cationic complexes are more water soluble 
and bind more rapidly to DNA compared with cisplatin and displayed significant 
cytotoxicity against cisplatin-resistant ovarian cancer cells. 
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Multinuclear platinum complexes containing two, three or four platinum centers 
with both cis and/or trans configurations also bind to DNA differently from cisplatin. 
These complexes are generally connected by polyamines linkers. An example of this class 
of compounds is BBR3464, Fig. 1.2, a trinuclear complex which has entered a phase II 
clinical trial and exhibits activity against pancreatic, lung and melanoma cancers. 
Furthermore, this complex is effective against human tumor mouse xenografts containing 
the mutant p53 gene (Pratesi et al. 1999). The p53 gene is a tumor suppressor encoding a 
nuclear phosphoprotein that mediates cellular response towards genotoxic stress including 
cisplatin treatment. Over 60% of human cancers are characterized by nonfunctional p53 
(Zamble et al. 1998). The ability of BBR3464 to target cells with mutant p53 renders it a 
potent anticancer drug. BBR3464 can bind to DNA rapidly, forming various long-range 
interstrand and intrastrand cross-links because it is a highly charged 4+ species. 
 
 
 
Fig 1.2 Trinuclear  platinum complex, BBR3464 
 
Recently, Komeda et al. (2006) have reported a new mode of binding between a 
polynuclear platinum complex, TriplatinNC (Fig. 1.3) and DNA. TriplatinNC does not 
intercalate nor does it bind in either groove. Instead, it binds to phosphate oxygen atoms 
through specific hydrogen bonding interactions called phosphate clamps and thus associates 
with the backbone. The new binding mode was observed in the crystal structure of a 
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double-stranded B-DNA dodecamer with TriplatinNC. Another feature of TriplatinNC is 
that the cellular uptake is significantly enhanced over the “parent” BBR3464 due to the 
increase of charge. TriplatinNC  also displays micromolar activity against human ovarian 
cancer cell lines (Harris et al., 2005). The binding of a small molecule to DNA is greatly 
enhanced in the presence of positive charge. This is attributed to the increase in 
electrostatic interaction between the positively charged molecule and the negatively 
charged DNA backbone. 
 
 
Fig. 1.3 Polynuclear platinum(II) complex, TriplatinNC (Harris et al., 2005). 
 
Another strategy is to develop Pt(IV) complexes that are kinetically inert under 
biological conditions as prodrugs. These prodrugs are only activated upon reduction and 
provide a good mean of delivering cisplatin or its analog to tumor cells. The delivery of 
these prodrugs has been mentioned earlier (Feazell et al., 2007; Barnes et al., 2004). 
Detailed example of the prodrugs strategy will be discussed in the next section.  
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1.2.2 Utilization of prodrugs 
In overcoming toxicity of a therapeutic agent, one of the useful strategies is to develop a 
prodrug. Prodrugs are modified versions of substances that are administered in their 
inactive form with improved delivery features and need to be transformed in vivo to release 
the active drug. This strategy allowed for site selective drug delivery and minimizes the 
damaged to non-cancerous cells.  Activation can occur either chemically, enzymatically or 
through photo irradiation (Bruijnicx and Sadler, 2007; Zutphen and Reedijk, 2005). 
 
Platinum(IV) complexes are widely studied as prodrugs to tackle problems 
normally encountered  in the use of Pt(II) complexes because they are kinetically inert 
under biological conditions and can undergo two electron reduction to form reactive square 
planar Pt(II) complexes. Most of the Pt(IV) prodrugs undergo intracellular reduction to 
exert their cytotoxicity (Feazell et al., 2007; Barnes et al., 2004).  
 
Photochemical activation of platinum(IV) drugs to release active antitumor agents, 
rather than spontaneous intracellular reduction is a strategy that can provide localized 
treatment of cancers accessible to irradiation. Mackay et al. (2006) have discovered that a 
photoactivated trans-diammine platinum complex is as cytotoxic as cisplatin. The trans-
dihydroxy platinum(IV) prodrugs, Fig. 1.4 are non-toxic in the dark and incorporate two 
azide ligands, trans to each other. Irradiation results in growth inhibition of human bladder 
cancer cells and cytotoxicity towards human skin cells (HaCaT keratinocytes). The potency 
of this complex can be elevated by introduction of a pyridine ligand, Fig. 1.5 (Mackay et 
al., 2007).  
9 
 
 
Fig. 1.4 Trans-dihydroxy platinum(IV) prodrugs 
 
 
Fig. 1.5 trans, trans, trans-[Pt(N3)2(OH)2(NH3)(py)] 
 
 Designing non-toxic prodrugs that can selectively be activated by enzymes at the 
tumor open up another opportunity for the development of targeted therapies. Based on the 
knowledge that a number of enzymes are found at elevated concentration around tumor 
tissue has led to the use of prodrug monotherapy (PMT) that involves a single 
administration of a prodrug, which is activated locally to yield the active drug. An example 
of this approach is the activation of cephalosporin-platinum complex by B-lactamases 
(Hanessian et al., 1993) and a B-glucuronyl-platinum conjugate by B-glucuronuidase 
(Tromp et al., 2004). In both cases, the enzymes managed to activate the prodrug resulting 
in the release of a modified oxaliplatin type species. Meanwhile, Kageyama et al. (2004) 
have made platinum compounds with hydrophobic side chains link via an ester bond that 
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show improved cell permeability with respect to cisplatin. These compounds are activated 
by ester hydrolysis and show a 10-fold difference in activity between the (R) and (S)-
enantiomers.  
 
1.2.3 Non-platinum DNA targeting drugs 
The desire to overcome significant side effects and drug resistance associated with the use 
of platinum-based drugs for the treatment of cancer has spurred chemists to look for non-
platinum DNA targeting drugs. This class of compound that can bind to DNA either 
through covalent binding or non-covalent (groove binder or intercalator or electrostatic 
interaction), or a combination of these modes of interaction are anticipated to have different 
mechanism in leading to cell death.  
 
Among the non-platinum anticancer drugs, ruthenium holds a promising future. A 
variety of ruthenium complexes which interact with the classical target, DNA have been 
reported recently (Ang & Dyson, 2006; Liu et al., 2006). Yan et al. (2005) has synthesized 
a family of ruthenium(II)-arene complexes that exhibits high in vitro and in vivo anticancer 
activity. The complex synthesized by Liu et al. (2006) is not cross-resistant to cisplatin. 
This may be explained by the ability of the complexes to induce different DNA structural 
distortions compared to cisplatin. In addition, direct coordinative binding to N7 of G bases 
in DNA, this complex also intercalates with the DNA through the biphenyl ligand and 
forms specific hydrogen bonds with C6O of guanine via its ethylenediamine NH2 groups. 
 
Transition metal complexes that can bind and cleave DNA under physiological 
conditions open up another exciting opportunity for developing non-platinum DNA 
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targeting drugs. The binding of one class of compound is normally achieved by 
introduction of an intercalating ligand. The mode of interaction is non-covalent and 
involves intercalation between nucleobase or binding to the major or minor groove of 
DNA. A second ancillary ligand is normally introduced to form a ternary complex, which 
often acts either as a bioactive moiety itself, a photosensitizer, or a homing device to target 
a specific sequence of DNA or to modulate the redox properties of the metal ion. Cleavage 
of DNA can be achieved by targeting its basic constituents like base and/or sugar by an 
oxidative pathway or by hydrolysis of phosphoester linkages. Iron and copper complexes 
are known to be useful for oxidative cleavage of DNA involving nucleobase oxidation 
and/or degradation of sugar by abstraction of deoxyribose hydrogen atom(s), while 
complexes containing strong Lewis acids like copper(II) and zinc(II) are suitable for 
hydrolytic cleavage of DNA. Oxidative cleavage of DNA could take place by chemical or 
photochemical means (Ng et al., 2008; Seng et al., 2008; Chakravarty, 2006). 
 
  An example of ternary copper(II) complex of 1,10-phenanthroline with L-threonine 
that utilize this strategy has been reported by Zhang et al. (2004). The complex exhibited 
highly in vitro cytotoxic effects toward HL-60 and SGC-7901 tumor cell lines and was 
more potent than cisplatin at most experimental concentrations. The complex was shown to 
intercalate into DNA and cleave pBR322 DNA efficiently in the presence of ascorbate with 
hydroxyl radicals as the active species. The introduction of L-threonine in the copper 
complex gave rise to potential selective interactions with DNA, which may result in the 
variation of nuclease activity of the Cu–phen system as well as its cytotoxicity towards 
tumor cell lines. 
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1.2.4 DNA intermediates as target 
The paradigm shift towards the targeting of intermediate DNA structures other than the 
form in which DNA is stored, and design of compounds with specificity for certain DNA 
forms, may open up access to the targeting of certain types of biological activity. In 
eukaryotic cells, DNA is stored in its supercoiled duplex form and is arranged in 
supramolecular structures that are stabilized by ancillary proteins. However, during 
activation toward processes such as replication and transcription, this stable storage 
complex is rearranged and the DNA may form structures that differ from the Watson–
Crick-induced B-DNA duplex. The most studied and well-known of these structures is the 
Holliday (four-way) junction, which is the key intermediate in nearly all recombination 
processes, although three-way forks also occur in major steps of both RNA and DNA 
metabolism. As they are landmarks of pivotal events in the cell cycle, these transient 
conformations are attractive targets to control diseases at the source (Oleksi et al., 2006; 
Boer et al., 2008).  
  
 An example of complex that recognizes the DNA three way junction (3WJ) by a 
supramolecular helicate was reported by Oleksi et al. (2006) recently.  The interaction 
mode observed involves a highly stable complex between the DNA junction and the 
‘helicate’, a compound that consists of three organic stranded ligands wrapped around two 
Fe2+ atoms, as shown in Fig. 1.6. The helicate combines the two positively charged centers 
with an extensive hydrophobic surface formed by four aromatic rings of each respective 
ligand. The X-ray structure that was determined, illustrated in Fig. 1.7, shows that the 
positive charge of the helicate, together with the large hydrophobic surface of the aromatic 
rings (with π-stacking potential), are the driving forces behind this specific interaction. This 
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unprecedented mode of non-covalent DNA recognition shows that three-way junctions, 
naturally occurring both in DNA and RNA can be new structural targets for the design of 
novel and highly specific drugs. 
 
Fig. 1.6  Assembly of the [Fe2L3]4+ (L=C25H20N4) tetracationic supramolecular helicate 
(Oleksi et al. 2006) 
 
 
Fig 1.7 The saturated iron triple helicate binds to a three-way DNA junction 
(Oleksi et al. 2006) 
 
  Based on the same strategy, Pascu et. al. (2007) have synthesized  a ruthenium 
metallohelicate which induces a similar bending/coiling effect, further illustrating that the 
helicate is responsible in recognizing the three-way DNA junction. The Ru triple helicate 
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exhibits cytotoxicity towards human breast cancer HBL-100 and T47D cells, which is 2–5-
fold less potent than cisplatin. Meanwhile, a related unsaturated dinuclear ruthenium double 
helicate, capable of classic coordinative binding to DNA, show greatly improved 
cytotoxicity towards the same cell lines (30-fold more active than cisplatin). These 
complexes illustrate the many possibilities of using metallosupramolecular architectures 
that target unique DNA structure in anticancer drugs design (Hotze et al., 2006). 
 
 Another DNA intermediate that deserves attention as a new anticancer target is 
telomere. Telomere recognition and regulation has been marked as an important potential 
target for cancer therapy because the behavior of these regions differs in somatic and cancer 
cells. In a normal cell, telomeric DNA shortens after every cell division and after critical 
shortening of the telomeres (upon reaching the Hayflick limit) cells stop dividing and 
commit suicide. In contrast, telomere lengths are actively maintained at a certain length in 
cancer cells due to the over expression of telomerase, an enzyme responsible in maintaining 
the length of the telomeric DNA. This renders the cancer cells with the ability to replicate 
indefinitely and thus proliferate (Neidle and Parkinson, 2002). 
 
Single-stranded ends of human telomeric DNA, which consists of guanine-rich TTAGGG 
repeats known to fold into G-quadruplex structures. Since telomerase accepts only the 
single-stranded overhang, stabilization of the G-quadruplexes provides an attractive means 
of inhibiting the telomerase. The desirable features of these stabilizing molecules are: 
(1) a π-delocalized system that is able to stack on the face of a guanine quartet 
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(2) a partial positive charge that is able to lie in the center of the quartet, increasing 
stabilization by substituting the cationic charge of the potassium or sodium that 
would normally occupy that site 
(3) positively charged substituents to interact with the grooves and loops of the 
quadruplex and the negatively charged backbone phosphates. 
 
A recent example of stabilization of G-quadruplex DNA and inhibition of telomerase 
activity by square-planar nickel(II) complexes has been reported by Reed et al. (2006). The 
substituted salicylidene phenylenediamine-nickel(II) complex , Fig. 1.8, is water soluble in 
slightly acidic pH and fulfills the main requirements of a G-quadruplexes stabilizing 
molecule. These compounds induce high degree of quadruplex DNA stabilization and 
telomerase inhibition with telEC50 in the range of 0.1 uM. 
 
Fig. 1.8 Substituted salicylidene phenylenediamine-nickel(II) complex 
(Reed et al. 2006) 
 
 
Riding on the previous success of Reed et al. (2006), Dixon et al. (2007) have 
developed a metalloporphyrin, Fig. 1.9, that shows both a very high affinity and an 
excellent selectivity for G-quadruplex DNA over GC-rich or AT-rich DNA . This 
compound shows an exceptional 10,000-fold selectivity for quadruplex over duplex DNA 
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(IC50 of around 0.6 mM) , while the Ni(II)–salphen complex, Fig 1.8 only shows selectivity 
of >50-fold. These results illustrate the potential of metal complexes as telomere-targeted 
chemotherapeutics. 
 
 
 
 
Fig. 1.9 Pentacationic manganese(III) porphyrin 
(Dixon et al. 2007) 
 
1.2.5 Metal complexes targeting protein and enzyme 
The advents of genomics and proteomics have resulted in a wealth of information 
concerning the biology of cancer cells that were not known previously. The data have 
greatly facilitated the development of targeted therapies, an approach of designing novel 
agents that target cellular signaling pathways specific to cancer cells. Interestingly, cancer 
cells normally have an elevated level of particular enzymes or metal ions compared to 
normal cells. Approaches that focus on the differences between healthy and cancer cells are 
more selective and are anticipated to overcome the drawbacks of the traditional DNA-
targeting anticancer drugs that affect cancer and healthy cells as well (Bruijnicx and Sadler, 
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2007; Zhang and Lippard, 2003; Dyson and Sava, 2006). A few examples of protein and 
enzymes as target will be illustrated. 
 
Gold complexes well known for treatment of rheumatoid arthritis are also active as 
antitumor agents. These complexes display a wide spectrum of antitumor activity in vivo, 
especially in some cisplatin-resistant cell lines. Mechanistic studies suggest that, in contrast 
to cisplatin, DNA is not the primary target of these complexes. Rather, their cytotoxicity is 
mediated by their ability to alter mitochondrial function and inhibit protein synthesis 
(Mckeage et al., 2002; Plilasertty et al., 2003). A recent example of gold-containing 
anticancer agents are the gold(III) porphyrins studied by Sun et al. (2007). These 
complexes exhibit potent in vitro and in vivo anticancer activity towards hepatocellular and 
nasopharyngeal carcinoma by targeting the mitochondrial death pathway. 
 
Human thioredoxin reductase (hTrxR) is associated with many cellular processes 
such as antioxidant defence and redox homeostasis. The hTrxR is an interesting target for 
anticancer drugs because it is found at elevated levels in human tumor cell lines and it is 
strongly associated with tumor proliferation (Urig et al., 2006a). Urig et al. (2006b) have 
developed a series of gold(I) complexes that are potent inhibitors of hTrxR, a feature 
attributable to the high electrophilicity of Au(I) and its preference for the selenocysteine 
residue of hTrxR.  
 
Another non-DNA target is proteasome. It is a protein responsible for degrading a 
large number of cellular protein. It is an interesting target in cancer therapy due to the over 
expression of proteasome activities in cancer cells. Proteasome inhibition could lead to 
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rapid and selective induction of apoptosis in oncogened transformed cells but not in healthy 
cells. Milacic et al. (2006) have synthesized a gold(III) thiocarbamate compound which 
inhibits proteasome that is more cytotoxic in vitro than cisplatin, including intrinsically 
resistant cell lines. However, the mode of action in proteasome inhibition is yet to be 
understood. 
 
Instead of targeting DNA like most ruthenium anticancer drugs, Meggers’s group 
has pioneered the development of organometallic ruthenium complexes that mimic organic 
enzyme inhibitors. Structural variation by simple substitution of the ligands on the metal to 
optimize the enzyme-inhibitor interactions has resulted in the discovery of nanomolar and 
even picomolar protein kinase inhibitors. This class of complexes illustrates the 
possibilities of using the metal as a scaffold instead of a reactive centre in anticancer drug 
design. In this method, metals can be used as building blocks for well-defined, three-
dimensional constructs with unique stereochemistry and orientation of organic ligands and 
structures which are not accessible through purely organic, carbon-based compounds. 
(Mergers et al., 2007; Bregman et al., 2006). 
 
Another biological target is topoisomerase. Topoisomerases are enzymes that break 
and rejoin DNA strands required for cells to divide and grow, are becoming promising 
target in anticancer drugs. Since the initial discovery that [Ru(η6-C6H6)(DMSO)Cl2] can 
inhibit topoisomerase II activity, Gopal et al. (2002) have prepared three new derivatives 
by replacing the DMSO ligand with 3-aminopyridine, p-aminobenzoic acid or 
aminoguanidine. These analogs show improved efficacy as topoisomerase II inhibitors and 
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have higher cytotoxicity against breast and colon carcinoma cells compared to the parent 
compound. 
 
Other ruthenium complexes that deserves attention are [Ru(Im)(Me2SO)Cl4] 
(NAMI) and its analog (ImH)trans-[Ru(Im)(Me2SO)Cl4] (NAMI-A) that posses 
antimetastatic properties by interfering with type IV collagenolytic activity (Clarke, 2003). 
Type IV collagenolytic activity is a process of breaking down collagen found primarily in 
the basal lamina. These compounds which are devoid of in vitro cytotoxicity but capable of 
in vivo metastasis inhibition have led to development of new metallopharmacheuticals by 
identifying metastasis as target (Bergamo and Saya, 2007). These examples should be a 
wake up call for the needs of developing new assays that look beyond traditional in vitro 
cytotoxicity tests (Dyson and Sava, 2006). 
 
1.2.6 Conclusion 
Metal-based drugs have and will continue to play important roles in treating cancers. These 
examples show that many creative approaches have been taken in designing and improving 
metal complexes with anticancer properties. The main objectives are to design compounds 
with higher selectivity, reduced side-effects and to overcome drug resistance. Platinum-
based drugs still remain the most widely used metal based drugs even though there are a 
few downsides such as toxicity and acquired resistance. There is still a long way to go for 
the commercialization of emerging non-platinum anticancer agents because drug approval 
still required vigorous testing to understand the mechanism of action and potential side 
effects. Ruthenium and gold complexes are emerging rapidly as promising candidates with 
mode of action that departs from the cisplatin paradigm of activity. Targeted delivery and 
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utilization of prodrugs offer a future of more selective and effective treatments of cancer 
with lesser side effects. To discover new compounds and new targets like DNA 
intermediates, enzymes and protein as well as to gain understanding on mechanism of 
action of drugs in the post-genomic era, there is a need to rely heavily on interdisciplinary 
collaboration. All these examples show that there is light at the end of the tunnel for those 
who are interested in developing metal based anticancer agents. 
 
1.3 Thiosemicarbazones in general 
Thiosemicarbazones are a class of Schiff base formed from the condensation of a carbonyl 
compound with a thiosemicarbazide. Thiosemicarbazone are normally named by placing 
the name of the ketone or aldehyde as the prefix followed by thiosemicarbazone as the 
suffix (Casas et al., 2000). Thiosemicarbazones are well known for wide range of 
biological activities and are widely used in industrial and analytical fields. The presence of 
an intact ＝NNH(CS)NH— moiety is essential for their chemical properties and biological 
activities (Casas et al., 2000; West et al., 1993). 
 
Thiosemicarbazones are one class of versatile ligands that are of interest to many 
researchers because of its ability to chelate to metal. Thiosemicarbazones are widely used 
in coordination chemistry because of their abilities to form complexes, in which they are 
monodentate, bidentate or multidentate ligands (Padye and Kaufman, 1985). The 
thiosemicarbazone moiety without substituents attached to the thione sulfur coordinates as 
either a neutral or anionic NS bidentate ligand. Depending on the method of complex 
preparation a third coordinating atom often gives ONS (e.g. 2-hydroxybenzaldehyde 
thiosemicarbazones) or NNS (e.g. 2-acetylpyridine thiosemicarbazones) tridentate ligands. 
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Some examples of higher denticity involving one or more thiosemicarbazone moieties, as 
well as monodentate thiosemicarbazone have been reported (West et al., 1993; Campbell, 
1975).  
 
Due to the tendency of thiosemicarbazone ligands to form complexes with metals, it 
has been widely used in analytical applications. The basic mode of action is through the 
formation of colored chelates. Reddy et al. (2003) have determined the presence of Cu(II) 
and Ni(II) simultaneously with spectrophotometric methods by using 1-phenyl-1,2-
propanedione-2-oxime thiosemicarbazone as a reagent. The presence of sulphur, a soft 
base, in thiosemicarbazone enhances its affinities to soft acids like Hg2+ and Ag+. Majahan 
et al. (2003) have prepared the first ion selective electrode for Hg2+ by using neutral 
salicylaldehyde thiosemicarbazone as an ionophore. This electrode displays good 
selectivity towards Hg2+ over alkali metal and a few transition metal ions. The low cost of 
thiosemicarbazones as well as their easy preparative methods could provide a major 
attraction for the development of analytical reagents for a wide range of metal ions.  
 
A survey of the literature reveals that thiosemicarbazones and their metal complexes 
posses a wide range of biological activities such as antibacterial, antifungal, antitumor, and 
antiviral owing to their property to diffuse through the semi permeable membrane of the 
cell lines (Lobana et al., 2009; Beraldo and Gambino, 2004; West et al., 1993).  
 
The discovery that the intermediate in the antitumor activity of 3-ethoxy-2-
oxobutyraldehyde bis(thiosemicarbazone) was the 4-coordinate copper chelate (Petering 
and Giessen, 1966), has inspired the search for bioactive metal complexes of 
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thiosemicarbazones. The enhanced effect may be attributed to the increased lipophilicity of 
the complexes compared to the ligand alone. Lipophilicity, which controls cells 
permeability, is modified by coordination (Farrel, 2002). The mechanism of action can 
involve binding to a metal in vivo or the metal complex may be a vehicle for activation of 
the ligand as the cytotoxic agent. Chelating agents are often powerful inhibitors of 
metalloenzymes so that the ligands may act by inhibiting the enzymes whose activity 
depends on metals (Fahmi and Singh, 1996). 
 
The following examples are just a small illustration of the wide range of biological 
activites of thiosemicarbazones and their metal complexes. Dittes et al. (1997) show that 
bismuth complexes of thiosemicarbazone are active towards Helicobacter pylori, a 
bacterium responsible for gastric and peptic ulcer. 2-Benzoylpyridine thiosemicarbazone, 
and its copper(II) complexes exhibit antifungal activity against various strains of the 
pathogenic fungi. The activity varied with the nature of the substituent at the amino 
nitrogen of thiosemicarbazone. 2-Benzoylpyridine-N(1)-isopropyl thiosemicarbazone as 
well as its square pyramidal complex, [Cu(HL)Cl2] where HL is undeprotonated Schiff 
base were fungitoxic against the human pathogenic fungi, A. niger and P. variotti (West et 
al., 1995).  Meanwhile the antiviral activity of thiosemicarbazone against meurovaccinal 
infection in mice was first reported in 1950 by Hamre et al. It has since prompted the 
investigations by other groups and the results have been reviewed by Baeur (1972). Singh 
et al. (2000) have prepared metal complexes of thiosemicarbazone with d3 metal ions. In 
vitro and in vivo antitumor testing showed that complexation can enhance the cytotoxicity. 
Since our main focus is to develop metal complexes with anticancer properties, more 
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examples of some thiosemicarbazones or their complexes with significant anticancer 
properties will be discussed in the next section. 
 
1.4  Anticancer properties of thiosemicarbazone and their metal complexes 
Since the antileukemic effect of 2-formylpyridine thiosemicarbazone was reported by 
Brockman et al. in 1956, a tremendous amount of thiosemicarbazones and their complexes 
were subjected to screening in search of a compound with better anticancer properties and 
lower systemic toxicity. Vigorous testing has led to the discovery of thiosemicarbazones 
with potent anticancer properties and a better understanding of their modes of action (West 
et al., 1993; Beraldo and Gambino; 2004; Kalinowski and Richardson, 2007). 
 
Even though thiosemicarbazone is a class of very old compound and their biological 
activities have been extensively studied, a survey of the literature still shows a resurgence 
interest is this class of compounds in the last ten years. The discovery of Triapine (3-
aminopyridine-2-carboxaaldehyde thiosemicarbazone) as a potent inhibitor of 
ribonucleotide reductase by Finch et al. (1999), may have sparked off this interest. Beside 
the cleavage of DNA, an anticancer drug can also work by inhibiting ribonucleotide 
reductase that is essential to DNA repair and synthesis. Recently, some researchers 
discovered that Triapine that has completed phase I clinical trial, can actually induce 
apoptosis in ovarian cancer cell. Apoptosis has been identified as the key mechanism by 
which chemotherapeutic agents like carboplatin and paclitaxel induce cell death (Alvero et 
al., 2006). This discovery further substantiates the fact that the thiosemicarbazone class of 
compound, well known for a wide spectrum of biological activities, has good potential to 
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be developed as anticancer drugs. Triapine is currently in phase II clinical trial for various 
cancers. 
 
In addition, Adsule et al. (2006) have discovered that copper complexes of quinoline-2 
carboxaldehyde thiosemicarbazone are proteasome inhibitor in human prostate cancer cells. 
A proteasome is a large protein complex that helps destroy other cellular proteins when 
they are no longer needed. Proteasome is an interesting target in cancer therapy because 
proteasome inhibition could induce apoptosis rapidly and selectively in oncogene 
transformed cells but not in healthy cells. 
 
Besides proteasome inhibition, Chen et al. (2004) have developed a class of              
1,2-naphthoquinone thiosemicarbazone and metal derivatives which are cytotoxic  towards 
MCF-7 human breast cancer cells. These compounds exert their cytotoxicity by inhibition 
of topoisomerase. These compounds stabilize the cleavable complex of DNA and Topo II, 
and turned the complex into an enzymatic DNA cleavage agent. This happened when the 
compound poisoned an essential enzyme such as topoisomerase and stripped off its ability 
to religate the DNA strand after uncoiling it in the first place.  
 
The above illustrates the potential of thiosemicarbazones and their metal complexes as 
anticancer agents that targets enzymes and proteins similar to those compounds discussed 
earlier in section 1.2.5. Targeted therapy may offer a more selective treatment of cancer 
with fewer side-effects. 
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1.5 Thiosemicarbazones with polyhydroxybenzaldehyde 
The coordination chemistry and biological properties of salicylaldehyde 
thiosemicarbazones have been extensively studied. However, polyhydroxybenzaldehye 
thiosemicarbazones are less well known. 
 
Zhu et al. (1997) have prepared some Fe(II) and Ni(II) complexes with 3,4-
dihydroxybenzaldehyde thiosemicarbazone. Biological activity tests show that the 
complexes exhibit strong superoxide dismutase activity and inhibitory actions towards 
Escherichia coli, Bacillus subtilis, Staphylococcus aureus and Cryptococcus neoforms. The 
complexes are more active than the free ligand and the nickel complex is less active 
compared to the iron complex. 
 
The catalytic oxidation of 3,5-di-tert-butylcatechol into the corresponding o-
benzoquinone by copper(II) complexes of 2,3-dihydroxybenzaldehyde N(4)-substituted 
thiosemicarbazone have been reported in the presence of H2O2 or t-butylhydroperoxide as 
co-oxidants by Al-Kubaisi (2002). Dang et al. (2002) have developed a new method for the 
spectrophotometric detection of trace copper ion by using 2,4-dihydroxybenzaldehyde 
thiosemicarbazone (DBT). But to the best of our knowledge there are no reports on 
anticancer properties and DNA interaction of binary and ternary complexes from 
polyhydroxybenzaldehyde.  
 
1.6  Purpose of  research  
The purpose of our research is to synthesize and characterize various mononuclear and 
polynuclear transition metal complexes with both polypyridyl ligands and ligands derived 
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from polyhydroxybenzaldehye thiosemicarbazone. Some biological properties (e.g DNA 
binding, nucleolytic, topoisomerase I inhibition and antimicrobial) of the above complexes 
and ligands and the factors influencing such properties will also be investigated. 
 
Our interest in thiosemicarbazones stems from the fact that it has the potential as 
anticancer agents that can target protein and enzyme. In addition, we were inspired by the 
work of Thomas et al. (2004) that ternary copper complexes of thiosemicarbazone can 
exhibit light induced DNA cleavage at 312 nm and 532 nm. Their complexes can bind to 
the DNA minor groove and major groove. In the ternary complexes, the thiosemicarbazone, 
dipyridoquinoxaline and dipyridophenazine moiety can actually act as photosensitizers, 
while the planar heterocyclic bases are binders to DNA. Compounds that can cleave DNA 
upon light activation can be utilized in photo dynamic therapy (PDT). 
 
At the same time, we are interested in Schiff base derived from 
polyhydroxybenzaldehye because it was reported by Tonde et al. (2006) that copper(II) 
complexes of hydroxyl-rich ligands with anthralinic acid are capable of cleaving DNA 
without any exogenous agent or light activation. Self activating nucleases such as these are 
interesting because they can be used as diagnostic or therapeutic agent that cleave DNA in 
parts of the biological system which are not accessible to exogenous agent or light 
activation.  Furthermore, thiosemicarbazone derived from polyhydroxybenzaldehyde, 
unlike the salicylaldehyde derivatives, would have uncoordinated hydroxyl group that can 
enhance the solubility of the compound in common solvent to facilitate biological testing. 
The uncoordinated hydroxyl group also offers the opportunity for further derivatization to 
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form bimetallic complexes. It can also be utilize to interact with DNA or other 
biomolecules through hydrogen bonding. 
 
By combining some or all the features in one compound, we hope to design a 
molecule that contains an intercalator (i.e. 1,10'-phenanthroline) that can bind to DNA 
through non-covalent interactions, a thiosemicarbazide moiety that can act as a 
photosensitizer or bioactive moiety that may inhibit  ribonucleotide reductase, 
topoisomerase or proteasome. The presence of uncoordinated hydroxyl group may render 
the molecule with higher solubility or self-activating nuclease property. 
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Chapter 2 
Synthesis, characterization and biological properties of zinc(II) complexes of           
2,4-dihydroxybenzaldehyde N4-substituted thiosemicarbazones and 2,2'-bipyridine 
2.1. Introduction 
Thiosemicarbazones are a class of Schiff bases that have been evaluated for various 
biological properties such as anticancer, antimicrobial and antiviral properties (Padyhe and 
Kaufman, 1985; Liberta and West, 1992; Beraldo and Gambino, 2004). Research on the 
biological properties of thiosemicarbazones, as well as on those of their metal complexes, 
has recently revealed the abilities of these compounds to act as ribonucleotide reductase 
(Attia et al. 2008; Odenike et al. 2008; Ma et al. 2008), topoisomerase (Afrasiabi et al. 
2004; Chen et al. 2004; Wei et al. 2006; Rao et al. 2009) and proteasome (Adsule et al. 
2006; Barve et al. 2006) inhibitors. In particular, the metal complexes of salicylaldehyde 
N4-substituted thiosemicarbazones have been most studied (West et al. 1993; Latheef et al. 
2007 & 2008; Seena and Kurup, 2007 & 2008; Lobana et al. 2008). On the other hand, the 
polyhydroxybenzaldehyde thiosemicarbazones derivatives (Zhu et al. 1997) have been less 
studied.  To the best of our knowledge, there is no report of ternary Zn(II) complexes of 
2,2'-bipyridine and   2,4-dihydroxybenzaldehyde N(4)-substituted thiosemicarbazone. 
 
As the metal complexes themselves are Lewis acceptors, the coordination chemistry 
of their adducts, particularly the N-heterocycles, can yield information on the mode of 
biological activity.  A suitable metal for this purpose is zinc, whose ion is involved in many 
enzymatic reactions and is relatively less toxic compared with other metal ions (Vallee and 
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Auld 1990; Waterborg et al. 1982).  Zinc is also known to enhance antitumor activity of 
thiosemicarbazones (Kovala-Demertzi et al. 2006 & 2008).  The IC50 value for HAcTsc 
against the MCF-7 cell line is 3.29 µM  and for the zinc(II) complexes of HAcTsc, the IC50 
value is 1.36 and 0.88 µM  for [ZnCl2(HAcTsc)] and [Zn(AcTsc)2] respectively (Kovala-
Demertzi et al. 2006 & 2008).   
 
Metal complexes containing 2,2'-bipyridine have been extensively studied for their 
ability to bind to DNA (Carter et al. 1989; Pyle et al. 1989; Jenkins et al. 1992; Tysoe et al
, 1998). These studies normally utilized the 2,2'-bipyridine 
heterocycle as a primary ligand bound to metal as a control. Further variations were carried 
out by using bipyridine derivatives or additional secondary ligands to study the effect of 
shape or hydrophobicity on DNA binding.  Metal complexes derived from 
polyhydroxybenzaldehyde thiosemicarbazones would have an additional uncoordinated 
hydroxyl group, directed away from the coordination sphere,that can help to enhance 
solubility in common polar solvents and to interact with DNA through hydrogen bonding in 
contrast to salicylaldehyde derivatives. This class of compound may also act as a self-
activating nuclease that can cleave DNA without any activation as reported by Tonde et al. 
(2006) for copper(II) complexes of Schiff base derived from polyhydroxybenzaldehyde and 
anthralinic acid. Normally, cleavage of DNA by metal complexes proceeds in the presence 
of exogenous agents such as hydrogen peroxide or sodium ascorbate and some may occur 
through activation by light. Self-activating nuclease reported by Tonde et al. (2006) most 
likely involves singlet oxygen or a singlet oxygen-like moiety as the reactive species 
responsible for the cleavage of plasmid pBR322 DNA. These radicals were generated by 
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sequence of reactions involving concomitant copper and hydroquinone redox cycles. 
Antineoplastic activity of thiosemicarbazones are highly dependent on the substituent at the 
N(4) position. For example, palladium(II) complexes of 2-benzoylpyridine 
thiosemicarbazone with a phenyl substituent at the N(4) is the most cytostatic compared to 
the methyl substituted and non-substituted derivatives (Rebolledo et al. 2005).  
 
Therefore in this chapter, the study of the effect of varying the N(4) substituent of 
the thiosemicarbazone ligand from hydrogen, methyl, ethyl to phenyl towards the chemical 
and biological properties (DNA binding, nucleolytic, topoisomerase I inhibition and 
antimicrobial) of ternary Zn(II) complexes containing this 2,2'-bipyridine ligand as the 
heterocyclic base is described. 
 
2.2. Experimental 
2.2.1. Materials and solutions 
The solvents were purchased from Merck and the reactants for syntheses were from Sigma. 
The pBR322, gene ruler 1 kb DNA ladder, 6x loading buffer and Tris-
(hydroxymethyl)aminomethane (Tris) were procured from BioSyn Tech (Fermentas). 
Analytical grade agarose powder was obtained from Promega. PAGE grade self-
complimentary 12-mer oligonucleotides (CG)6, (AT)6, (CGCGAATTCGCG), 
(CGCGATATCGCG), HPLC grade human telomeric sequence 22-mer oligonucleotide 5’-
AGGGTTAGGGTTAGGGTTAGGG-3’, and 17-mer complementary oligonucleotides 5’-
CCAGTTCGTAGTAACCC-3, 3’-GGTCAAGCATCATTGGG-5’ were purchased from 
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1st BASE and Eurogentec Ait. The respective duplex or quadruplex were annealed as 
speciﬁed by the supplier. Sodium chloride, human DNA topoisomerase I and ethidium  
bromide were purchased from Sigma Chemical Co. (USA).  The aqueous solutions for 
DNA experiments were prepared with ultra-pure water from an Elga PURELAB ULTRA 
Bioscience water purification system with a UV light accessory. The Tris-NaCl (TN) buffer 
was prepared from the combination of Tris-(hydroxymethyl)aminomethane (Tris) base and 
NaCl dissolved in water and its pH was adjusted with hydrochloric acid (HCl) solution to 
pH 7.5. The Tris-NaCl buffer pH 7.5 contains Tris at 5 mM and NaCl at 50 mM. All stock 
solutions of aqueous H2O2 and sodium ascorbate in deionized water and the test compounds 
in N,N-dimethylformamide (DMF) were freshly prepared daily.  
 
2.2.2. Physical measurements 
IR spectra were recorded as KBr pellets by using a Perkin-Elmer Spectrum RX-1 
spectrophotometer.  NMR spectra were recorded in deuterated DMSO-d6 on a JEOL JNM-
LA400 or ECA 400 MHz instrument. Elemental analyses were performed on a Thermo 
Finnigan Eager 300 CHNS elemental analyzer. UV–visible spectroscopic measurements 
were carried out on a Perkin–Elmer Lambda 40 spectrophotometer. The circular dichroism 
study of the interaction of metal complexes with ds(oligonucleotide) or G-quadruplex was 
carried out with a 1.0 cm or 1.0 mm quartz cell respectively, using a Jasco J-810 
spectropolarimeter. 
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2.2.3 Syntheses 
2.2.3.1 Synthesis of 2,4-dihydroxybenzaldehyde thiosemicarbazone, H3T (1) 
The ligand was synthesized by minor modification to the procedure reported by Zhu et al. 
(1997). Thiosemicarbazide (0.09 g, 1 mmol) and 2,4-dihydroxybenzaldehyde (0.14 g, 1 
mmol) were heated in an ethanol/water mixture (20/5 ml) for 3 hours. Slow evaporation of 
the solvent yielded yellow crystals. The crystals were filtered, washed with cold methanol 
and ether, dried in air and kept in a desiccator over silica gel.  
(Yield: 0.18 g, 85%). Anal. Calc. for C8H9N3O2S: C, 45.49; H, 4.29; N, 19.89. Found: C, 
45.98; H, 3.94; N, 20.01%. IR (KBr disc, cm-1): 3478 m, 3342 m, 3174s , 2997 w, 1625 s, 
1555 s,  1507 s, 1379 m, 1317 m, 1287 m, 1239 s, 1165 s, 1122 s, 864 m, 810 m, 792 m, 
482 m, 452 m (s, strong; m, medium ; w, weak).  
Characteristic 1H-NMR signals (DMSO-d6, TMS, p.p.m.): 11.49 (s, 1H, NHCS), 9.75 (s, 
2H, OH), 8.20 (s, 1H, CH=N), 7.92 (s, 1H, NH2), 7.71 (s, 1H, NH2), 7.64 (d, 1H, aromatic, 
J = 8 Hz), 6.26 (s, 1H, aromatic), 6.21(d, 1H, aromatic, J = 8 Hz). Characteristic 13C-NMR 
signals (DMSO-d6, TMS, p.p.m.): 177.40 (C=S), 161.04 (C-O), 158.56 (C-O), 140.97 
(C=N), 128.67  112.11, 108.26, 102.80 (C-aromatic).   
 
2.2.3.2 Synthesis of 2,4-dihydroxybenzaldehyde  4-methylthiosemicarbazone, H3M (2) 
4-Methylthiosemicarbazide (0.11 g, 1 mmol) and 2,4-dihydroxybenzaldehyde (0.14 g, 1 
mmol) were heated in ethanol (10 ml) for 1 h. Slow evaporation of the solvent yielded 
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yellow crystals. The crystals were filtered, washed with cold methanol and ether, dried in 
air and kept in a desiccator over silica gel.  
(Yield: 0.20 g, 89%). Anal. Calc. for C9H11N3O2S: C, 47.99; H, 4.92; N, 18.65. Found: C, 
48.28; H, 5.21; N, 18.98%. IR (KBr disc, cm-1): 3342m, 3249m, 3127 w, 1625 s, 1573 s, 
1521 m, 1459 w, 1331 s, 1270 m, 1231 s, 1166m, 1125 m, 1019 m, 967 w, 868 m, 817 m, 
780 w, 670 m, 635 m, 586 w, 547 w, 497w, 374w (s, strong; m, medium ; w, weak). 
Characteristic 1H-NMR signals (DMSO-d6, TMS, p.p.m.): 11.18 (s, 1H, NHCS), 9.88 (s, 
1H, OH), 9.74 (s, 1H, OH), 8.20 (s, 1H, CH=N), 8.24 (d, 1H, NHCH3, J = 4 Hz), 7.68 (d, 
1H, aromatic, J = 8 Hz), 6.26 (s, 1H, aromatic), 6.24 (d, 1H, aromatic, J = 8 Hz), 2.95 (d, 
3H, NCH3, J = 4 Hz). Characteristic 13C-NMR signals (DMSO-d6, TMS, p.p.m.): 177.61 
(C=S), 160.87 (C-O), 158.40 (C-O), 140.54 (C=N), 128.67, 112.45, 108.19, 102.80          
(C-aromatic), 31.28 (N-CH3).  
 
2.2.3.3 Synthesis of 2,4-dihydroxybenzaldehyde  4-ethylthiosemicarbazone, H3E (3) 
4-Ethylthiosemicarbazide (1.19 g, 10 mmol) and 2,4-dihydroxybenzaldehyde (1.38 g, 10 
mmol) were refluxed in ethanol (40 ml) for 3 h. Slow evaporation of the solvent yielded 
yellow crystals. The crystals were filtered, washed with cold methanol and ether, dried in 
air and kept in a desiccator over silica gel.  
(Yield: 2.05 g, 86%). Anal. Calc. for C10H13N3O2S: C, 50.19; H, 5.48; N, 17.56. Found: C, 
50.32; H, 5.28; N, 17.78%. IR (KBr disc, cm-1): 3382 m, 3295 m, 3163 s, 2979w, 1626 s, 
1579 m, 1551 s, 1499 s, 1401 m, 1302 s, 1241 s, 1166 s, 1126 m, 1099 m, 938 w, 867 w, 
820 w, 801 w, 741 w, 642 w, 621 w, 522 m (s, strong; m, medium ; w, weak). 
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11.16 (s, 1H, NHCS), 9.76 (s, 2H, OH), 8.26 (s, 1H, CH=N), 8.31 (d, 1H, NHCH2-, J = 4 
Hz), 7.72 (d, 1H, aromatic, J = 8 Hz), 6.32 (s, 1H, aromatic), 6.30 (d, 1H, aromatic, J = 8 
Hz), 3.57 (m, 2H, NCH2-, J = 4 Hz) 1.14 (d, 3H, NCH2CH3, J = 4 Hz). Characteristic 13C-
NMR signals (DMSO-d6, TMS, p.p.m.): 176.34 (C=S), 160.84 (C-O), 158.40 (C-O), 
140.99 (C=N), 128.88, 112.34, 108.32, 102.81 (C-aromatic), 32.20 (N-CH2-), 15.21 
(NCH2CH3). 
 
2.2.3.4 Synthesis of 2,4-dihydroxybenzaldehyde  4-phenylthiosemicarbazone, H3P (4) 
4-Phenylthiosemicarbazide (0.17 g, 1 mmol) and 2,4-dihydroxybenzaldehyde (0.14 g, 1 
mmol) were heated in ethanol (20 ml) for 3 h. Slow evaporation of the solvent yielded 
yellow crystals. The crystals were filtered, washed with cold methanol and ether, dried in 
air and kept in a desiccator over silica gel.  
(Yield: 0.23 g, 80%). Anal. Calc. for C14H13N3O2S: C, 58.52; H, 4.56; N, 14.62. Found: C, 
58.38; H, 4.26; N, 14.29%. IR (KBr disc, cm-1):  3331 m, 3144m, 2974 m, 1629 s, 1542 s, 
1223 m, 1264 s, 1210 s, 1121 s, 978 m, 838 w, 743 w, 694 w(s, strong; m, medium ; w, 
weak). 
Characteristic 1H-NMR signals (DMSO-d6, TMS, p.p.m.): 11.54 (s, 1H, NHCS), 9.93 (s, 
1H, OH), 9.89 (s, 1H, OH), 8.72 (s, 1H, NHC6H5), 8.34 (s, 1H, CH=N), 7.82 (d, 1H, 
aromatic, J = 8 Hz), 7.53 (d, 2H, aromatic, J = 8), 7.33 (t, 12H, aromatic, J = 8), 7.16 (t, 1H, 
aromatic, J = 8), 6.29 (s, 1H, aromatic), 6.27 (d, 1H, aromatic, J = 4 Hz). Characteristic 13C-
NMR signals (DMSO-d6, TMS, p.p.m.): 175.57 (C=S), 161.21 (C-O), 158.75 (C-O), 
141.73 (C=N), 139.64, 129.25, 126.06, 125.66, 112.23, 108.38, 102.84 (C-aromatic).  
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2.2.3.5 Synthesis of (4-Hydroxy-2-oxidobenzaldehyde thiosemicarbazonato)-(2,2'-
bipyridine)zinc(II) , [Zn(bipy)(HT)] (5) 
Zinc acetate dihydrate (0.22 g, 1 mmol) and 2,2'-bipyridine (0.16 g, 1 mmol) were heated in 
ethanol (20 ml) for 1 hour followed by addition of 2,4-dihydroxybenzaldehyde 
thiosemicarbazone, H3T (0.21 g, 1 mmol) in hot ethanol (20 ml) and the mixture was 
refluxed for another 3 hours. The yellow complex that formed was filtered, washed with 
cold methanol and ether, dried in air and kept in a desiccator over silica gel. (Yield: 0.28 g, 
65 %). Anal. Calc. for C18H15N5O2SZn: C, 50.18; H, 3.51; N, 16.26. Found: C, 50.43; H, 
3.26; N, 16.54 %. IR (KBr disc, cm-1): 3428 w, 3316 m, 3142 w, 3070 w, 3069w, 1604 s, 
1478 s, 1444 m, 1315 m, 1252 m, 1219 s, 1175s m, 1122 m, 842 w, 763 m, 553 w, 420 w (s, 
strong; m, medium ; w, weak). 
Characteristic 1H-NMR signals (DMSO-d6, TMS, p.p.m.): 9.47 (s, broad, 1H, OH), 8.62 (d, 
2H, bipy, J = 4 Hz), 8.42 (d, 2H, bipy, J = 8 Hz), 8.18 (s, 1H, CH=N), 7.98 (t, 2H, bipy, J = 
8 Hz), 7.48 (d, 2H, bipy, J = 4 Hz), 6.92 (s, broad, 1H, aromatic), 6.30 (s, broad, 1H, 
aromatic), 6.02 (s, broad, 1H, aromatic + 2H, -NH2) 
 
2.2.3.6 Synthesis of (4-Hydroxy-2-oxidobenzaldehyde 4-methylthiosemicarbazonato)-(2,2'-
bipyridine)zinc(II) trihydrate, [Zn(bipy)(HM)]. 3H2O (6) 
Zinc acetate dihydrate (0.22 g, 1 mmol) and 2,2'-bipyridine (0.16 g, 1 mmol) were heated in 
ethanol (20 ml) for 1 hour followed by addition of 2,4-dihydroxybenzaldehyde 4-
methylthiosemicarbazone, H3M (0.23 g, 1 mmol) in hot ethanol (20 ml) and the mixture 
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was refluxed for another 3 hours. The yellow complex that formed was filtered, washed 
with cold methanol and ether, dried in air and kept in a desiccator over silica gel.  
(Yield: 0.40 g, 80%). Anal. Calc. for C19H23N5O5SZn: C, 45.74; H, 4.65; N, 14.04. Found: 
C, 4.53; H, 4.21; N, 13.59%. IR (KBr disc, cm-1): 3378 m (broad), 3236 m, 3075 w, 1602 s, 
1441 m, 1405 m, 1332 m, 1273 m, 1220 m, 1175 m, 849 w m, 765 m, 652 w 551 w, 450 w 
(s, strong; m, medium ; w, weak). 
Characteristic 1H-NMR signals (DMSO-d6, TMS, p.p.m.): 8.54 (s, 2H, bipy), 8.45 (d, 2H, 
bipy, J = 8 Hz), 8.27 (s, 1H, CH=N), 8.05 (s, broad, 2H, bipy), 7.57 (s, broad, 2H, bipy), 
6.94 (d, 1H, aromatic, J = 4 Hz), 6.40 (s, broad, 1H, -NH-CH3), 6.27 (s, broad, 1H, 
aromatic), 6.01 (s, broad, 1H, aromatic), 2.71 (s, 3H, NCH3) 
 
2.2.3.7 Synthesis of (4-Hydroxy-2-oxidobenzaldehyde 4-ethylthiosemicarbazonato)-(2,2'-
bipyridine)zinc(II) trihydrate, [Zn(bipy)(HE)].3H2O (7) 
Zinc acetate dihydrate (0.22 g, 1 mmol) and 2,2'-bipyridine (0.16 g, 1 mmol) were heated in 
ethanol (20 ml) for 1 hour followed by addition of 2,4-dihydroxybenzaldehyde 4-
ethylthiosemicarbazone, H3E (0.24 g, 1 mmol) in hot ethanol (20 ml) and the mixture was 
refluxed for another 3 hours. The yellow complex that formed was filtered, washed with 
cold methanol and ether, dried in air and kept in a desiccator over silica gel. 
(Yield: 0.38 g, 75 %). Anal. Calc. for C20H25N5O5SZn: C, 46.83; H, 4.91; N, 13.65. Found: 
C, 47.09; H, 4.42; N, 13.30%. IR (KBr disc, cm-1):  3400 m, 3221 m, 3064 w, 2974 m, 
1603 s, 1442 m, 1336 m, 1268 m, 1227 m, 1172 m, 853 m, 799 m, 762 m, 591 m, 420 w,(s, 
strong; m, medium ; w, weak). 
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Characteristic 1H-NMR signals (DMSO-d6, TMS, p.p.m.): 8.61(d, 2H, bipy, J = 4 Hz ), 
8.45 (d, 2H, bipy, J = 8 Hz), 8.22 (s, 1H, CH=N), 8.01 (s, broad, 2H, bipy), 7.51 (s, broad, 
2H, bipy), 6.94 (d, 1H, aromatic, J = 4 Hz), 6.30 (s, broad, 1H, aromatic), 6.25 (t, 1H, -NH-
CH2CH3), 6.01 (s, broad, 1H, aromatic), 3.21 (m, 2H, -NHC-H2CH3, J = 4 Hz), 1.01 (t, 3H, 
-NHCH2C-H3, J = 4 Hz) 
 
2.2.3.8 Synthesis of (4-Hydroxy-2-oxidobenzaldehyde 4-phenylthiosemicarbazonato)-(2,2'-
bipyridine)zinc(II) dihydrate, [Zn(bipy)(HP)].2 H2O (8) 
Zinc acetate dihydrate (0.22 g, 1 mmol) and 2,2'-bipyridine (0.16 g, 1 mmol) were heated in 
ethanol (20 ml) for 1 hour followed by addition of 2,4-dihydroxybenzaldehyde 4-
phenylthiosemicarbazone, H3P (0.29 g, 1 mmol) in hot ethanol (20 ml), and the mixture 
was refluxed for another 3 hours. The yellow complex that formed was filtered, washed 
with cold methanol and ether, dried in air and kept in a desiccator over silica gel. 
(Yield: 0.44 g, 81 %). Anal. Calc. for C24H23N5O4SZn: C, 53.09; H, 4.27; N, 12.90. Found: 
C, 53.54; H, 4.31; N, 12.55%. IR (KBr disc, cm-1): 3620 w, 3327 m, 3109 w, 3070 w, 1598 
m, 1484 s, 1429 m, 1313 m, 1217 m. 1172 m, 846 m, 755 m, 588 w, 568 w, 508 w, 450 w 
(s, strong; m, medium ; w, weak). 
Characteristic 1H-NMR signals (DMSO-d6, TMS, p.p.m.): 9.61 (s, broad, 1 H, OH), 8.64 
(d, 2H, bipy, J = 4 Hz ), 8.41 (d, 2H, bipy, J = 8 Hz), 7.96 (t, 2H, bipy, J = 8 Hz), 7.76 (d, 
2H, bipy, J = 8 Hz), 7.47 (t, 2H, aromatic, J = 4 Hz), 7.15 (t, 2H, aromatic, J = 8 Hz), 7.01 
(s, broad, 1H, aromatic), 6.79 (t, 1H, aromatic, J = 4 Hz), 6.38 (s, broad, 1H, aromatic), 
5.92 (s, broad, 1H, aromatic) 
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2.2.4 X-ray crystallography 
Yellow crystal of compound 2 and compound 3 were grown from slow evaporation from 
their ethanolic solutions. While yellow crystals for complex 5 and green crystal for 
complex 8 were recrystallised from dimethylsulphoxide (DMSO) and dimethylformamide 
(DMF), respectively. The unit cell parameters and the intensity data were collected on a 
Bruker SMART APEX CCD diffractometer, equipped with a Mo Kα X-ray source 
(λ=0.71073 Å). The APEX2 software was used for data acquisition and the SAINT 
software for cell refinement and data reduction (Bruker, 2007). Absorption corrections on 
the data were made using SADABS (Sheldrick, 1996). The structures were solved and 
refined by SHELXL97 (Sheldrick, 2008). Molecular graphics were drawn by using XSEED 
(Barbour, 2001). Material for publication was prepared using publCIF (Westrip, 2009). The 
structures were solved by direct-methods and refined by a full-matrix least-squares 
procedure on F2 with anisotropic displacement parameters for non-hydrogen atoms. 
Carbon-bound H-atoms for compound 2, were placed in calculated positions (C—H 0.95 to 
0.98 Å) and were included in the refinement in the riding model approximation, with 
Uiso>(H) set to 1.2-1.5 Ueq(C). Whereas, the hydroxy and amino H-atoms were located in 
a difference Fourier map, and were refined with distance restraints of O–H = 0.84.01 and 
N–H = 0.88.01 Å; their temperature factors were freely refined. Hydrogen atoms for 
compounds 3, 5 and 8 were placed in their calculated positions and refined using a riding 
model.  
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2.2.5 DNA binding 
PAGE grade self-complimentary 12-mer oligonucleotides (CG)6, (AT)6, 
(CGCGAATTCGCG), (CGCGATATCGCG), HPLC grade human telomeric sequence  22-
mer oligonucleotide 5’-AGGGTTAGGGTTAGGGTTAGGG-3’, and 17-mer 
complementary oligonucleotides 5’-CCAGTTCGTAGTAACCC-3, 3’-
GGTCAAGCATCATTGGG-5’ were annealed to give the respective duplex or quadruplex, 
as speciﬁed by the supplier, 1st BASE and Eurogentec Ait. The circular dichroism spectra 
were obtained by scanning Tris-NaCl buffered solutions of the DNA without and with the 
complexes. 
 
2.2.6 Nucleolytic study 
Agarose gel electrophoresis experiments were carried out on supercoiled plasmid DNA 
pBR322 (4.4 kb) using a horizontal gel system. For the cleavage studies, each 20 µL 
sample consisted of the zinc(II) complex (5 mM) dissolved in DMF, DNA, and the required 
volume of additional buffer. All samples were incubated in the dark in an oven incubator at 
a temperature of 37 oC. The reaction mixtures (20 uL) were prepared as follows: 
compounds or salt with different concentration were added to a standard mixture of 0.5 µl 
of supercoiled plasmid DNA pBR322 (0.25 µg/µl) and Tris-NaCl buffer pH 7.5. The 
reactions were performed after incubating the reaction mixture at 37 °C for 2 or 24 hours. 3 
µl of 6x loading buffer was added to 20 µl of the reaction mixtures and electrophoresis was 
performed at 80 V for 90 minutes in Tris-acetate-EDTA (TAE) buffer, pH 8.1, using 1.5 % 
agarose gel. After electrophoresis, the agarose gel was stained with ethidium  bromide 
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solution (0.5 µg/ml). For the oxidative or reductive cleavage studies, incubation of the 
samples were similarly carried out in the presence of H2O2 or sodium  ascorbate. The DNA 
cleavage profile was analyzed using 1.5% agarose gel in a horizontal gel tank set with a 
running time of 2 hours, at a constant voltage of 80 V. Each reaction mixture consisted of 
0.5 μg/μl DNA and Tris-NaCl buffer pH 7.5 unless otherwise mentioned. The resultant 
DNA bands after the electrophoresis step for each set of experiments were stained with 
ethidium  bromide before being photographed under UV light using a Syngene Bio Imaging 
system and the digital image was viewed with Gene Flash software. 
  
2.2.7 Human Topoisomerase I inhibtion assay 
The human DNA topoisomerase I inhibitory activity was determined by measuring the 
relaxation of supercoiled plasmid DNA pBR322. A positive result is indicated by the 
reduction of the nicked band (containing nicked and fully relaxed DNA) (Form II) and 
formation of various faster moving bands of topoisomers with different degree of relaxation 
as compared to the Topoisomerase I with DNA control. For measurement of human 
topoisomerase I activity, the reaction mixture was comprised of 10 mM Tris-HCl, pH 7.5, 
100 Mm NaCl, 1mM phenylmethylsulfonyl fluoride (PMSF), α-toluenesulfonyl fluoride, 
and 1 mM 2-mercaptoethanol, 0.25 μg plasmid DNA pBR322, 1 unit of human DNA 
topoisomerase I, and metal complex with final concentration of 40 µM . All reactions were 
conducted at a final volume of 20 μl and were prepared on ice. Upon enzyme addition, 
reaction mixtures were incubated at 37oC for 30 minutes. The reactions were terminated by 
the addition of 2 μl of 10% sodium  dodecyl sulphate (SDS) and then followed by 3 μl of 
dye solution comprising 0.02% bromophenol blue and 50% glycerol. SDS is required to 
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observe a linear DNA fragment and to denature topoisomerase I, preventing further 
functional enzymatic activity, and thus DNA is prevented from being relegated by 
topoisomerase. The mixtures were applied to 1.2% agarose gel and electrophoresed for 5 
hours at 33 V with running buffer of Tris-acetate EDTA (TAE) at pH 8.1. The gel was 
stained, destained, and photographed under UV light using a Syngene Bio Imaging system 
and the digital image was viewed with Gene Flash software.  
 
 In the Human DNA topoisomerase I inhibition condition study, the same protocol 
was applied. This study is designed to investigate the effect of the metal complex on 
topoisomerase I and DNA, and to do a preliminary study on the mode of action of metal 
complex in the Human DNA topoisomerase I inhibition study. The sequence of addition of 
the main components (human DNA topoisomerase I, plasmid DNA pBR322, and metal 
complex) was varied. Two conditions were studied in this assay. For the first condition, 
human DNA topoisomerase I with the metal complex was incubated at 37 oC for 30 
minutes before the addition of DNA. This mixture was incubated for another 30 minutes at 
the same temperature after the addition of DNA. As for the second condition, the metal 
complex and DNA was incubated for 30 minutes at 37 oC first, and then followed by the 
addition of topoisomerase I. This mixture was incubated for another 30 minutes at 37 oC 
after the addition of topoisomerase I.  
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2.2.8 Antibacterial and antifungal assay 
The antibacterial and antifungal activities of the ligands and complexes were assessed 
against several strains of Gram-positive bacteria, Gram-negative bacteria and fungi. A 
colorimetric broth microdilution method using p-iodonitrotetrazolium violet (INT) as the 
growth indicator was employed to quantify the minimum inhibitory concentration (MIC) 
value of the complexes in the antibacterial and antifungal assay. The test was performed as 
serial two fold dilutions on sterile, 96 well u-bottom plate. The complexes were tested with 
concentration range of 0.49 to 250 µg/ml. The complexes (1000 µg) are dissolved in 1 ml 
80% DMF because at this concentration, DMF does not show inhibition towards the 
microorganisms tested. 
 
The inocula were each diluted in broth to a final concentration of 5 x 105 CFU/ml 
where CFU stands for colony forming unit. In the antibacterial assay, bacteria that were 24 
hours old were prepared to match the turbidity of a McFarland standard corresponding to (1 
x 108 CFU/ml) at 625 nm. The inocula were each diluted in broth to a final concentration of 
5 x 105CFU/ml. Mueller Hilton Broth was used as the broth medium. The concentrations of 
the antibacterial drug Chloramphenicol, which was as the positive control was between 
0.25 to 128 µg/ml. In the antifungal assay, 24 hour old candida species and 48 hour old c. 
neoformans and a. niger were prepared to match the turbidity of a McFarland standard 
corresponding to (1 x 106 CFU/ml) at 530 nm. The inocula of candida species were each 
diluted in broth to a final concentration of 0.5-2.5 x 103 CFU/ml, c. neoformans at 0.5-2.5 x 
104 CFU/ml and a. niger at 0.5-2.5 x 105 CFU/ml. RPMI - 1640 with L-glutamine, without 
bicarbonate and buffered at pH 7 with 3-(N-morpholino) propanesulfonic acid was used as 
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the broth medium. The concentrations of the antifungal drug fluconazole (positive control) 
were between 0.63 to 32 µg/ml. After incubation for 24 hours for bacteria and candida 
species and 48 hours for c. neoformans and a. niger, the MIC in µg/ml was defined as the 
lowest concentration of solvent in which there was no microbial growth, evidenced by no 
color change. 
 
2.3. Results and discussion 
2.3.1 Synthesis of ligands and complexes 
Proposed structures for all the compounds with IUPAC numbering scheme are shown in 
Fig. 2.1.  The stoichiometries, colors and partial elemental analyses of the ligands and 
complexes are shown in Table 2.1. Results from partial elemental analyses are in good 
agreement with the proposed formulation of Zn(bipy)L where bipy = 2,2'-bipyridine and L 
is the doubly deprotonated thiosemicarbazones. Complexes 6 and 7 contain three hydrated 
water molecules while complex 8 exist as a dihydrate. All the complexes are yellow in 
appearance except 8, which is green. Ligands 1-4 are prepared in high yield from the 
condensation of 2,4-dihydroxybenzaldehyde and the various thiosemicarbazides in 
refluxing ethanol while the complexes are prepared in high yield by refluxing zinc acetate 
dihydrate, 2,2’-bipyridine and the thiosemicarbazones in ethanol. Spectroscopic and 
crystallographic data show that all the free ligands exist in the thione tautomer form in both 
solid and solution. However, all the complexes were isolated with the ligands coordinating 
in the thiolate form. This implies that the presence of acetate in the reaction mixture 
facilitate the formation of the ligand in the thiolate form by deprotonating the thiol proton. 
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Once the ligand was deprotonated and coordinated to the metal in the thiolate form, it 
cannot tautomerize back to the thione form. In the absence of acetate, reaction of similar 
ligands with zinc chloride has led to formation of a dinuclear complex with the 
thiosemicarbazone moiety coordinating in the thione form (Tan et al. 2009).  
 
 
HO OH
N1
N2
C3
S
N4
R
HH
 
1     R = H 2 R = -CH3 3 R = -C2H5 4 R = -C6H5 
 
5 R = H 6 R = -CH3 7 R = -C2H5 8 R = -C6H5 
Fig. 2.1 Proposed structures for all the compounds 
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Table 2.1 
Stoichiometries, color and partial elemental analyses of the ligands and zinc(II) complexes 
Compound Stoichiometries Color Anal. Calc. (Found )%  
   C H N 
H3T (1) C8H9N3O2S Pale yellow 45.49 (45.98) 4.29 (3.94) 19.89 (20.01) 
H3M (2) C9H11N3O2S Pale yellow 47.99 (48.88) 4.92 (5.21) 18.65 (18.98) 
H3E (3) C10H13N3O2S Pale yellow 50.19 (50.32) 5.48 (5.28) 17.65 (17.78) 
H3P (4) C14H13N3O2S 
Yellow 
green 
58.52 (58.38) 4.56 (4.26) 14.62 (14.29) 
[Zn(bipy)(HT)] (5) C18H15N5O2SZn Yellow 50.18 (50.43) 3.51 (3.26) 16.26 (16.54) 
[Zn(bipy)(HM)].3H2O (6) C19H23N5O5SZn Yellow 45.74 (45.53) 4.65 (4.21) 14.04 (13.59) 
[Zn(bipy)(HE)].3H2O (7) C20H25N5O5SZn Yellow 46.83 (47.09) 4.91 (4.42) 13.65 (13.30) 
[Zn(bipy)(HP)].2H2O (8) C24H23N5O4SZn 
Yellow 
green 
53.09 (53.54) 4.27 (4.31) 12.90 (12.55) 
 
Complexes 6 and 7 are soluble in methanol, DMF and DMSO. While complexes 5 and 8 
are insoluble in common polar and non-polar solvents but are soluble in DMF and DMSO. 
None of the complexes are sufficiently soluble in DMSO for acquisition of 13C NMR 
spectra. The compounds synthesized were subjected to biological tests before 
recrystallization. Therefore, the absolute structure of the compounds in solution, used for 
biological tests, may not be exactly identical compared to those determined 
crystallographically. The numbers and type of solvent molecules in the crystal packing may 
affect the absolute structure in the solid state. 
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2.3.2 Crystal structure analysis 
2.3.2.1 Crystal structure of H3M (2) 
Ligand 2 crystallised into a monoclinic lattice with space group symmetry Cc. The 
perspective view of the compound with numbering scheme is shown in Fig. 2.2.  
 
Fig. 2.2 Thermal ellipsoid (Barbour, 2001) plot of 2 drawn at the 70% probability level. 
Hydrogen atoms are drawn as spheres of arbitrary radii. 
 
Selected bond lengths and angles are presented in Table 2.3.  Compound 2 adopts an E 
configuration about the C=N bond. The N1-C7 bond length of 1.283 (4) Å is characteristic 
of azomethine linkage in Schiff base. The N2-C8 bond length of 1.354 (4) Å and C8-S1 
bond length of 1.699 (3) Å indicates that the ligand exists in the thione tautomer form. 
Formation of thiol tautomer is indicated by decrease in N2-C8 bond length and increase of 
C8-S1 bond length due to the gain and loss in double bond character accompanying 
tautomerization (Fig 2.3). 
 
Fig. 2.3 Thione-thiol tautomerization for the ligands 
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Hydrogen bonding interactions for compound 2 is shown in Fig. 2.4 while hydrogen 
bonding parameters are shown in Table 2.4. Each molecule is connected to four adjacent 
molecules through hydrogen bonds. The essentially planar ligand is stabilized by O1—
H1O---N1 intramolecular hydrogen bond. The molecule is linked to adjacent molecules by 
O2—H2O···S hydrogen bonds to form a zigzag chain as shown in Fig. 2.5.   
 
Fig. 2.4 Hydrogen bond interactions for compound 2 
 
Fig. 2.5 Intermolecular O2—H2O···S hydrogen bonds for compound 2 
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 These adjacent chains are consolidated by N2—H2N···O1 hydrogen bonds into a two 
dimensional array intermolecular hydrogen bonding contacts as shown in Fig. 2.6.  
 
Fig. 2.6 Intermolecular N2—H2N···O1 hydrogen bonds for compound 2 
Packing diagram for compound 2 is shown in Fig. 2.7. The packing of molecules in the unit 
cell is stabilised by hydrogen bonding interactions. 
 
Fig. 2.7 Unit cell packing diagram of 2 along c axis.  
a 
b 
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Table 2.2 
Crystal data and structure refinement parameters for compounds 2, 3, 5 and 8. 
Compound H3M (2) H3E (3) [Zn(bipy)(HT)] (5) [Zn(bipy)(HP).2H2O 
(8) 
Empirical formula  C9H11N3O2S C10H13N3O2S C18H15N5O2 S Zn C24H23N5O4 S Zn 
Formula weight   225.27  239.29  430.78 542.90 
Crystal system  Monoclinic Monoclinic Monoclinic Orthorhombic 
Space group  Cc         P21/n P21/c Pbca 
Unit cell dimensions     
a (Å) 18.0046 (6)  4.6592 (6)  16.1256 (4)  17.9569 (9)  
b (Å)  4.64360 (10)  24.067 (3)   7.0478 (2)  12.9769 (7)  
c (Å) 12.2842 (4)  10.0466 (13)   17.6387 (5)   20.4834 (11)  
β (°) 106.695 (2) 99.060 (2) 113.646 (2) 90 
Volume, V (Å3) 983.74 (5)  1112.5 (2)   1836.33 (9) 4773.1 (4) 
Z   4 4  4  8 
F(0 0 0)  472  504  880 2240 
Density (calculated), (mg m−3) 1.521  1.429   1.558 1.511 
Absorption coefficient, µ 
(mm−1) 0.31  0.28  1.48  1.16  
Temperature, T (K) 100 (2)  100 (2)  100(2) 100 (2)  
Crystal size (mm) 0.09 × 0.06 × 0.03 0.40× 0.12 × 0.06 0.10 × 0.04 × 0.02 0.35 × 0.25 × 0.15 
Reflections collected  4390 6303 15773 25918 
Independent reflections  2128  
[R(int) = 0.034] 
2517 
[R(int)= 0.028] 
4191 
[R(int) = 0.086] 
5481 
[R(int) = 0.029] 
Data/restraints/parameters  2128/6/153 2517/0/148 4191/24/245 5481/20/350 
R[F2 > 2σ(F2)] 0.038  0.039 0.062 0.028 
wR(F2) 0.109  0.109 0.195 0.076 
S  1.11 1.08 1.04 1.03 
Largest difference  
peak and hole (e Å−3) 
0.31 and -0.22  0.38 and -0.25 0.88 and -0.96 0.34 and -0.33 
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Table 2.3 
Selected bond lengths (Å) and angles (˚) for H3M (2) 
Bond lengths   Bond angles  
S1—C8 1.699 (3) O1—C2—C3 117.7 (3) 
O1—C2 1.367 (4) O1—C2—C1 121.6 (3) 
O1—H1O 0.838 (10) O2—C4—C3 117.9 (3) 
O2—C4 1.360 (4) O2—C4—C5 121.6 (3) 
O2—H2O 0.836 (10) N1—C7—C1 123.2 (3) 
N1—C7 1.283 (4) N3—C8—N2 118.3 (3) 
N1—N2 1.392 (3) N3—C8—S1 123.4 (2) 
N2—C8 1.354 (4) N2—C8—S1 118.3 (2) 
N2—H2N 0.871 (10)   
N3—C8 1.328 (4)   
N3—C9 1.451 (4)   
N3—H3N 0.880 (10)   
 
 
Table 2.4 
Hydrogen-bond geometry (Å, °) for H3M (2) 
D—H···A D—H H···A D···A D—H···A 
O1—H1O···N1 0.840 (10) 1.93 (3) 2.694 (3) 151 (6) 
O2—H2O···S1i 0.840 (10) 2.540 (10) 3.365 (2) 170 (4) 
N2—H2N···O1ii 0.870 (10) 2.110 (10) 2.950 (4) 162 (3) 
Symmetry codes: (i) x+1/2, −y−1/2, z+1/2; (ii) x, −y, z−1/2. 
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2.3.2.2 Crystal structures of H3E (3) 
Ligand 3 crystallised into a monoclinic lattice with space group symmetry P21/n. 
The perspective view of the compound with numbering scheme is shown in Fig. 2.8. 
Selected bond lengths and angles are presented in Table 2.5. 
 
Fig. 2.8 Thermal ellipsoid (Barbour, 2001) plot of 3 drawn at the 70% probability level. 
Hydrogen atoms are drawn as spheres of arbitrary radii. 
 
As for ligand 2, ligand 3 similarly adopts an E configuration about the C=N bond (C4-N3). 
The essentially planar ligand is stabilized by O1—H1O---N3 intramolecular hydrogen bond. 
The N3-C4 bond length of 1.291 (2) Å is characteristic of azomethine linkage in Schiff 
base. The N2-C3 bond length of 1.357 (2) Å and C3-S1 bond length of 1.6826 (19) Å 
indicates that the ligand exist in the thione tautomer form similar to compound 2.  
 
Hydrogen bonding interactions for compound 3 is shown in Fig. 2.9 and hydrogen 
bonding parameters are shown in Table 2.6. Adjacent molecules are linked by O2—
H2···O1 hydrogen bonds to furnish a zigzag chain as shown in Figs. 2.9 and 2.10. The 
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assembly of the molecules in the unit cell is stabilised by hydrogen bonding as shown in 
Fig. 2.10. 
 
 
Fig. 2.9 Hydrogen bonding interactions for compound 3 
 
Fig. 2.10 Unit cell packing diagram of 3 along c axis.  
a 
b 
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Table 2.5 
Selected bond lengths (Å) and angles (˚) for H3E (3) 
Bond lengths   Bond angles  
S1—C3 1.6826 (19) N1—C3—N2 116.86 (17) 
O1—C6 1.367 (2) N1—C3—S1 123.11 (14) 
O2—C8 1.355 (2) N2—C3—S1 120.03 (14) 
N1—C3 1.333 (2) N3—C4—C5 120.45 (16) 
N1—C2 1.458 (2) O1—C6—C7 117.76 (17) 
N2—C3 1.357 (2) O1—C6—C5 120.57 (17) 
N2—N3 1.374 (2) O2—C8—C7 116.98 (17) 
N3—C4 1.291 (2) O2—C8—C9 123.01 (17) 
 
Table 2.6 
Hydrogen-bond geometry (Å, °) for H3E (3) 
D—H···A D—H H···A D···A D—H···A 
O1—H1···N3 0.84 1.84 2.583 (2) 147 
O2—H2···O1i 0.84 1.92 2.7139 (18) 158 
Symmetry codes: (i) x−1/2, −y+1/2, z+1/2. Hydrogen atoms are placed at calculated 
positions. 
 
2.3.2.3 Crystal structures of [Zn(bipy)(HT)](5) 
Complex 5 crystallised into a monoclinic lattice with space group symmetry P21/c. The 
perspective view of the complex with numbering scheme is shown in Fig. 2.11. Selected 
bond lengths and angles are presented in Table 2.7. 
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Fig. 2.11 Thermal ellipsoid (Barbour, 2001) plot of 5 drawn at the 70% probability level. 
Hydrogen atoms are drawn as spheres of arbitrary radii. 
 
The complex 5 is mononuclear and five-coordinated with the doubly deprotonated 
thiosemicarbazone as a tridentate ligand coordinating through one phenolic oxygen, 
azomethine nitrogen and thiolate sulfur while the 2,2'-bipyridine is coordinated as the N,N’-
bidentate ligand. A five coordinated complex can adopt either square pyramidal or trigonal 
bipyramidal geometry and are known to interconvert through a process known as pseudo-
Berry rotation. However, five coordinated complexes are also known to adopt intermediate 
coordination geometry between square pyramidal or trigonal bipyramidal. Therefore to 
effectively illustrate the distortion from ideal coordination geometry, the index of 
trigonality were proposed by Addison et al. in 1984. In a five-coordinate system, the index 
of trigonality is defined by the angular structural parameter (τ). The value of τ is calculated 
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by the formula τ = (β−α)/60, where β(the greatest basal angle) = N1—Zn1—N6 = 
175.77 (18)˚ and α(the second greatest angle) = O1—Zn1—S1 = 146.44(12)˚ . The values 
of τ are zero and unity for perfect square pyramidal and trigonal bipyramidal geometries 
respectively. Since distortion from ideal geometry can be distorted square pyramidal, 
distorted trigonal bipyramidal or intermediate between the two, we classified a complex 
with τ < 0.33 as having distorted square pyramidal geometry. In this thesis, a complex with 
τ value between 0.33 and 0.66 is described as trigonal bipyramidal distorted square based 
pyramid (TBDSBP) whereas complex with τ > 0.66 is assigned with distorted trigonal 
bipyramidal geometry. The trigonality index τ of 0.49 for 5 indicates that the coordination 
geometry around zinc is intermediate between trigonal bipyramidal and square pyramidal 
geometries and is better described as trigonal bipyramidal distorted square based pyramid 
(TBDSBP). 
 
The deviation from an ideal stereochemistry may due to the restricted bite angle 
imposed by both the thiosemicarbazone and bipy ligands (Seena and Kurup, 2008). The 
bite angle around the metal for N,N’-heterocycle of 77.46(19)˚ may be considered normal 
when compared with an average value of 77˚ reported  in the literature for zinc complexes 
with 2,2'-bipyridine (Chang and Janiak, 2001; Seena and Kurup, 2008). Zn –Nazomethine bond 
length of 2.045(5) Å is shorter than the Zn-Nbipy bond length of 2.109(5) and 2.112(5) Å. 
This indicates that the azomethine nitrogen is coordinated more strongly to zinc compared 
to the bipyridine nitrogen and the thiosemicarbazone moiety dominates equatorial bonding. 
The Zn–Nbipy bond lengths are similar to those reported for mononuclear zinc(II) 
complexes (Chang and Janiak, 2001; Seena and Kurup, 2008). The imine bond formation is 
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evidenced from N1-C7 and N2-C8 distances of 1.306(7) Å and 1.310(7)Å.  The C-N bond 
length of 1.306(7) Å and C-S bond length of 1.746(6) is similar to those reported for 
coordination of thiosemicarbazone in the thiolate form (Seena and Kurup, 2008; Demirci, 
2008).  
 
Hydrogen bonding interactions for complex 5 is shown in Fig. 2.12 and hydrogen 
bonding parameters are shown in Table 2.8.  
 
Fig. 2.12 Simplified hydrogen bonding interactions for complex 5. Bipyridine carbons have 
been omitted for clarity. 
 
Each mononuclear molecule is linked to four adjacent molecules through N-H---N and O-
H---O hydrogen bonds to form a 2-dimensional layer structure.  The packing of the 
molecules are stabilized by hydrogen bonding as shown in Fig. 2.13. No obvious π-π 
interactions were observed in the crystal packing. 
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Fig. 2.13 Unit cell packing diagram of complex 5 along c axis.  
 
 
 
 
b 
a 
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Table 2.7 
Selected bond lengths (Å) and angles (˚) for [Zn(bipy)(HT)](5) 
Bond lengths   Bond angles  
Zn1—O1 1.983 (4) O1—Zn1—N1 90.29 (16) 
Zn1—N1 2.045 (5) O1—Zn1—N4 102.37 (18) 
Zn1—N4 2.109 (5) N1—Zn1—N4 100.70 (19) 
Zn1—N5 2.112 (5) O1—Zn1—N5 93.82 (16) 
Zn1—S1 2.3911 (15) N1—Zn1—N5 175.77 (18) 
S1—C8 1.746 (6) N4—Zn1—N5 77.46 (19) 
O1—C1 1.329 (7) O1—Zn1—S1 146.42 (12) 
N1—C7 1.306 (7) N1—Zn1—S1 81.14 (13) 
N1—N2 1.403 (6) N4—Zn1—S1 111.10 (15) 
N2—C8 1.310 (7) N5—Zn1—S1 95.92 (13) 
N3—C8 1.355 (7) C8—S1—Zn1 92.73 (19) 
N4—C9 1.338 (8) C1—O1—Zn1 128.1 (3) 
N4—C13 1.346 (8)   
N5—C18 1.333 (7)   
N5—C14 1.340 (7)   
    
Table 2.8 
Hydrogen-bond geometry (Å, °) for [Zn(bipy)(HT)](5) 
D—H···A D—H H···A D···A D—H···A 
O2—H2···O1i 0.84 1.85 2.625 (5) 153 
N3—H32···N2ii 0.88 2.15 2.936 (7) 148 
Symmetry codes: (i) − x, y−1/2, − z+3/2; (ii) − x+1, y+1/2, − z+3/2. Hydrogen atoms are 
placed at calculated positions. 
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2.3.2.4 Crystal structures of [Zn(bipy)(HP)].2H2O (8) 
Complex 8 crystallized into a orthorhombic lattice with space group symmetry Pbca. The 
perspective view of the complex with numbering scheme is shown in Fig. 2.14. Selected 
bond lengths and angles are presented in Table 2.9.  
 
Fig. 2.14 Thermal ellipsoid (Barbour, 2001) plot of 8 drawn at the 70% probability level. 
Hydrogen atoms are drawn as spheres of arbitrary radii. 
 
The complex is mononuclear and five coordinated with the doubly deprotonated 
thiosemicarbazone as a tridentate ligand coordinating through the phenolic oxygen, 
azomethine nitrogen and thiolate sulfur while 2,2’-bipyridine as the N,N’-bidentate ligand. 
The trigonality index τ of 0.57 for 8 indicates that the coordination geometry around zinc is 
intermediate between trigonal bipyramidal and square pyramidal geometries and is better 
described as trigonal bipyramidal distorted square based pyramid (TBDSBP). This value is 
similar to the value reported by Seena and Kurup (2008) for [Zn(bipy)L] where L = 
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salicylaldehyde 4-phenylthiosemicarbazone. Higher distortion from square pyramidal 
geometry is observed for complex 8 in contrast to complex 5 where the N(4) proton is 
unsubstituted. Higher distortion towards trigonal bipyramidal geometry for complex 8 may 
be due to the presence of a bulkier phenyl group at the N(4) position. The repulsion 
between the ligands are reduced in a trigonal bipyramidal geometry in contrast to square 
pyramidal. 
 
The deviation from an ideal stereochemistry may due to the restricted bite angle 
imposed by both the thiosemicarbazone and bipy ligands (Seena and Kurup, 2008). The 
bite angle around the metal for 2,2'-bipyridine of 78.19(6)˚ may be considered larger when 
compared with an average value of 77˚ reported  in the literature for zinc complexes with 
2,2'-bipyridine (Chang and Janiak, 2001; Seena and Kurup, 2008). Zn –Nazomethine bond 
length of 2.0535(14) Å is shorter than the Zn-Nbipy bond lengths of 2.1220(15) and 
2.0954(15) Å. This indicate that the azomethine nitrogen is coordinated more strongly to 
zinc compared to the bipyridine nitrogen and the thiosemicarbazone moiety dominates 
equatorial bonding. The imine bond formation is evidenced from N1-C7 and N2-C9 
distances of 1.290(2) Å and 1.306(2) Å.  The C-N bond length of 1.306(2) Å and C-S bond 
length of 1.7500(17) is similar to those reported for coordination of thiosemicarbazone in 
the thiolate form (Seena and Kurup, 2008; Demirci, 2008).  
 
Hydrogen bonding interactions for complex 8 is shown in Fig. 2.15 and 2.16. 
Hydrogen bonding parameters are shown in Table 2.10.  
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Fig. 2.15 Zig-zag chain formed from N3-H3---O2 hydrogen bonding interactions for 
complex 8 
 
The mononuclear complexes form a zig-zag chain through N3-H3---O2 hydrogen bonding 
as shown in Fig. 2.15 due to the presence of uncoordinated hydroxyl group. The water 
molecules in the crystal lattice play an important role in the crystal packing. In addition to 
the direct intermolecular hydrogen bonding (N3-H3---O2) between the mononuclear 
complexes, water molecules in the crystal lattice help to bridge the adjacent mononuclear 
complexes into a three-dimensional network through a series of complex hydrogen bonding 
interactions (O2—H2···O2w, O1w—H11···O1, O2w—H21···N2i and O2w—H22···O1wii) 
as shown in Fig. 2.16. These observations underscore the important role played by the 
uncoordinated hydroxyl group in hydrogen bonding interactions which is not observed in 
metal complexes derived from salicyaldehyde N(4)-substituted thiosemicarbazone (Latheef 
et al. 2007 & 2008; Seena and Kurup, 2007 & 2008).  
b 
c 
  
62 
Fig. 2.16 Water molecules (green) bridging the adjacent mononuclear complexes into a 
three-dimensional network through hydrogen bonding. 
 
The packing of the molecules is shown in Fig. 2.17.  The molecules in the crystal 
lattice are stabilized by combination of hydrogen bonding and π-π interactions between 
aromatic rings. The expected offset or slipped stacking interactions were observed because 
of no substantial overlap of aromatic surface area. π stacking becomes favorable with 
increase in ring numbers (Janiak 2000).  
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Fig. 2.17 Unit cell packing diagram of  8 view along b axis. 
 
 
 
 
 
 
 
c 
a 
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Table 2.9 
Selected bond lengths (Å) and angles (˚) for [Zn(bipy)(HP)].2H2O (8) 
Bond lengths  Bond angles  
Zn1—O1 2.0069 (12) O1—Zn1—N1 89.21 (5) 
Zn1—N1 2.0535 (14) O1—Zn1—N5 109.88 (6) 
Zn1—N5 2.0954 (15) N1—Zn1—N5 100.24 (6) 
Zn1—N4 2.1220 (15) O1—Zn1—N4 91.39 (5) 
Zn1—S1 2.3657 (5) N1—Zn1—N4 178.43 (6) 
S1—C9 1.7500 (17) N5—Zn1—N4 78.19 (6) 
O1—C1 1.327 (2) O1—Zn1—S1 144.46 (4) 
O2—C3 1.364 (2) N1—Zn1—S1 82.23 (4) 
N1—C7 1.290 (2) N5—Zn1—S1 105.58 (4) 
N1—N2 1.3951 (19) N4—Zn1—S1 98.10 (4) 
N2—C9 1.306 (2) C9—S1—Zn1 92.65 (6) 
N3—C9 1.367 (2) C1—O1—Zn1 126.12 (10) 
N3—C10 1.408 (2)   
N4—C16 1.332 (3)   
N4—C20 1.350 (3)   
N5—C25 1.338 (3)   
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Table 2.10 
Hydrogen-bond geometry (Å, °) for [Zn(bipy)(HP)].2H2O (8) 
D—H···A D—H H···A D···A D—H···A 
O2—H2···O2w 0.84 (1) 1.84 (1) 2.66 (1) 172 (2) 
O1w—H11···O1 0.84 (1) 1.91 (1) 2.72 (1) 161 (3) 
O2w—H21···N2i 0.84 (1) 2.15 (1) 2.94 (1) 159 (3) 
O2w—H22···O1wii 0.83 (1) 1.88 (2) 2.70 (1) 172 (3) 
N3—H3···O2iii 0.87 (1) 2.19 (1) 3.04 (1) 171 (2) 
Symmetry codes: (i) −x+1, −y+2, −z+1; (ii) −x+1, y+1/2, −z+3/2; (iii) x+1/2, −y+3/2, −z+1. 
 
2.3.3 Infrared and electronic spectra  
Important IR bands for the ligands and complexes are given in Table 2.11. IR spectra for all 
the ligands are shown in Fig. 2.18 while the spectra for the complexes are shown in Fig. 
2.19. 
 
The bands in the region of 3100-3500 cm-1 are quite difficult to assign in 
polyhydroxybenzaldehyde thiosemicarbazones due to the presence of complex inter and 
intra molecular hydrogen bonds between the amino and hydroxyl groups from ligands and 
solvents. Tentative assignments of bands in this region are assigned base on comparison 
with spectra of all the starting material and reference from literature. The bands from 3331-
3478 cm-1 are assigned to ν(O-H) of the free ligands (West et al. 1993). Meanwhile, the 
bands from 3248-3342 cm-1 are assigned to ν(N(4)-H) (Lobana et al. 2008).  
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Fig. 2.18 IR spectra for the ligands 
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Fig. 2.19 IR spectra of all the complexes 
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The bands at around 3127-3174 cm-1 are assigned to ν(N(2)-H) (Latheef et al. 2007; 
Lobana et al. 2008). Thiosemicarbazones are known to exhibit thione-thiol tautomerization 
(Fig 3). The absence of any band around 2600-2800 cm-1 ν(S-H) indicates that in the solid 
form, all the ligands exist in the thione form (Bindu et al. 1999; Afrasiabi et al. 2005).  
 
In contrast to complexes of salicylaldehyde thiosemicarbazone, the bands around 
3380 cm-1 due to ν(O-H) are still seen in the spectra of all the complexes indicating that 
only one of the phenolic oxygen atoms from each thiosemicarbazone ligand is deprotonated 
and involved in coordination. The disappearance of the ν(N(2)-H) band in the spectra of all 
the complexes indicates the deprotonation of the hydrazinic proton which is in accordance 
with coordination of the sulfur atom in the thiolate form (West et al. 1993; Latheef et al. 
2007 & 2008; Seena and Kurup, 2007 & 2008; Lobana et al. 2008). 
 
Coordination of the azomethine nitrogen is confirmed by the shift of ν(C=N) from 
1620-1629 cm-1 to 1598-1604 cm-1. Evidence of coordination of the thiolate sulfur is 
further supported the decrease in frequency of the thioamide band found at around 1323-
1379 cm-1  and 838-868 cm-1 to 1273-1316 and 799-849 respectively as reported by 
Campbell (1975). The bands from 1231-1264 cm-1 due to ν(C-O) decrease by 20-40 cm-1 
upon coordination. This confirms the coordination of the phenolic oxygen to zinc (Latheef 
et al., 2007; Seena and Kurup, 2008). The decrease in frequency of all these bands is due to 
the decrease in electron density upon complexation to metal. The decrease in electron 
density led to the weakening of the bond between carbon and nitrogen or oxygen. 
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The ν(N-N) band of the thiosemicarbazones is found at 1121-1166 cm-1. The 
increase in the frequency of this band upon complexation is due to the increase in the 
double bond character off-setting the loss of electron density via donation to the metal and 
is a confirmation of the coordination of the ligand through the azomethine nitrogen atom 
(Latheef et al. 2007).  The appearance of new ν(Zn-N)  bands in the range of 420-450 cm-1 
confirms the coordination through azomethine and polypyridyl  nitrogens. Coordination 
through phenolic oxygen is confirmed by the presence of a new ν(Zn-O) band in the spectra 
of the complexes at 551-591 cm-1 (Latheef et al. 2007; Seena and Kurup, 2008). The mode 
of coordination for the ligands and complexes determined by IR spectra is in good 
agreement with the crystal structures of complexes 5 and 8. Complexes 5-8 have very 
similar IR spectra (Fig. 2.19), this indicates that they share the similar mode of coordination.  
Since all the ligands have the same ligating atoms and the only variation in the structure of 
these complex is at the N(4)-substituent which is not involved in coordination to zinc, it is 
reasonable to propose that the coordination geometry around zinc for complexes 6 and 7  is 
intermediate between trigonal bipyramidal and square pyramidal geometries and is better 
described as trigonal bipyramidal distorted square based pyramid (TBDSBP). 
 
Electronic spectral assignments for the ligands and their zinc(II) complexes in DMF 
are presented in Table 2.12. All the ligands and the Zn(II) complexes have a ring (phenolic 
and diimine) π-π* band at around 37,593 cm-1 (West et al. 1995). No significant red shift is 
observed for these bands upon complexation (Swearingan and West, 2000). All the free 
thiosemicarbazones also have two bands at around 32,985 cm-1 and 29,411 cm-1 due to n-π* 
transition of azomethine and thioamide function respectively. 
  
70 
 Upon complexation, the n-π* band of the thioamide function is shifted above 
30,000 cm-1 due to thioenolization and merges with the azomethine n-π* band at around 
31,348 cm-1 (Swearingan and West, 2000). Thioenolization causes the weakening of the 
C=S bond attributed to the loss in double bond character. A moderately intense band in the 
range 26,455-27,473 cm-1, found only in the spectra of the complexes, is assigned to 
Zn(II)S metal to ligand charge transfer band (MLCT) (Latheef et al. 2007; Swearingan 
and West, 2000). The MLCT band for Zn(II)O shows line broadening that runs into the 
visible part of the spectrum. However, the maxima of this band is not observed probably 
due to the overlapping with the low energy side of Zn(II)S transitions (Latheef et al. 
2007; Seena and Kurup, 2008). The absence of bands below 22,000 cm-1 due to d-d 
transitions is in accordance with the d10 electron configuration of Zn(II) ion (Latheef et al. 
2007; Seena and Kurup, 2008). 
Table 2.11 
IR spectral assignments for the ligands and their zinc(II) complexes 
Compound ν(C=N) ν(C-O) ν(N-N) ν (C=S)/ 
ν (C-S) ν(Zn-O) ν(Zn-N) 
Bands due to 
bipyridine 
H3T (1) 1620 1239 1165 1379, 863 - - - 
H3M (2) 1625 1231 1166 1331,868 - - - 
H3E (3) 1626 1241 1166 1325, 867 - - - 
H3P (4) 1629 1264 1121 1323,838 - - - 
[Zn(bipy)(HT)] (5) 1604 1219 1175 1315, 842 553 420 1419,  763 
[Zn(bipy)(HM)].3H2O 
(6) 1602 1220 1175 1273, 849 551 450 1441, 765 
[Zn(bipy)(HE)].3H2O (7) 1603 1227 1172 1316, 799 591 421 1442, 762 
[Zn(bipy)(HP)].2H2O (8) 1598 1217 1172 1313, 846 568 450 1429, 755 
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Table 2.12 
Electronic spectral assignments (cm-1) for the ligands and their zinc(II) complexes in DMF . 
Compound π-π* n-π* MLCT 
H3T (1) 37593 33003, 29411  
H3M (2) 37593 33003, 29411  
H3E (3) 37593 32895, 29240  
H3P (4) 37453 32680, 28409  
[Zn(bipy)(HT)] (5) 37736 31250 27473 
[Zn(bipy)(HM)].3H2O (6) 37736 31447 27027 
[Zn(bipy)(HE)].3H2O (7) 37736 31348 27248 
[Zn(bipy)(HP)].2H2O (8) 37593 31152 26455 
 
2.3.4 1H and 13C NMR spectra 
1H NMR spectral assignments for the ligands and their zinc(II) complexes in DMSO are 
presented in Table 2.13. All the thiosemicarbazones ligands have a sharp signal in the 
region of 11.14-11.79 ppm that integrates to one proton which is assigned to N(2)H. The 
downfield position of these protons are due to the presence of inter and intra hydrogen 
bonding interactions. The presence of hydrogen bonds decrease the electron density about 
N(2) protons and hence move the absorption down field (Ackerman et al, 1999).  In the 
spectra of the thiosemicarbazones, the signals for the phenolic protons are found at 9.74-
9.93 ppm ( et al. 2008). These signals are broad and integrate to 2 protons in 
accordance to the presence of two phenolic groups in dihydroxybenzaldehyde 
thiosemicarbazones. Meanwhile, the azomethine protons of all the ligands are found as a 
sharp singlet at 8.20-8.34 ppm due to the absence of any neighboring protons. The absence 
of signals at around 4 ppm, due to the –SH (thiol) group, indicates that all the ligands exist 
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in the thione form. The signal for N(4)H appears in the region of  7.65-8.72 ppm and the 
value is highly dependent on the substituent groups.  Compound 4 has the highest chemical 
shift for the N(4)H signal due to the presence of an electron withdrawing phenyl group. The 
N(4)H signal for other ligands appear slightly upfield due to the presence of electron 
donating  alkyl groups. It is noteworthy that the N(4)H protons for compounds 2 and 3 exist 
as a doublet with a coupling constant J = 4 Hz due to the 3JH-H splitting by the alkyl group 
attached to the N(4) atom. This sort of coupling through a nitrogen bond is seldom seen due 
to N-H exchange or quadrupole broadening (Ackerman et al. 1999).  The aromatic protons 
for all the ligands are found in the region of 6.22-7.82 ppm. The aromatic protons of the 
hydroxyl substituted ring appears slightly upfield because the presence of the hydroxyl 
group decreases the electron density in the aromatic ring leading to the decrease in ring 
current and strength of the induced field. This causes the aromatic protons to be less 
deshielded and absorb at a higher field (McMurry 1999). 
 
The absence of the N(2)H peak in the spectra of all the complexes indicates the 
deprotonation of the hydrazinic proton and supports the coordination of sulfur in the 
thiolate form. The integration for phenolic protons decreases from two to one upon 
complexation suggesting deprotonation of one of the phenolic group and coordination of 
the oxygen atom to zinc. However, the phenolic proton signals for complexes 6 and 7 are 
not observed due to –OH exchange with the solvent. Coordination of the azomethine 
nitrogen is confirmed by the shifting of the -CH=N signal from 8.20-8.34 ppm in the free 
ligands to 8.18-8.27 ppm in the spectra of the complexes. Even though the -CH=N signal 
normally shifts downfield upon complexation, irregularities in this trend is not uncommon 
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(Lobana et al., 2009). The –CH=N and N(4)H signals for complex 8 are resolved due to 
overlapping with the bipyridine protons signals at around 8.64-8.40 ppm. The aromatic 
protons on the dihydroxybenzaldehyde moiety also shifted slightly upfield upon 
coordination due to the decrease in electron density. Unlike aliphatic protons, aromatic 
protons tend to shift upfield with the decrease in electron density because the decrease in 
strength of the induced field, which is proportional to electron density, will cause the 
protons to be less deshielded. The formation of ternary complexes is shown by the presence 
of four signals with different multiplicity in the region of 7.48-8.62 ppm ascribed to the 
coordinated 2,2'-bipyridine ligand. The presence of the bipyridine moiety is also supported 
by elemental analyses, IR spectroscopy and confirmed by the crystal structures of 
complexes 5 and 8. 
 
Table 2.13 
1H NMR spectral assignments for the thiosemicarbazone ligands and their zinc(II) complexes in 
DMSO 
Compound Chemical shifts, δ (ppm) 
 N(2)H OH N(4)H CH=N Aromatic Aliphatic 
H3T (1) 11.14 (s, 1 H) 9.74 (s, 2 H) 7.92 (s, 1 H) 
7.65 (s, 1 H)    
 
8.20 ( s, 1 H) 
 
7.62 (d, 1 H) 
6.25 (s, 1 H) 
6.22 ( d, 1 H) 
- 
H3M (2) 11.79 (s, 1 H) 9.88 (s, 1 H) 
9.74 (s, 1 H) 
8.24 (t, 1 H) 
 
 
8.20 ( s, 1 H) 
 
7.67 (d, 1 H) 
6.26 (s, 1 H) 
6.24 ( d, 1 H) 
2.95 (d, 3 H) 
N-CH3 
H3E (3) 11.16 (s, 1 H) 9.76 (s, 2 H) 
 
8.31 (t, 1 H) 
 
 
8.26 ( s, 1 H) 
 
7.72 (d, 1 H) 
6.32 (s, 1 H) 
6.30 ( d, 1 H) 
3.57 (m, 2H) 
NCH2 
1.14 (t, 3H) 
NCH2CH3 
H3P (4) 11.54 (s, 1 H) 9.93 (s, 1 H) 8.72 (s, 1 H) 8.34 ( s, 1 H) 7.82 (d, 1H) - 
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9.89 (s, 1 H) 
 
 
 
 7.53 (d, 2H) 
7.33 (t, 2H) 
7.16 (t, 1H) 
6.29 (s, 1H) 
6.27 (d, 1H) 
[Zn(bipy)(HT)] (5) - 9.47 (s, 1 H) 
 
6.03 (s, 2 H) 
overlap with 
ar-H 
 
8.18 (s, 1 H) 
 
8.62 (d, 2H) 
8.42 (d, 2H) 
8.00 (d, 2H) 
7.48 (d, 2H) 
6.93 (s, 1H) 
6.30 (s, 1 H) 
6.03 (s, 1 H) 
 
Compound Chemical shifts, δ (ppm) 
 N(2)H OH N(4)H CH=N Aromatic Aliphatic 
[Zn(bipy)(HM)].3H2O 
(6) 
- - 
 
6.41 (s, 1 H) 
 
 
8.27 (s, 1 H) 
 
8.54 (s, 2H) 
8.45 (d, 2H) 
8.05 (d, 2H) 
7.56 (s, 2H) 
6.95 (s, 1H) 
6.27 (s, 1 H) 
6.02 (s, 1 H) 
2.71 (d, 3 H) 
N-CH3 
[Zn(bipy)(HE)].3H2O  
(7) 
- - 
 
6.25 (d, 1 H) 
 
 
8.22 ( s, 1 H) 
 
8.61 (s, 2H) 
8.45 (d, 2H) 
8.01 (d, 2H) 
7.51 (s, 2H) 
6.94 (s, 1H) 
6.30 (s, 1 H) 
6.02 (s, 1 H) 
3.21 (m, 2H) 
NCH2 
1.01 (t, 3H) 
NCH2CH3 
[Zn(bipy)(HP)].2H2O 
(8) 
- 9.61 (s, 1 H) 
 
-overlap 
with bipy 
 
 
-overlap 
with bipy 
 
8.64 (d, 2 H) 
8.41 (d, 2 H) 
7.98 (t, 2 H) 
- 
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7.76 (d, 2 H) 
7.49 (t, 2 H) 
7.15 (t, 2 H) 
7.02 (s, 1 H) 
6.80 (t, 1 H) 
6.38 (d, 1 H) 
5.92 ( s, 1 H) 
Table 2.13 continued. 
 
13C NMR spectral assignments for the thiosemicarbazones in DMSO are presented in Table 
2.14. All ligands show a signal in the region 175.57-177.61 ppm due to C=S. Each ligand 
shows two signals that correspond to C-O are observed in the region of 158.40-161.21 ppm. 
The formation of the Schiff base is confirmed by the presence of the azomethine carbon 
signal (C=N) at around 141 ppm in the spectra of all the ligands. The signals due to 
aromatic carbons are found at 102.81-139.64 ppm. Compound 3 has an additional peak due 
to N-CH3 at 31.28 ppm while compound 4 has two signals at 15.21 and 32.20 due to 
NCH2CH3 and NCH2- respectively. The total numbers of C signals in the spectra of all 
ligands are in agreements with the proposed structures. The values reported are similar to 
those in the literature (Bindu et al. 1998).  None of the complexes were sufficiently soluble 
in DMSO to record acceptable 13C spectra. 
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Table 2.14 
13C spectral assignments for the thiosemicarbazone ligands in DMSO. 
Compound Chemical shifts, δ (ppm) 
 C=S C-O C=N Aromatic Aliphatic 
H3T (1) 177.40 161.03 
158.56 
140.97 128.49, 112.11 
108.26, 102.80 
- 
H3M (2) 177.61 160.87 
158.40 
140.54 128.67, 112.45 
108.19, 102.80 
31.28 (N-CH3). 
H3E (3) 176.34 160.84 
158.40 
140.99 128.88, 112.34 
108.32, 102.81 
32.20 (N-CH2-) 
15.21 (NCH2CH3) 
H3P (4) 175.57   161.21 
158.75 
 
141.73 139.64, 129.25 
126.06, 125.66 
112.23, 108.38 
102.84 
- 
 
2.3.5 DNA binding 
2.3.5.1 Duplex DNA 
The interaction of the complexes with (i) duplex oligonucleotides of various specified 
nucleotide sequences, and (ii) quadruplex DNA of the 23-mer oligonucleotide 5’-
AG3(T2AG3)3-3’ and its corresponding duplex were investigated with CD spectroscopy. CD 
spectroscopy is a technique that is widely used in diagnosing changes in DNA morphology 
during drug–DNA interactions. This is due to the extreme sensitivity of CD in detecting 
changes in the conformations of DNA (Ivanov et al. 1973). In addition, this method is also 
easier, faster and relatively inexpensive compared to X-ray diffraction of crystal and NMR 
spectroscopy (Kypr et al., 2009).  
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The CD spectra of all the duplex oligonucleotides show a negative band at ~250 nm 
due to DNA with right-handed helicity and a positive band at ~275 nm due to base-pair 
stacking interaction, confirming the B-form conformation of these duplexes (Table 2.15). 
These bands are very useful in studying small molecules interaction with DNA because 
simple groove binding and electrostatic interaction of small molecules show less or no 
perturbation on the base-stacking and helicity bands, while intercalation enhances the 
intensities of both bands due to stabilization of the right-handed B conformation of DNA 
(Maheswari and Palaniandavar, 2004). 
 
  The first investigation was to find out the DNA binding preference for CG or AT 
sequences by the zinc complex. Complex 5 at a complex:duplex ratio of 1:8 slightly 
decreases  the positive (6.7%) and negative (7.2%) band of the ds(AT)6 (Fig. 2.20). This 
suggests that binding of the complex causes a change of conformation from B to Z-like, 
similar to those observed in interaction of [Cu(5,6-dmp)2]2+ with calf thymus DNA 
(Mahadevan and Palaniandavar, 1996). Complex 5 does not induce a significant change to 
the positive band (< 2%) in the CD spectrum of the ds(CG)6, suggesting a retention of the 
B-form conformation (Fig. 2.20). This implies that complex 5 can differentiate ds(AT)6 
from ds(CG)6 and induced different conformation change to the duplex DNA upon binding.  
 
 Interestingly, complex 6 with a methyl substituent at N(4) induced the greatest 
decrease (17.1%) in the negative band (helicity) of the CD spectrum  of  ds(CG)6            
(Fig. 2.21)   in contrast to complexes 5, 7 and 8. This indicates that the binding of the 
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complex 6 causes the DNA to unwind more. Complex 6 also induces the same 
conformational change to ds(AT)6 similar to complex 5 (B to Z like). However, the changes 
are less significant when compared to the interaction with ds(CG)6. From the above 
discussion, complex 6 can thus be used to differentiate ds(CG)6 from ds(AT)6 DNA.   The 
ability of complex 6 to show different mode of binding with AT rich and CG rich sequence 
of DNA is quite remarkable. Recently, Shelton et al. (2007) have synthesized a cationic 
porphyrin zinc complex, Zn(tMe2D4) that shows mode of binding that varies with the base 
content of a DNA host. This complex remains five-coordinate and binds externally when it 
encounters AT rich base pair. However, it will lose its axial ligand and binds by 
intercalation if the host only contains CG base pair. Thus, Zn(tMe2D4) is like complex 6, it 
can differentiate DNA with AT rich bases from DNA with only CG bases. 
 
The mode of interaction of 7 (Fig. 2.22) and 8 (Fig. 2.23) differs from complex 5. 
Complexes 7 and 8 cause a slight increase and decrease in intensity of the positive and 
negative bands suggesting partial intercalation of the complexes to ds(AT)6. This type of 
changes in CD has been ascribed to a conformational change from B to ψ, which is similar 
to those observed in [Zn(phen)edda] (Seng et al., 2008) and [Ru(NH3)4qdppz)]2+ 
(Maheswari and Palaniandavar, 2004). No significant changes were observed in the CD 
spectra of ds(CG)6 upon interaction with complex 7. On the other hand, complex 8 induces 
a conformational change from B to ψ for ds(CG)6. It is noteworthy that the N(4) substituent 
in the thiosemicarbazones plays important role in determining the ability of the complexes 
in differentiating the duplex DNA base sequences and the types of structural changes to 
duplex DNA upon drug interaction. 
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Table 2.15 
CD spectral bands of duplex oligo or quadruplex + zinc complex: wavelength, λ  
(molar  ellipcity) 
 λ/nm (molar ellipcity) 
(-) band (+) band 
15 µM ds(AT)6 248 (-419344) 270 (339753) 
15 µM ds(AT)6 + 120 µM complex 5 249 (-387802) 269 (320390) 
15 µM ds(AT)6 + 120 µM complex 6 249 (-392987) 270 (326059) 
15 µM ds(AT)6 + 120 µM complex 7 249 (-401598) 270 (360260) 
15 µM ds(AT)6 + 120 µM complex 8 249 (-374922) 270 (358565) 
15 µM ds(CG)6 252 (-585418) 278 (213799) 
15 µM ds(CG)6 + 120 µM complex 5 257 (-573286) 278 (217725) 
15 µM ds(CG)6 + 120 µM complex 6 253 (-482117) 279 (203453) 
15 µM ds(CG)6 + 120 µM complex 7 252 (-602978) 280 (216090) 
15 µM ds(CG)6 + 120 µM complex 8 253 (-582921) 279 (229141) 
10 µM ds(CGCGAATTCGCG)2 251 (-603665) 279 (215560) 
10 µM ds(CGCGAATTCGCG)2 + 120 
µM complex  5 
252 (-577290) 278 (246140) 
10 µM ds(CGCGAATTCGCG)2 + 120 
µM complex  6 
253 (-558732) 277 (236179) 
10 µM ds(CGCGAATTCGCG)2 + 120 
µM complex  7 
251 (-520213) 278 (242670) 
10 µM ds(CGCGAATTCGCG)2 + 120 
µM complex  8 
251 (-562839) 279 (254099) 
10 µM ds(CGCGATATCGCG)2 248 (-286559) 277 (174875) 
10 µM ds(CGCGATATCGCG)2 + 120 
µM complex  5 
248 (-306538) 277 (192374) 
10 µM ds(CGCGATATCGCG)2 + 120 
µM complex  6 
249 (-258973) 277 (171370) 
10 µM ds(CGCGATATCGCG)2 + 120 
µM complex 7 
249 (-257970) 277 (195999) 
10 µM ds(CGCGATATCGCG)2 + 120 
µM complex  8 
249 (-291739) 277 (212751) 
20 µM G-duplex 250 (-82682) 279 (283975) 
20 µM guanine rich duplex+ 120 µM 
complex 5 
249 (-36849) 279 (142761) 
20 µM guanine rich duplex+ 120 µM 
complex 6 
250 (-113866) 278 (289906) 
20 µM guanine rich duplex+ 120 µM 
complex 7 
250 (-94748) 279 (254455) 
20 µM guanine rich duplex+ 120 µM 
complex 8 
250 (-121369) 279 (319436) 
20 µM G-quadruplex 266 (-116489) 247 (106239)  
296 (180571) 
20 µM G-quadruplex + complex 5 266 (-91462) 247 (121896) 
296 (212408) 
20 µM G-quadruplex + complex 6 264 (-104679) 249 (122276) 
296 (217413) 
20 µM G-quadruplex + complex 7 264 (-116932) 246 (115484) 
296 (213537) 
20 µM G-quadruplex + complex 8 267 (-109694) 246 (123178) 
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296 (192358) 
guanine rich duplex =(5’-CCAGTTCGTAGTAGTAACCC-3’)·(3'-GGTCAAGCATCATCATTGGG-5’)  
Table 2.15 continued. 
 
 
Fig. 2.20 CD spectra of 15 µM  of oligonucleotide in the absence and presence of 120 µM  
of complex 5; (a) ds(AT)6 alone, (b) ds(AT)6 with complex 5, (c) ds(CG)6 alone and (d) 
ds(CG)6 with complex 5. 
 
 
Fig. 2.21 CD spectra of 15 µM  of oligonucleotide in the absence and presence of 120 µM  
of complex 6; (a) ds(AT)6 alone, (b) ds(AT)6 with complex 6, (c) ds(CG)6 alone and (d) 
ds(CG)6 with complex 6 
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Fig. 2.22 CD spectra of 15 µM  of oligonucleotide in the absence and presence of 120 µM  
of complex 7; (a) ds(AT)6 alone, (b) ds(AT)6 with complex 7, (c) ds(CG)6 alone and (d) 
ds(CG)6 with complex 7 
 
 
Fig. 2.23 CD spectra of 15 µM  of oligonucleotide in the absence and presence of 120 µM  
of complex 8; (a) ds(AT)6 alone, (b) ds(AT)6 with complex 8, (c) ds(CG)6 alone and (d) 
ds(CG)6 with complex 8. 
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The pair of oligonucleotides ds(CGCGAATTCGCG)2 and ds(CGCGATATCGCG)2 
were used to investigate any binding preferences in interaction with duplex DNA as the 
central sequence on each chain is varied from non-alternating to alternating purine-
pyrimidine bases in the grooves of the duplex.  For the AATT sequence (Fig. 2.24-2.27), 
complexes 5-8 cause a respective increase and decrease in the positive and negative band of 
the CD spectra of the duplex which suggests partial intercalation of each complex to the 
duplex. This observation also correspond to conformational change from B to ψ, as 
mentioned earlier (Maheswari and Palaniandavar, 2004; Seng et al. 2008).  
 
Unlike binding to DNA, with a central AATT sequence, complexes 5-8 induce a 
wider variety of changes to the conformation of the duplex with ATAT sequence. Complex 
5 for example, causes a slight increase in both the positive and negative bands of the duplex 
indicating intercalation to the duplex base pair (Maheswari and Palaniandavar, 2004). For 
the same DNA with ATAT sequence, only complex 6 causes a decrease in the negative 
band with no significant changes to the positive band. This observation is similar for the 
interaction of complex 6 with ds(CG)6 (Fig. 2.21). This observation has been ascribed to the 
ability of complex 6 to differentiate ds(CG) form ds(AT)6. This may imply that complex 6 
retains its ability in recognizing the CG sequence and bind to the CG sequence in 
ds(CGCGATATCGCG)2 instead of the AT sequence therefore inducing similar 
conformational changes  to the DNA. On the other hand, complex 7 induces a 
conformational change from B to ψ for interaction with ATAT sequence similar to its 
interaction with the AATT sequence.  Complex 8 causes an increase in both the positive 
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and negative bands of the duplex with ATAT sequence suggesting the intercalation of the 
N(4) phenyl group in between the nucleobase pair.  
 
Comparing the CD results of these four ds(oligos)2, we can conclude that complexes  
5-8 can bind to all the duplexes investigated in this study. In the absence of additional 
information such as binding constant attributed to solubility problem of these complexes, it 
is difficult to make conclusions about the selectivity of the complexes towards different 
DNA base sequences. However, the diverse changes in conformation, helicity or base 
stacking of DNA upon interaction with the complexes suggest that some of the complexes 
can differentiate DNA with different base sequences. Since electrostatic interaction is not 
likely because these complexes are neutral, the binding modes most likely involve a 
combination of partial intercalation, hydrogen bonding and groove binding that varies with 
complex and base sequences. Intercalation will result in an increase in the positive band of 
the CD spectra ascribed to base stacking. Changes in the conformation of the DNA that 
resulted in decrease of the positive band in the CD spectra most likely involve hydrogen 
bonding or groove binding. We postulate that the observed DNA recognition is conferred 
by the ability of the complexes to form hydrogen bonds with the DNA through various 
hydrogen donor and acceptor groups on the thiosemicarbazone moiety. The ability of the 
complexes in forming hydrogen bonds can be seen from the crystal structure of the ligands 
and complexes. The N(4)-substituent seems to be responsible in DNA recognition through 
hydrophobic interaction or groove binding because each complex has a substituent with 
different hydrophobicity  and bulkiness (alkyl chain or aromatic ring). The size of the 
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molecules and the orientation of different substituted bulky group in space may affect their 
ability to bind into the groove (major or minor) with different cavity size or steric hindrance. 
 
 
Fig. 2.24 CD spectra of 10 µM  of oligonucleotides in the absence and presence of 120 µM  
of complex 5; (a) ds(CGCGATATCGCG)2 alone, (b) ds(CGCGATATCGCG)2 with 
complex 5, (c) ds(CGCGAATTCGCG)2 alone and (d) ds(CGCGAATTCGCG)2  with 
complex 5. 
 
Fig. 2.25 CD spectra of 10 µM  of oligonucleotides in the absence and presence of 120 µM  
of complex 6; (a) ds(CGCGATATCGCG)2 alone, (b) ds(CGCGATATCGCG)2 with 
complex 6, (c) ds(CGCGAATTCGCG)2 alone and (d) ds(CGCGAATTCGCG)2  with 
complex 6. 
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Fig. 2.26 CD spectra of 10 µM  of oligonucleotides in the absence and presence of 120 µM  
of complex 7; (a) ds(CGCGATATCGCG)2 alone, (b) ds(CGCGATATCGCG)2 with 
complex 7, (c) ds(CGCGAATTCGCG)2 alone and (d) ds(CGCGAATTCGCG)2  with 
complex 7. 
 
Fig. 2.27 CD spectra of 10 µM  of oligonucleotides in the absence and presence of 120 µM  
of complex 8; (a) ds(CGCGATATCGCG)2 alone, (b) ds(CGCGATATCGCG)2 with 
complex 8, (c) ds(CGCGAATTCGCG)2 alone and (d) ds(CGCGAATTCGCG)2  with 
complex 8. 
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2.3.5.2 G-quadruplex and guanine-rich duplex 
Next, we examine the interaction of the complexes with a non-B form DNA structure. 
Guanine rich regions of DNA such as human telomeric DNA can be folded into higher-
order DNA structure known as G-quadruplex under physiological ionic conditions (Burge 
et al. 2006). Recently, there is growing interest in compounds that can induce or stabilize 
quadruplex structure (Reed et al. 2009; Pierce et al. 2009; Arola and Vilar, 2008; Arola et 
al. 2008) due to the discovery that these compounds can lead to inhibition of telomerase 
(Neidle and Parkinson, 2002). The telomerase is a nucleoprotein that catalyzes the 
elongation of telomere and plays a key role in bestowing immortality to cancer cells. The 
telomerase is a promising target for anticancer agent because it is over expressed in 80-85% 
of cancer cells but not in normal somatic cells (Kim et al. 1994). Since the substrate of 
telomerase is the 3’-single-stranded overhang of telomeric DNA, the stabilisation of 
quadruplex DNA structures by small molecules can lead to telomerase inhibition (Reed et 
al. 2007; Neidle and Parkinson, 2002).    
 
Therefore, we used CD spectroscopy to investigate the interaction of the zinc 
complexes with the single strand G-quadruplex DNA annealed from human telomeric 
sequence 5’-AG3(T2AG3)3-3’ and with the duplex DNA annealed from two complementary 
17 bp primers, 5’-CCAGTTCGTAGTAACCC-3’ and 3’-GGTCAAGCATCATTGGG-5’ 
to evaluate the ability of these complexes in stabilizing G-quadruplex and differentiating 
the guanine rich duplex structure.  Single stranded quadruplexes with parallel structure has 
been determined by X-ray crystallography (Parkinson et al. 2002) whereas antiparallel 
structure or a mixture of both have been determined by others using NMR (Kypr et al. 2009, 
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Zhang et al. 2007; Baker et al. 2006). The structure of the quadruplex is highly dependent 
on the type of ion and ionic strength. Human telomeric sequence d[G3(T2AG3)3] can formed 
antiparallel quadruplex in the presence of  100 mM Na+ but formed a hybrid mixture of 
parallel and antiparallel structures in the presence of K+ (Burge et al. 2006).  The CD 
spectrum of our G-quadruplex alone annealed from 5’-AG3(T2AG3)3-3’ oligonucleotides 
with human telomeric sequence in the presence of  Na+ ions shows two maxima at 295 nm 
and 246 nm and a minimum  at 267 nm  (Fig. 2.28, Table 2.15). This spectrum is typical of 
other reported anti-parallel quadruplexes, viz. d(T2AG3)4, d(T2AG3)6 and dAG3(T2AG3)3 
(Baker et al. 2006, Burge et al. 2006). Thus, our G-quadruplex annealed from 5’-
AG3(T2AG3)3-3’ oligonucleotides with human telomeric sequence in the presence of 100 
mM  Na+ ions should have an antiparallel structure as revealed by NMR earlier (Wang and 
Patel, 1993). The CD positive band at 297 nm for the antiparallel G-quadruplex has been 
ascribed to G-G base stacking (Kypr et al. 2009; Burge et al. 2006) 
 
 The CD spectra of the antiparallel G-quadruplex 5’-AG3(T2AG3)3-3’ (20 μM) with 
different complexes (120 μM) were obtained.  The intensity of the positive band for G-
quadruplex at 296 nm is enhanced while the negative band at 267 nm decreases upon 
addition of complexes 5, 6 and 8. Complex 7 induces an increase in both the positive and 
negative bands. The overall shape and the two bands position of G-quadruplex remain 
unchanged, suggesting retention of the antiparallel structure (Fig. 2.28, Table 2.15). The 
enhancement of the positive band at 296 nm due to G-G base stacking suggests partial 
intercalation between G-tetrads and stabilization by the zinc complex similar to 
enhancement of positive, base-base stacking band at ~270 nm attributed to intercalation of 
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the B-form duplex DNA. This observation is in contrast to those observed for the 
interaction of acridine and bis-acridine with G-quadruplex where the decrease in the 
intensity of the positive band at 293 nm was interpreted as destabilization of the quadruplex 
structure (Nagesh et al. 2003). Thus, enhancement of the positive band of the CD spectrum 
of the present quadruplex suggests stabilization of the antiparallel quadruplex structure by 
our zinc complexes as suggested by Musseti et al. (2009). Musseti et al. (2009) have 
monitored changes in the melting profile of the synthetic oligonucleotide (HTS) in the 
presence of metal ions and phenanthroline-based G-quadruplex binding ligand. Ligands 
that bind effectively to G-quadruplex will produce an increase in the melting temperature. 
An enhanced melting temperature for the oligonucleotide (HTS) in the presence of 
(K34)2Ni(II) which is consistent with stabilisation of G-quadruplex is confirmed by the 
increase in the band intensity (290 nm) of the CD spectra for G-quadruplex . In contrast, 
CD spectral titration of ruthenium (II) complexes with known intercalating ligands, viz. 
[Ru(phen)2(dpqC)]2+, [Ru(phen)2(dpq)]2+, [Ru(phen)2(dppz)]2+ and [Ru(phen)3]2+, with four 
stranded G-quadruplex (TTGGGGGT)4 shows a significant decrease in ellipticity of both 
CD positive and negative bands with increasing Ru(II)-complex:G-quadruplex ratio (Talib 
et al. 2008). The positive CD band at 265 nm was found to be split into distinct bands at 
higher concentration of the Ru(II)-complex. These complexes have higher binding affinity 
towards duplex DNA than towards quadruplex. 
 
The overall enhancement of the positive band at 296 nm in G-quadruplex by the 
complexes decreases in the following order: 6 > 7 > 5 > 8.  Based on the enhancement in 
the positive band (Fig. 2.28, Table 2.15) complex 6 is most effective in stabilizing while 
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complex 8 is the least effective. The ability of complex 6 in differentiating the CG sequence 
from AT in duplex DNA may be responsible in facilitating its binding to guanine rich 
quadruplex. The absence of cytosine in the quadruplex sequence suggests that the ability of 
complex 6 in recognizing the CG sequence that we observed earlier maybe related to its 
ability to recognize guanine. Interestingly, complex 8 shows the lowest enhancement in the 
positive band for G-quadruplex but the enhancement for this complex is highest when 
compared to the other complexes for interactions with any duplex sequences. This indicates 
that the presence of a planar phenyl group on the thiosemicarbazone moiety enhances the 
ability of the complex to bind to duplex structure through intercalation. However, this 
feature is unfavourable for interaction with the G-quadruplex which may be due to the 
greater steric effect conferred by the bulkier phenyl group making it more difficult for the 
molecule to approach the binding sites in the highly folded structure of G-quadruplex.  
 
Fig. 2.28 CD spectra of  20 µM  of G-quadruplex in the absence and presence of 120 µM  
of complex; (a) G-quadruplex alone, (b) G-quadruplex  with complex 5, (c) G-quadruplex  
with complex 6, (d) G-quadruplex  with complex 7 and (e) G-quadruplex  with complex 8 
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However, the ability of a complex to merely bind to quadruplex alone is not 
sufficient for it to be developed as an anticancer agent. Selectivity is always a major 
challenge in developing DNA binding agents for application either as DNA probes or 
therapeutic agents.  Perhaps, the best example was shown recently by Dixon et al. (2007) 
where they managed to synthesized a pentacationic manganese(III) porphyrin complex 
which exhibits 10000-fold selectivity for G-quadruplex over duplex DNA. The noncovalent 
equilibrium  binding constants of the porphyrin with duplex and quadruplex DNA were 
measured by surface plasmon resonance (SPR). SPR grants access to the ratio of the 
equilibrium  binding constants, which is a measure of the G-quadruplex binding selectivity. 
The sensorgrams show an obvious selectivity of the complex for quadruplex DNA as the 
binding of the complex to GC and AT duplex DNA gives affinity constants in the 104 M-1 
range, whereas it reaches 108 M-1 with quadruplex DNA.  However, Talib et al. (2008) 
found that ruthenium(II) complexes with known intercalating ligands, viz.  
[Ru(phen)2(dpq)]2+, [Ru(phen)2(dppz)]2+ and [Ru(phen)3]2+ (where dpq = 
dipyridoquinoxaline; dppz = dipyridophenazine and phen = 1,10'-phenanthroline) 
complexes have higher binding affinity towards duplex DNA than towards quadruplex.  
 
This prompted us to investigate the interaction of complexes 5–8 with guanine rich 
duplex DNA annealed from two complementary 17 bp primers, 5’-
CCAGTTCGTAGTAACCC-3’ and 3’-GGTCAAGCATCATTGGG-5’. Complex 5 (Fig. 
2.29, Table 2.15) induces the greatest decrease in both positive and negative bands. This 
indicates that the binding of complex 5 to guanine rich duplex leads to conformational 
change from B-like to Z (Mahadevan and Palaniandavar, 1996). Complex 6 (Fig. 2.29, 
Table 2.15) that has always shown high preference to the GC rich sequence does not induce 
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significant increase (1.8%) to the positive band of G-duplex. However, it induces a great 
increase in the negative band (37.8%) of guanine rich duplex in contrast to the great 
decrease in negative band (17.1%) of ds(CG)6 (Fig. 2.21). This suggest that besides being 
capable of recognizing CG sequence, complex 6 may be utilized to detect purely CG 
repeating sequences from the CG sequence in a mixture of other alternative nucleobase 
such as adenine and thymine in G-duplex. Complexes 6 and 8 (Fig. 2.29, Table 2.15) both 
cause an increase in the positive and negative bands in the CD spectra of guanine rich 
duplex with the latter having slightly greater enhancement. This type of changes can be 
ascribed to a conformational change from B to ψ, which is similar to those observed in 
[Zn(phen)edda] (Seng et al., 2008) and [Ru(NH3)4qdppz)]2+ (Maheswari and Palaniandavar, 
2004). 
 
Fig. 2.29 CD spectra of  20 µM  of guanine rich duplex in the absence and presence of 120 
µM  of complex; (a) guanine rich duplex alone, (b) guanine rich duplex with complex 5, (c) 
guanine rich duplex with complex 6, (d)   rich duplex with complex 7 and (e) guanine rich 
duplex with complex 8 
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By comparing the extent of changes induced in both the positive and negative bands 
of G-quadruplex and guanine rich duplex we can see that the complexes can differentiate 
G-quadruplex from G-duplex. Since the complexes can bind to both structures and induced 
different conformational change, it is not possible to compare their selectivity based on CD 
data alone. However, we still can conclude that complexes 6 and 7, with alkyl group favor 
the stabilization of quadruplex with complex 6 being slightly more effective than 7. Similar 
observations has been reported by Talib et al. (2008) when they studied the interaction of 
duplex and quadruplex DNA with platinum complexes with methylated phenanthroline 
ligands. It was found that introduction of a methyl groups onto the phenanthroline greatly 
enhanced the binding affinity towards DNA. It is noteworthy that the least reactive 
platinum complex towards both duplex DNA and quadruplex DNA was [Pt(en)(phen)]2+, 
while the most reactive was [Pt(en)(Me4phen)]2+. This highlights the important role that 
hydrophobic interactions can play in determining overall binding affinities towards DNA. 
While complex 5 can bind to quadruplex with similar enhancement of base stacking as for 
complexes 6 and 7, it is not a good candidate for a quadruplex binding agent because it may 
bind strongly to duplex DNA resulting in a great conformational change of the duplex DNA 
as observed in the CD spectrum. Finally, complex 8 which has a hanging pendant planar 
aromatic ring, which favors intercalation, is proven to bind to all the duplexes with greatest 
enhancement of positive band (Table 2.15). However, the binding to quadruplex is less 
favourable when compared to complexes 5, 6 and 7. This again is consistent with the idea 
that metal complexes do not interact with quadruplex DNA via the standard intercalative 
mode and the conceptual design used in molecules that bind to duplex DNA may not apply 
to quadruplex DNA. 
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2.3.6 Nucleolytic study 
Zinc complexes that can hydrolytically cleave DNA and RNA have been extensively 
studied due to their biological relevance to various metalloenzymes (Bazzicalupi et al. 
2008; Mancin et al. 2007; Qian et al. 2007). However, some zinc complexes need 
activation by an exogeneous agent or a change in chemical environment or reaction 
conditions for DNA cleavage to occur (Ramakrisnan et al. 2008; Seng et al. 2008).  
Although many mononuclear and multinuclear zinc(II) complexes can bind to DNA and 
induce hydrolytic cleavage DNA or model substrate, the ability to do so is highly 
dependent on the unsaturated coordination sphere of zinc and its ability to activate labile 
bonded nucleophiles (Liu et al. 2004; Mancin et al. 2007; He et al. 2009).  
 
In this study, we examine the ability to cleave pBR322 under hydrolytic conditions 
and in the presence of exogenous agents, i.e. sodium ascorbate and hydrogen peroxide, 
using gel electrophoresis. When circular plasmid DNA is subjected to electrophoresis, 
relatively fast migration will be observed for the intact supercoil form (form I). If scission 
occurs on one strand (nicking), the supercoil will relax to generate a slower moving open 
circular form (form II). If both strands are cleaved, a linear form (form III) that migrates 
between form I and form II will be generated (Seng et al. 2008). Incubating the zinc 
complexes with pBR322 at varying concentrations of the zinc complex (10 – 1000 μM) for 
24 h at 37 oC, no DNA cleavage was observed except for complex 6 (Fig. 2.30, Lane L8 & 
L9)  and 8  (Fig. 2.31: Lane L8). Complex 6 started to show cleavage at 500 μM with the 
appearance of a nicked band with very low intensity and the amount of cleavage increased 
with the increase in concentration of the complex. Complex 8 is less active compared to 6 
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because the appearance of a very low intensity nicked band can only be observed at the 
very high complex concentration of 1000 μM. Both the complexes are very weak 
hydrolytic cleavage agents. 
 
Fig. 2.30 Electrophoresis results of incubating pBR322 (0.5 μg/μL) in the presence of 
complex 6 in TN buffer (5 mM Tris, 50 mM NaCl) pH 7.5 at 37 oC for 24 h.  L1 & L4, 
gene ruler 1 Kb DNA ladder; L2, DNA alone; L3, DNA + 1000 μM ZnCl2; DNA + various 
complex concentrations L5-L9: L5, 10 μM; L6, 50 μM; L7, 200 μM; L8, 500 μM; L9, 1000 
μM. 
 
 
Fig. 2.31 Electrophoresis results of incubating pBR322 (0.5 μg/μL) in the presence of 
complex 8 in TN buffer (5 mM Tris, 50 mM NaCl) pH 7.5 at 37 oC for 24 h.  L1, gene ruler 
1 Kb DNA ladder; L2, DNA alone; L3, DNA + 1000 μM ZnCl2; DNA + various complex 
concentrations L4-L8: L4, 10 μM; L5, 50 μM; L6, 200 μM; L7, 500 μM; L8, 1000 μM.  
Compound 6 
Compound 8 
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Fig. 2.32 Electrophoresis results of incubating pBR322 (0.5 μg/μL) with ZnCl2 or 
complexes 5-8 in TN buffer (5 mM Tris, 50 mM NaCl) pH 7.5 at 37 oC for 2 h in the 
absence and presence of exogenous agents: Lane 1, 5, 11, 17 gene ruler 1 Kb DNA ladder; 
Lane 2, DNA alone (0.5 µg/µL) control; Lane 3, DNA + 30μM sodium  ascorbate; Lane 4, 
DNA + 30μM H2O2;  Lane 6, DNA + 300μM ZnCl2; Lane 7, DNA + 300μM 7; Lane 8, 
DNA + 300μM 6; Lane 9, DNA + 300μM 8; Lane 10, DNA + 300μM 5; Lane 12, DNA + 
300μM ZnCl2 + 30μM sodium  ascorbate; Lane 13, DNA + 300μM 7+ 30μM sodium  
ascorbate; Lane 14, DNA + 300μM 6+ 30μM sodium  ascorbate;  Lane 15, DNA + 300μM 
8+ 30μM sodium  ascorbate; Lane 16, DNA + 300μM 5+ 30μM sodium  ascorbate; Lane 
18, DNA + 300μM ZnCl2 + 30μM H2O2; Lane 19, DNA + 300μM 7+ 30μM H2O2; Lane 20, 
DNA + 300μM 6+ 30μM H2O2; Lane 21, DNA + 300μM 8 + 30μM H2O2; Lane 22, DNA + 
300μM 5+ 30μM H2O2 
 
When the DNA was incubated with 300 µM of zinc complex in the presence of 30 μM 
NaAsc or 30 μM H2O2, no activation of zinc complexes towards DNA cleavage by sodium  
ascorbate or hydrogen was observed as the gel pattern is the same as that for DNA alone 
(Fig. 2.32, lane L2).  No cleavage was observed even when the concentration of hydrogen 
peroxide was varied from 250 μM to 500 μM by maintaining the complex concentration at 
300 µM  (results not shown). 
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2.3.7 Topoisomerase I inhibition assay 
Topoisomerases are important nuclear enzymes that modify the topological state of DNA 
by catalyzing the relaxation of negative supercoils and the negative supercoiling of DNA 
(Wang et al. 1998). DNA cleavage by all topoisomerases involves the formation of a 
transient phosphodiester bond between a tyrosine residue in the protein and one of the ends 
of the broken strand. DNA topology can be modified during the lifetime of the covalent 
intermediate, and the enzyme is released as the DNA is religated. Those enzymes that 
cleave only one strand of the DNA are defined as type I and are further classified as either 
type IA subfamily members if the protein link is to a 50 phosphate (formerly called type I-
50) or type IB subfamily members if the protein is attached to a 30 phosphate (formerly 
called type I-30). Topoisomerases that cleave both strands to generate a staggered double-
strand break are grouped together in the type II subfamily of topoisomerases (Champoux, 
2001). These enzymes play essential roles in mitosis, particularly in DNA transcription and 
replication (Nitiss, 1998). Topoisomerases have been identified as important targets in 
cancer chemotherapy and microbial infections (Kumar Singh et al. 2007). In fact, 
topoisomerase I inhibitors are quoted as having a wide range of antitumor activities and are 
among the most widely used anticancer drugs clinically (Sunani et al. 2009; Rothenberg 
1997; Beretta et al. 2008). However, very few metal complexes have been reported to 
inhibit topoisomerases and even fewer zinc complexes have been reported to inhibit 
topoisomerase I and II (Kikuta et al. 2000; Chuang et al. 1996).  
 
Supercoiled plasmid DNA pBR322 is a suitable substrate for study with 
topoisomerase I, which is a one strand DNA cutter. The supercoiled pBR322 (Form I) is 
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very compact and moves faster in the gel during electrophoresis. When one strand of the 
supercoilded DNA is cut, the resultant unwound, more relaxed open circular pBR322 
(Form II) is formed and this nicked DNA moves slower. When two strands of the 
supercoiled DNA are cut, the linear DNA (Form III) is formed and it moves at intermediate 
speed. The commercial pBR322 (4.4 kb) has a small amount of both more relaxed Form II 
and Form III DNA (Fig. 2.33, lanes L1). In our DNA relaxation assay, one unit of human 
topo I can completely convert all the supercoiled plasmid pBR322 (4.4 kb) to fully relaxed 
topoisomer, which is the completely unwound covalently bonded closed circular DNA (Fig. 
2.33, lane L7). This is found in the slowest moving DNA band (labelled Form II) which 
contains the fully relaxed closed circular pBR322 and the originally present, small amount 
of nicked DNA. No cleavage or unwinding of the DNA was observed when pBR322 was 
incubated with 40 μM of complexes 5-8 alone (Fig. 2.33, lane L2-L5). As can be seen from 
Fig. 2.33 (lane L10) only complex 8, Zn(bipy)(HP) is capable of inhibiting topo I with total 
disappearance of the nicked band (containing nicked and fully relaxed DNA).  
 
Fig. 2.33 Human topoisomerase I inhibition assay by gel electrophoresis. 
Electrophoresis results of incubating human topoisomerase I (1 unit/21μL) with pBR322 in 
the absence or presence of 40 μM  of complex:  Lane 1 & 6, gene ruler 1 Kb DNA ladder; 
Lane 2, DNA + 40µM 7 (control);Lane 3, DNA + 40µM 6 (control); Lane 4, DNA + 40µM 
8 (control); Lane 5, DNA + 40µM 5 (control); Lane 7, DNA+ 1 unit Human 
Topoisomerase I (control); Lane 8, DNA + 40µM 7+ 1unit Human Topoisomerase I; Lane 
9, DNA + 40µM 6+ 1unit Human Topoisomerase I; Lane 10, DNA + 40µM 8 + 1unit 
Human Topoisomerase I; Lane 11, DNA + 40µM  8 + 1 unit Human Topoisomerase I 
Form I 
Form II 
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As a preliminary investigation into the mechanism of action of the above topo I 
inhibition, we used three variations of mixing the DNA, topo I and the zinc complex 8 (at 
40 µM) for the topo I inhibition assay. When the three components are mixed 
simultaneously, there is slight inhibition of topo I as seen by the presence of the fastest 
moving band with low intensity (Form I) which consists of supercoiled DNA and poorly 
relaxed DNA (Fig. 2.34, lane L5). The bands of topoisomers with different degrees of 
relaxation can also be seen in between Form I and Form II. Secondly, when complex 8 was 
incubated first with topo I before the addition of DNA, the intensity of the fastest moving 
band is the highest with almost total disappearance of the slowest moving band (Form II), 
suggesting that almost total inhibition of topo I (Fig. 2.34, lane  L6). Finally, when the 
DNA is first incubated with the zinc complex for 30 minutes before adding the topo I (Fig. 
2.34, lane L7), the fastest moving band (Form I) almost totally disappears. The intensity of 
Form II is slightly lower compared to the control in lane L4. The presence of relaxed 
topoisomers just below the fully relaxed topoisomer band (Form II) indicates that inhibition 
of topo I is less than the two methods of mixing earlier. These observed differences in 
inhibition of topo I suggest initial binding of the zinc complex to either the topo I or the 
DNA giving rise to differences in mode of action.  Therefore, two pathways of 
toposisomerase inhibitions are suggested, one involves the binding of complex to DNA 
while the other involves the binding to toposiomerase. By comparing lane L6 and L7, we 
can infer that since greater inhibition of topo I is observed when the complex is incubated 
with topo first, the inhibition process involving the binding of the complex to the 
toposiomerase enzyme may be a more dominant pathway. However, further investigation is 
crucial to confirm this. 
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.  
Fig. 2.34 Effect of sequence of mixing for the human topoisomerase I inhibition assay of 
complex 8. Electrophoresis results of incubating human topoisomerase I (1 unit/21μL) with 
pBR322: Lane 1, 1 kb DNA ladder; Lane 2, Plasmid DNA pBR 322 (control); Lane 3, 
DNA + 40µM complex (control); Lane 4, DNA+ 1unit Human Topoisomerase I (control); 
(a) All components mixed at the same time; Lane 5, DNA + 40µM complex + 1 unit 
Human Topoisomerase I ; (b) Complex + TopoI incubated for 30 minutes first before DNA 
is added; Lane 6, DNA + 40µM complex + 1unit Human Topoisomerase I; (c) Complex + 
DNA incubated for 30 minutes first before TopoI is added; Lane 7, DNA + 40µM complex 
+ 1unit Human Topoisomerase I 
 
2.3.8 Antibacterial and antifungal assay 
2.3.8.1 Antibacterial activity 
The urge to discover new classes of antibacterial compounds is driven by the emergence of 
bacterial pathogens resistant to multiple antibacterial drugs in both the hospital and 
community setting (Tse-Dinh, 2009). Thiosemicarbazones and their metal complexes are 
good candidates for this purpose because of their well known antibacterial activity and 
(a) (b) (c) 
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limited usage in clinical practice ( et al. 2009; Joseph et al. 2004 & 2006; Jeragh 
and El-Dissouky, 2005). Therefore, the antibacterial activity of ligands and complexes were 
assessed against two species of Gram positive bacteria and four species of Gram negative 
bacteria to tap into the potential antibacterial activity of our compounds. All the ligands and 
complexes had some degree of inhibitory activity against the bacteria tested (Table 2.16).  
Table 2.16. 
 Mean MIC value (µg/ml) towards microbes tested. 
Compound Bacteria 
 S. aureus B. cereus P. aeruginosa K. pneumoniae E. coli  E. coli  
              
(penicillin- 
sensitive strain) 
(penicillin- 
resistant strain) 
1 62.50 62.50 62.50 62.50 62.50 62.50 
2 125.00 62.50 125.00 62.50 62.50 62.50 
3 62.50 62.50 62.50 62.50 62.50 62.50 
4 62.50 31.25 62.50 31.25 62.50 62.50 
5 62.50 62.50 62.50 62.50 62.50 62.50 
6 62.50 62.50 62.50 62.50 62.50 62.50 
7 62.50 62.50 62.50 62.50 62.50 62.50 
8 15.63 15.63 31.25 15.63 62.50 62.50 
ZnCl2 - - - - - - 
bipy 125.00 62.50 62.50 62.50 62.50 62.50 
Drug 8.00 4.00 4.00 4.00 4.00 4.00 
 “ - ” : no activity     
Drug used in antibacterial assay = Chloramphenicol   
  
 Among the four ligands tested, ligand 4 shows the highest inhibition against B. 
cereus and K. pneumonia with MIC value 31.25 µg/ml. This may be due to the presence of 
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a more hydrophobic phenyl substituent that can enhance membrane permeability. The 
planar phenyl substituent may also enhance binding of the compound towards the DNA of 
the bacteria through intercalation. Ligands 1, 2 and 3 show very weak antibacterial activity 
with MIC value of 62.50 µg/ml towards most of the bacteria except S. aureus and P. 
aeruginosa. These two bacteria are very resistant towards compound 2, showing MIC value 
of  125.0 µg/ml.  
 
 Upon complexation, improvement of antibacterial activity is seen for complex 8. 
Complexes 5-7 have the same degree of inhibitory activity against six species of bacteria 
with MIC value 62.50 µg/ml. But complex 8 exhibited higher inhibitory activity against S. 
aureus, B. cereus and K. pneumonia with MIC value 15.63 µg/ml and towards  P. 
aeruginosa with MIC value of 31.25 µg/ml. The high antibacterial activity of complex 8 is 
compatible with its ability to inhibit topoisomerase I. Similar correlation of increased 
antibacterial activity with topoisomerase inhibition has been reported by Kikuta et al. 
(2000).  The recent discovery that the accumulation of the covalent cleavage complex of 
bacterial topo I could indeed lead to rapid bacterial cell death has helped to validate 
bacterial type IA topoisomerases as useful targets for discovery of novel bactericidal 
compounds (Tse-Dinh, 2009). Therefore, complex 8 has the potential to be developed as 
antibacterial agent that targets topoisomerase. Bacterial topoisomerase inhibitors continue 
to be actively developed as clinical antibacterial agents, largely owing to the success of the 
currently marketed inhibitors, the quinolones, and the increasing resistance to these agents 
(Bradbury and Pucci, 2008).  
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2.3.8.2 Antifungal activity 
The antifungal activity of ligands and complexes were assessed against four species of 
fungi. All the ligands and complexes had some degree of inhibitory activity against the 
fungi tested (Table 2.17).  The antifungal property of the ligands is very dependent on the 
N(4) substituent and  strains of fungal used in the assay. This indicates that the ligands are 
more selective towards certain fungal than the other. Ligands 2 and 3 which are alkyl 
substituted show moderate antifungal activitiy towards C. albicans, C. parapsilosis and C. 
neoformans with a MIC value of 31.25 µg/ml while their antifungal activity towards 
A.niger is very weak with a MIC value of   62.50 µg/ml. Compound 1 which is 
unsubstituted show similar activity with ligands 2 and 3 with the exception of C. 
parapsilosis with a MIC value of 62.50 µg/ml. This indicates that alkyl substitution of the  
free ligands does not play important role in improving their antifungal property. However, a 
drastic improvement can be seen in compound 4 when a phenyl substituent is attached to 
the N(4) atom. Compound 4 shows very good antifungal towards C. neoformans with a 
MIC value of  7.81 µg/ml and moderate  antifungal towards A. niger  with a MIC value of  
31.25 µg/ml which is much higher compared to the other ligands. This may due to the 
greater hydrophobicity conferred to the ligand by the phenyl ring. 
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Table 2.17. 
Mean MIC value (µg/ml) towards fungi tested. 
 Compound Fungi 
 C. albicans C. parapsilosis C. neoformans A.niger 
              
1 31.25 62.50 31.25 62.50 
2 31.25 31.25 31.25 62.50 
3 31.25 31.25 31.25 62.50 
4 31.25 62.50 7.81 31.25 
5 31.25 62.50 15.63 62.50 
6 15.63 31.25 15.63 62.50 
7 31.25 62.50 15.63 62.50 
8 31.25 15.63 7.81 31.25 
CuCl2 - - - - 
ZnCl2 - - - - 
bipy 15.63 15.63 31.25 31.25 
Drug 1.00 2.00 1.00 4.00 
 “ - ” : no activity     
Drug used in antifungal assay = fluconazole  
   
 Upon complexation, the antifungal property remains unchanged for most of the 
complexes. Improvement is only seen for complexes 5-7 towards C. neoformans with all of 
them having a MIC value of 15.63 µg/ml which is lower than the MIC value of free 
bipyridine and their respective free thiosemicarbazones ligands. Improvement of biological 
property for a free ligand upon complexation is normally attributed to the increase in 
lipophilicity or synergistic effect from a bioactive metal centre (Liberta and West, 1992). 
An anomaly is seen in complex 7 towards C. parapsilosis where the complex is less potent 
than the free ligand (compound 3). This may suggest that the antifungal property of 
compound 3 towards the particular strain of fungal is different from other ligands. The 
antifungal property of this ligand may lies in its ability to chelate free metal ion. 
Complexation removes its chelation ability therefore leads to decrease in its antifungal 
  
104 
property. Complex 8 which is derived from ligand 4 is the most potent antifungal agent 
with the lowest MIC value towards C. parapsilosis, C. neoformans and A.niger. However, 
the antifungal property of complex 8 does not surpass the activity of 2,2'-bipyridine 
towards C. parapsilosis and A.niger. Therefore, the complexation of the free ligands does 
not result in improved antifungal properties.  
 
2.4 Conclusions 
Spectroscopic and crystallographic data show that the free thiosemicarbazones ligands exist 
in the thione form. The zinc complexes are five-coordinated with the doubly deprotonated 
thiosemicarbazones ligands behaving as tridentate ligands coordinating through the 
phenolic oxygen, azomethine nitrogen and thiolate sulfur atoms, while the 2,2'-bipyridine 
ligand is coordinated in the N,N’-bidentate mode. The coordination geometry around the 
zinc complexes is intermediate between trigonal bipyramidal and square pyramidal 
geometries and is better described as trigonal bipyramidal distorted square based pyramid 
(TBDSBP). 
 
Results from biological tests indicate that the nature of the N(4) substituent plays a 
crucial role in determining the selectivity and potency of zinc(II) complexes of 2,4-
dihydroxybenzaldehyde N(4)-substituted thiosemicarbazones and 2,2-bipyridine. We can 
conclude that the complexes can differentiate DNA with different base sequences or 
structure. Complex 8 has the greatest potential to be developed as a drug due to its highest 
affinity in binding towards duplex DNA, ability to inhibit topoisomerase I and highest 
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antibacterial and antifungal properties. Complex 8 also holds the promise to be developed 
as an anticancer agent because compounds that can inhibit topoisomerase I and most 
compounds that show antifungal property are normally cytotoxic. This indicates that the 
presence of a phenyl group at the N(4) atom is crucial in elevating biological activities of 
this class of complex except for binding to G-quadruplex. On the other hand, complex 6, 
which can recognize CG sequence, has better potential to be developed into a quadruplex 
binding and stabilizing agent because of its selectivity towards G-quadruplex is higher over 
G-duplex. The presence of an alkyl group at the N(4) atom is a desirable feature in 
developing complexes that bind selectively to G-quadruplex.  
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Chapter 3 
Synthesis, characterization and biological properties of zinc(II) complexes of 2,4-
dihydroxybenzaldehyde N4-substituted thiosemicarbazones and 1,10-phenanthroline  
3.1. Introduction 
Previously, we observed that the N(4) substituent play a role in determining the 
ability of zinc(II) complexes of 2,4-dihydroxybenzaldehyde N(4)-substituted 
thiosemicarbazones and 2,2-bipyridine in DNA sequence and structure recognition (chapter 
2). The N(4) substituents seem to affect  their biological activities from changing or 
stabilizing the conformation of duplex DNA, quadruplex binding, topoisomerase I 
inhibition, antibacterial to antifungal property. In the study of interactions of ternary 
complexes with DNA, another common strategy is to vary the N,N’-heterocyclic ligands 
with different intercalating capability. Normally, marked improvement in DNA interaction 
is observed when ligand like 2,2'-bipyridine is replaced by ligands with extended aromatic 
ring such as 1,10-phenanthroline (phen), dipyrido[3,2-d:2′,3′-f] quinoxaline (dpq),  
dipyrido[3,2-a:2′,3′-c]phenazine (dppz) and naphtha[2,3-a]dipyrido[3,2-h:2′, 3′-
f]phenazine-5,18-dione (qdppz). Metal complexes with intercalating ligands normally have 
higher binding constants in contrast to those of 2,2'-bipyridine derivatives. These 
intercalating ligands can promote better binding to DNA by deeper insertion of extended 
aromatic ring between nucleobase pair or simply by increased in π-π interaction with 
nucleobase attributed to increase in overlapping of  the aromatic ring (Ramakrishnan and 
Palaniandavar, 2008; Roy et al. 2007; Patra et al. 2005; Dhar et al. 2005; Thomas et al. 
2003). Sometimes, the intercalating ligand can even act as a recognition domain (Gao et al. 
2008).  Recently, Gao et al. (2008) have prepared a DNA intercalating Ru(II) polypyridine 
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complex, [Ru(bipy)2(appo)]2+ (appo = 11-aminopteridino[6,7-f][1,10]phenanthrolin-
13(12H)-one) that showed higher selectivity towards GC sequences. The sequence 
selectivity is hypothesized to be conferred by hydrogen bonding interaction between the 
introduced guanine group in the intercalating ligand (appo) and GC base pairs of DNA. 
 
Therefore in this chapter, we report the effect of varying the N(4) substituent of the 
thiosemicarbazones from hydrogen, methyl, ethyl to phenyl towards the chemical and 
biological properties (DNA binding, nucleolytic, topoisomerase I inhibition and 
antimicrobial) of ternary  Zn(II) complexes containing 1,10-phenanthroline . Cross 
comparison with the 2,2'-bipyridine analog in chapter 2 will be carried out to evaluate the 
effect of changing 2,2'-bipyridine to 1,10-phenanthroline on their biological properties.  
 
3.2. Experimental 
3.2.1. Materials and solutions 
The materials used were the same as mentioned in chapter 2. 
 
3.2.2. Physical measurements 
IR spectra were recorded as KBr pellets by using a Perkin-Elmer Spectrum RX-1 
spectrophotometer.  NMR spectra were recorded in deuterated DMSO-d6 on a JEOL JNM-
LA400 or ECA 400 MHz instrument. Elemental analyses were performed on a Thermo 
Finnigan Eager 300 CHNS elemental analyzer. UV–visible spectroscopic measurements 
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were carried out on a Perkin–Elmer Lambda 40 spectrophotometer. The circular dichroism 
study of the interaction of metal complexes with ds(oligonucleotide) was carried out with a 
1.0 cm or 1.0 mm quartz cells respectively using a Jasco J-810 spectropolarimeter. 
 
3.2.3 Syntheses  
3.2.3.1 Synthesis of (4-Hydroxy-2-oxidobenzaldehyde thiosemicarbazonato)-(1,10-
phenanthroline)zinc(II) monohydrate, [Zn(phen)(HT)].H2O (9) 
Zinc acetate dihydrate (0.22 g, 1 mmol) and 1,10-phenanthroline (0.20 g, 1 mmol) were 
heated in ethanol (20 ml) for 1 hour followed by addition of 2,4-dihydroxybenzaldehyde 
thiosemicarbazone (0.21 g, 1 mmol) in hot ethanol (20 ml) and the mixture was refluxed for 
another 3 hours. The yellow complex that separated was filtered, washed with cold 
methanol and ether, dried in air and kept in a desiccator over silica gel. (Yield: 0.38 g, 
81%). Anal. Calc. for C20H17N5O3SZn: C, 50.80; H, 3.62; N, 14.81. Found: C, 50.78; H, 
3.36; N, 14.63%. IR (KBr disc, cm-1): 3450 w, 3338 m, 3280 w, 3155 w, 3069w, 1603 s, 
1474 s, 1426 s, 1318 m, 1260 m, 1219 s, 1181 m, 1119 m, 847 m, 726 m, 554 w, 426 w (s, 
strong; m, medium; w, weak). Complex 9 is not sufficiently soluble in DMSO-d6 to acquire 
good NMR spectrum.  
 
3.2.3.2 Synthesis of (4-Hydroxy-2-oxidobenzaldehyde 4-methylthiosemicarbazonato)-
(1,10-phenanthroline)zinc(II) monohydrate, [Zn(phen)(HM)]. H2O (10)  
Complex 10 was similarly prepared as complex 9 by using 2,4-dihydroxybenzaldehyde 4-
methylthiosemicarbazone (0.23 g, 1 mmol) as the Schiff base ligand.  
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 (Yield: 0.40 g, 82%). Anal. Calc. for C21H19N5O3SZn: C, 51.80; H, 3.93; N, 14.38. Found: 
C, 51.50; H, 3.71; N, 14.42%. IR (KBr disc, cm-1): 3385 s (broad), 3249 w, 3014 w, 1601 s, 
1490 s, 1426 w, 1400 s, 1279 w, 1238 m, 1200 s, 1184 m, 848 m, 726 m, 550, 430 w (s, 
strong; m, medium; w, weak).  
Characteristic 1H-NMR signals (DMSO-d6, TMS, p.p.m.): 9.05 (s, broad, 1H, OH), 8.89 (s, 
broad, 2H, phen), 8.78 (s, broad, 2H, phen), 8.39 (s, 1H, CH=N), 8.15 (s, broad, 2H, phen), 
8.02 (s, broad, 2H, phen), 6.95 (d, 1H, aromatic, J = 8 Hz), 6.21 (s, broad, 1H, NH-CH3), 
5.66(s, 1H, aromatic), 5.88(d, 1H, aromatic, J = 8 Hz), 2.73 (d, 3H, NH-CH3 , J = 4 Hz)   
 
3.2.3.3 Synthesis of (4-Hydroxy-2-oxidobenzaldehyde 4-ethylthiosemicarbazonato)-(1,10-
phenanthroline)zinc(II) monohydrate, [Zn(phen)(HE)].H2O (11) 
Complex 11 was similarly prepared as complex 9 by using 2,4-dihydroxybenzaldehyde 4-
ethylthiosemicarbazone (0.24 g, 1 mmol) as the Schiff base ligand.  
 (Yield: 0.38 g, 76%). Anal. Calc. for C22H21N5O3SZn: C, 52.75; H, 4.23; N, 13.98. Found: 
C, 52.54; H, 4.35; N, 14.22%. IR (KBr disc, cm-1):  3501 w, 3458 w, 3331 w, 3048 w, 2962 
w, 1601 s, 1481 s, 1425 s, 1343 m , 1273 m, 1205 s, 1121 m, 845 m, 725 m 553 m, 421 m  
(s, strong; m, medium; w, weak). 
Characteristic 1H-NMR signals (DMSO-d6, TMS, p.p.m.): 8.99 (s, broad, 1H, OH), 8.86 (s, 
broad, 2H, phen), 8.77 (s, broad, 2H, phen), 8.35 (s, 1H, CH=N), 8.13 (s, broad, 2H, phen), 
8.00 (s, broad, 2H, phen), 6.92 (d, 1H, aromatic, J = 8 Hz), 6.16 (s, 1H, NH-CH2CH3) 
5.62(s, 1H, aromatic), 5.85(d, 1H, aromatic, J = 8 Hz), 3.22 (m, 2H, NHCH2-CH3, J = 4 Hz),  
1.01 (t, 3H, NHCH2-CH3,  J = 4 Hz) 
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3.2.3.4 Synthesis of (4-Hydroxy-2-oxidobenzaldehyde 4-phenylthiosemicarbazonato)-
(1,10-phenanthroline)zinc(II) monohydrate, [Zn(phen)(HP)]. H2O (12) 
Complex 12 was similarly prepared as complex 9 by using 2,4-dihydroxybenzaldehyde 4-
phenylthiosemicarbazone (0.29 g, 1 mmol) as the Schiff base ligand.  
 (Yield: 0.41 g, 77%). Anal. Calc. for C26H19N5O3SZn: C, 58.82; H, 3.61; N, 13.19. Found: 
C, 58.54; H, 3.31; N, 13.35%. IR (KBr disc, cm-1): 3394 m, 3053 w, 1603 s, 1532 m, 1484 
s, 1423 s, 1337 w, 1310 m, 1241 m, 1171 m, 849 m, 726 m, 503 w (s, strong; m, medium; 
w, weak). 
Characteristic 1H-NMR signals (DMSO-d6, TMS, p.p.m.): 9.15 (s, broad, 1H, OH), 8.95 (s, 
broad, 2H, phen), 8.80 (s, broad, 2H, phen), 8.56 (s, 1H, NH-C6H5), 8.52 (s, 1H, CH=N), 
8.17 (s, broad, 2H, phen), 8.03 (s, broad, 2H, phen), 7.81 (d, 2H, aromatic, J = 8 Hz),  7.18 
(t, 2H, aromatic, J = 8 Hz), 7.04 (d, 1H, aromatic, J = 8 Hz), 6.82 (t, 1H, aromatic, J = 8 Hz), 
5.91(d, 1H, aromatic, J = 8 Hz), 5.67 (s, 1H, aromatic) 
 
3.2.4. X-ray crystallography 
Yellowish crystals for complexes 9a and 11a were recrystallised from DMSO and DMF 
respectively. The unit cell parameters and the intensity data were collected on a Bruker 
SMART APEX CCD diffractometer, equipped with Mo Kα X-ray source (λ=0.71073 Å). 
The APEX2 software was used for data acquisition and the SAINT software for cell 
refinement and data reduction (Bruker, 2007). Absorption corrections on the data were 
made using SADABS (Sheldrick, 1996). The structures were solved and refined by 
SHELXL97 (Sheldrick, 2008). Molecular graphics were drawn by using XSEED (Barbour, 
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2001). Material for publication was prepared using publCIF (Westrip, 2009). The structures 
were solved by direct-methods and refined by a full-matrix least-squares procedure on F2 
with anisotropic displacement parameters for non-hydrogen atoms. Hydrogen atoms in their 
calculated positions were refined using a riding model. All the hydrogen atoms for 9a were 
fixed at calculated positions. Whereas, for the hydroxy and amino H-atoms for 11a were 
located in a difference Fourier map.  
 
3.2.5 DNA binding 
PAGE grade self-complimentary 12-mer oligonucleotides (CG)6, (AT)6, 
(CGCGAATTCGCG), (CGCGATATCGCG), HPLC grade 22-mer oligonucleotide 5’-
AGGGTTAGGGTTAGGGTTAGGG-3’, and 17-mer complementary pair of 
oligonucleotides 5’-CCAGTTCGTAGTAACCC-3, 3’-GGTCAAGCATCATTGGG-5’ 
were annealed, to give the respective duplexes and G-quadruplex, as speciﬁed by the 
suppliers, 1st BASE and Eurogentec Ait. The circular dichroism spectra were obtained by 
scanning Tris-NaCl buffered solutions of the DNA without and with the zinc complexes. 
 
3.2.6 Nucleolytic study 
Nucleolytic study was carried out according to the methods in chapter 2. 
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3.2.7 Human Topoisomerase I inhibtion assay 
The human DNA topoisomerase I inhibitory activity was determined according to the 
methods in chapter 2. 
 
3.2.8 Antibacterial and antifungal assay 
The antibacterial and antifungal activities of the ligands and complexes were assessed 
against several strains of Gram-positive bacteria, Gram-negative bacteria, and fungi. A 
colorimetric broth microdilution method using p-iodonitrotetrazolium violet (INT) as the 
growth indicator was employed to quantify the minimum inhibitory concentration (MIC) 
value of the complexes in the assay. The test was performed as mentioned in chapter 2. 
 
3.3. Results and discussion 
3.3.1 Synthesis of the complexes 
The stoichiometries, colors and partial elemental analyses of the complexes are shown in 
Table 3.1. Proposed structures for all the compounds with IUPAC numbering scheme are 
shown in Fig. 3.1. Results from partial elemental analyses are in good agreement with the 
proposed formulation of Zn(phen)L where phen = 1,10-phenanthroline and L is the doubly 
deprotonated thiosemicarbazones. The complexes exist as a monohydrate and are yellow. 
Complexes 9-12 were prepared in high yield by refluxing zinc acetate dihydrate, 1,10-
phenanthroline and the thiosemicarbazones in ethanol. Spectroscopic and crystallographic 
data show that all the free ligands exist in the thione tautomer form in both solid and 
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solution. However, all complexes were isolated with the ligands coordinated in the thiolate 
form. In the absence of acetate, reactions of similar ligands with zinc chloride is known to 
form dinuclear complex with the thiosemicarbazone moiety coordinating in the thione form 
(Tan et al. 2009).  All complexes are insoluble in common polar and non-polar solvents but 
are soluble in DMF and DMSO. 
 
 
 
9 R’ = H 10 R’ = -CH3 11 R’ = -C2H5 12 R’ = -C6H5 
Fig. 3.1 Proposed structure for all the complexes 
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Table 3.1 
Stoichiometries, color and partial elemental analyses of the zinc(II) complexes 
Compound Stoichiometries Color Anal. Calc. (Found )%  
   C H N 
[Zn(phen)(HT)].H2O (9) C20H17N5O3SZn Yellow 50.80(50.78) 3.62(3.36) 14.81(14.63) 
[Zn(phen)(HT)].H2O. DMSO 
(9a) C22H23N5O4S2Zn Yellow 47.96(48.31) 4.21(4.46) 12.71(13.04) 
[Zn(phen)(HM)].H2O (10) C21H19N5O3SZn Yellow 51.80(51.50) 3.93(3.71) 14.38(14.42) 
[Zn(phen)(HE)].H2O (11) C22H21N5O3SZn Yellow 52.75(52.54) 4.23(4.35) 13.98(14.22) 
[Zn(phen)(HE)].H2O .DMF(11a) C25H28N6O4SZn Yellow 52.31(52.63) 4.92(4.65) 14.64(14.33) 
[Zn(phen)(HP)].H2O (12) C26H19N5O3SZn 
Green 
Yellow 58.82(58.54) 3.61(3.31) 13.19(13.35) 
 
3.3.2 Crystal structure analysis 
3.3.2.1 Crystal structures of [Zn(phen)(HT)].H2O.DMSO (9a) 
Complex 9a crystallised into a triclinic lattice with space group symmetry Pī. The 
perspective view of the complex with numbering scheme is shown in Fig. 3.2. The complex 
is mononuclear and five coordinated with the doubly deprotonated 2,4-
dihydroxybenzaldehyde thiosemicarbazone as a tridentate ligand coordinating through the 
phenolic oxygen, azomethine nitrogen and thiolate sulfur atoms while 1,10-phenanthroline 
coordinates as the N,N’-bidentate ligand.  
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Fig. 3.2  Thermal ellipsoid (Barbour, 2001) plot of 9a drawn at the 70% probability level. 
Hydrogen atoms are drawn as spheres of arbitrary radii. 
 
The trigonality index τ of 0.47 for 9a indicates that the coordination geometry 
around zinc is intermediate between trigonal bipyramidal and square pyramidal geometries 
and we described it as trigonal bipyramidal distorted square based pyramid (TBDSBP). 
This value is very close to its 2,2'-bipyridine analog (complex 5) with trigonality index τ of 
0.49. This implies that the variation of the polypyridyl ligand has not much effect on the 
coordination geometry. On the other hand, complex 13a which is the copper and 2,2'-
bipyridine analog of complex 9a has a trigonality index τ of 0.03 which is close to a perfect 
square pyramidal. This shows that the metal ion exerts a great influence on the coordination 
geometry of a complex compared with these ligands.  The deviation from an ideal 
stereochemistry may be attributed to the restricted bite angle imposed by both the 
thiosemicarbazone and 1,10-phenanthroline ligands (Seena and Kurup, 2008). The bite 
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angle around the metal for N,N’-heterocycle of 78.60(19)° may be considered smaller when 
compared with an average value of 79.33(11)° reported  in the literature for zinc complexes 
with phenanthroline (Chang and Janiak, 2001).  
 
Selected bond lengths and angles are presented in Table 3.3. Zn –Nazomethine bond 
length of 2.081(5) Å is shorter than the Zn-Nphen bond lengths of 2.143(5) and 2.157(5) Å. 
This indicates that the azomethine nitrogen is coordinated slightly stronger to zinc 
compared to the phenanthroline nitrogen and the thiosemicarbazone moiety dominates 
equatorial bonding. The imine bond formation is evidenced from the N1-C7 and N2-C8 
distances of 1.282 (8) Å and 1.324(8) Å.  The C-N bond length of 1.324(8) Å and C-S bond 
length of 1.744(7) Å is similar to those reported for coordination of  other 
thiosemicarbazones in the thiolate form (Seena and Kurup, 2008; Demirci, 2008).   
 
 Hydrogen bonding interactions for complex 9a is shown in Fig. 3.3 (Table 3.4). 
Hydrogen bonds link the mononuclear molecule, the water and the dimethylsulphoxide 
(DMSO) molecules into a linear chain motif. These hydrogen bonding interactions may be 
responsible in DNA base sequence recognition as suggested by Gao et al. (2008) in their 
[Ru(bipy)2(appo)]2+ complex. 
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Fig. 3.3 Hydrogen bonding interactions for complex 9a 
 
The packing of the molecules is stabilized by the combination of hydrogen bonding 
and π-π interactions between aromatic rings as shown in Fig. 3.4.  
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Fig. 3.4 Unit cell packing diagram of 9a along b axis. 
 
 
 
 
 
 
 
 
 
 
 
c 
a 
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Table 3.2 
Crystal data and structure refinement parameters for complex 9a and 11a. 
Complex [Zn(phen)(HT)].H2O. 2 
DMSO (9a) 
[Zn(phen)(HE)].H2O.DMF 
(11a) 
Empirical formula  C24H29N5O5S3Zn C25H28N6O4SZn 
Formula weight   629.07 573.96 
Crystal system  Triclinic Monoclinic 
Space group   P21/c         
Unit cell dimensions   
a (Å) 9.3582 (5) 10.3744 (2)  
b (Å) 9.8181 (5)  26.5703 (5)  
c (Å) 15.2913 (8)  9.2815 (2)  
α (°) 73.641 (3) 90 
β (°) 82.482 (4) 97.080 (1) 
γ (°) 88.059 (4) 90 
Volume, V (Å3) 1336.49 (12) 2538.95 (9)  
Z  2 4 
F(0 0 0) 652 1192 
Density (calculated), (mg m−3) 1.563 1.502  
Absorption coefficient, µ(mm−1) 1.2  1.09  
Temperature, T (K) 293 (2) 100 (2)  
Crystal size (mm) 0.05 × 0.01 × 0.01 0.45 × 0.10 × 0.03 
Reflections collected  12760 17571 
Independent reflections  6125  
[R(int) = 0.097] 
5688  
[R(int) = 0.028] 
Data/restraints/parameters  6125/15/356 5688/5/349 
R[F2 > 2σ(F2)] 0.073 0.033 
wR(F2) 0.209 0.100 
S  0.97 1.08 
Largest difference  
peak and hole (e Å−3) 
1.5 and −1.28  0.40 and −0.60  
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Table 3.3 
Selected bond lengths (Å) and angles (˚) for [Zn(phen)(HT)].H2O. DMSO (9a) 
Bond lengths   Bond angles  
Zn1—O1 1.976 (4) O1—Zn1—N1 89.26 (19) 
Zn1—N1 2.081 (5) O1—Zn1—N5 104.24 (19) 
Zn1—N5 2.143 (5) N1—Zn1—N5 94.5 (2) 
Zn1—N4 2.157 (5) O1—Zn1—N4 95.45 (18) 
Zn1—S1 2.3541 (18) N1—Zn1—N4 172.4 (2) 
S8—C1 1.744(7) N5—Zn1—N4 78.60 (19) 
O1—C1 1.330 (7) O1—Zn1—S1 143.98 (15) 
O2—C3 1.372 (8) N1—Zn1—S1 82.37 (15) 
N1—C7 1.282 (8) N5—Zn1—S1 111.28 (14) 
N1—N2 1.383 (7) N4—Zn1—S1 97.11 (14) 
N2—C8 1.324 (8) C8—S1—Zn1 94.0 (2) 
N3—C8 1.348 (8) C1—O1—Zn1 122.6 (4) 
N4—C9 1.343 (8)   
N5—C17 1.356 (8)   
 
Table 3.4 
Hydrogen-bond geometry (Å, °) for [Zn(phen)(HT)].H2O. DMSO (9a) 
D—H···A D—H H···A D···A D—H···A 
O2—H2···O3 0.84 1.85 2.679 (6) 171 
N3—H31···N2i 0.88 2.11 2.986 (8) 175 
N3—H32···O4 0.88 2.33 3.075 (8) 143 
O1W—H1W1···O1ii 0.84 2.11 2.910 (7) 160 
O1W—H1W2···O2 0.84 2.25 3.056 (7) 161 
Symmetry codes: (i) −x+2, −y+2, −z+2; (ii) −x+1, −y+2, −z+1. Hydrogen atoms are placed 
at calculated positions. 
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3.3.2.2 Crystal structures of [Zn(phen)(HE)].H2O.DMF (11a) 
Complex 11a crystallised into a monoclinic lattice with space group symmetry P21/c. The 
perspective view of the complex with numbering scheme is shown in Fig. 3.5.  
 
Fig. 3.5 Thermal ellipsoid (Barbour, 2001) plot of 11a drawn at the 70% probability level. 
Hydrogen atoms are drawn as spheres of arbitrary radii. 
 
The complex is mononuclear and five coordinated with the doubly deprotonated 
thiosemicarbazone as a tridentate ligand coordinating through the phenolic oxygen, 
azomethine nitrogen and thiolate sulfur while 1,10-phenanthroline as the N,N’-bidentate 
ligand. Complex 11a with trigonality index τ of 0.58 can thus be described as trigonal 
bipyramidal distorted square based pyramid (TBDSBP). The τ value of 11a is slightly 
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higher than that of complex 9a. This could be attributed to the presence of an ethyl group in 
the N(4) position resulting in greater repulsion between the ligands. In order to minimize 
this repulsion, the geometry of the complex is distorted more towards a trigonal 
bipyramidal geometry.  
 
Selected bond lengths and angles are presented in Table 3.5. The imine bond 
formation in the complex is evidenced from N2-C8 and N1-C7 distances of 1.310 (3) and 
1.287 (3) Å. The C8-N2 bond length of 1.333(2) for the free ligand decreases to 1.310(3)  
while C8-S1 increases from 1.683(19) to 1.754(2) Å  upon complexation owing to partial 
loss and gain of double bond character in accordance to coordination of thiosemicarbazone 
in the thiolate form. Hydrogen bonds link the mononuclear molecule, the water and the 
dimethylformamide (DMF) molecules into a linear chain motif (Fig. 3.6) 
 
Fig. 3.6 Hydrogen bonding interactions for complex 11a 
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The molecules of 11a in the packing form infinite 2-dimensional array through extensive π-
π stacking between the aromatic rings of 1,10-phenanthroline as shown in Fig. 3.7.  
 
 
Fig. 3.7 Unit cell packing diagram of 11a view down in between a and c axes.  
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Table 3.5 
Selected bond lengths (Å) and angles (˚) for [Zn(phen)(HE)].H2O.DMF (11a) 
Bond lengths   Bond angles  
Zn1—O1 1.9636 (16) O1—Zn1—N1 90.55 (7) 
Zn1—N1 2.0719 (17) O1—Zn1—N4 111.50 (7) 
Zn1—N4 2.1165 (18) N1—Zn1—N4 96.27 (7) 
Zn1—N5 2.1583 (18) O1—Zn1—N5 93.26 (7) 
Zn1—S1 2.3508 (6) N1—Zn1—N5 174.04 (7) 
S1—C8 1.754 (2) N4—Zn1—N5 78.06 (7) 
O1—C1 1.321 (3) O1—Zn1—S1 139.27 (5) 
O2—C3 1.371 (3) N1—Zn1—S1 81.66 (5) 
N1—C7 1.287 (3) N4—Zn1—S1 109.08 (5) 
N1—N2 1.398 (2) N5—Zn1—S1 98.34 (5) 
N2—C8 1.310 (3) C8—S1—Zn1 92.59 (8) 
N3—C8 1.363 (3) C1—O1—Zn1 126.70 (13) 
N3—C9 1.458 (3)   
N4—C11 1.327 (3)   
N4—C15 1.351 (3)   
N5—C22 1.329 (3)   
 
Table 3.6 
Hydrogen-bond geometry (Å, °) for [Zn(phen)(HE)].H2O.DMF (11a) 
D—H···A D—H H···A D···A D—H···A 
O2—H2···O3 0.847 (10) 1.874 (11) 2.716 (3) 173 (3) 
O4—H41···O2 0.888 (10) 2.290 (17) 3.064 (3) 146 (3) 
O4—H42···O1i 0.889 (10) 1.931 (11) 2.804 (3) 167 (3) 
Symmetry codes: (i) −x+1, −y+1, −z+1. 
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3.3.3 Infrared and electronic spectra 
IR spectra for all the complexes are shown in Fig. 3.8. Important IR bands for the ligands 
and zinc complexes are listed in Table 3.7. In contrast to complexes of salicylaldehyde 
thiosemicarbazone, the bands around 3380 cm-1 due to ν(O-H) are still seen in the spectra 
of the complexes indicating that only one the phenolic oxygen from the ligands are 
deprotonated and involved in coordination. The deprotonation of the hydrazinic proton in 
accordance with coordination of the sulfur atom in the thiolate form is shown by the 
disappearance of the ν(N(2)-H) band in the spectra of all the complexes. (West et al., 1993; 
Latheef et al., 2007, 2008; Seena and Kurup, 2007, 2008; Lobana et al., 2008). 
 
Coordination of the azomethine nitrogen is confirmed by the shift of ν(C=N) from 
1620-1629 cm-1 to 1601-1604 cm-1. The coordination of the thiolate sulfur is supported the 
decrease in frequency of the thioamide band found at around 1302-1331 cm-1  and 867-868 
cm-1 to 1273-1327 and 800-848 respectively as reported by Campbell (1975).  The bands 
from 1231-1241 cm-1 due to ν(C-O) decrease by 20-40 cm-1 upon coordination confirm the 
coordination of the phenolic oxygen to zinc. The decrease of all these bands is due to the 
decrease in electron density upon complexation to the metal. The ν(N-N) of the 
thiosemicarbazones is found at 1121-1166 cm-1. Complexation will results in the increase 
in the frequency of this band upon due to the increase in the double bond character off-
setting the loss of electron density via donation to the metal and is a confirmation of the 
coordination of the ligand through the azomethine nitrogen atom (Latheef et al., 2007).  
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Table 3.7 
IR spectral assignments (cm-1) for the ligands and their zinc(II) complexes 
Compound ν(C=N) ν(C-O) ν(N-N) ν (C=S)/ 
 ν (C-S) 
ν(Zn-O) ν(Zn-N) Bands due to  
phenanthroline 
H3T (1) 1620 1239 1165 1379, 863 - - - 
H3M (2) 1625 1231 1166 1331,868 - - - 
H3E (3) 1626 1241 1166 1302, 867 - - - 
H3P (4) 1629 1264 1121 1323,838 - - - 
[Zn(phen)(HT)].H2O (9) 1604 1219 1181 1319, 848 554 426 1426,  726 
[Zn(phen)(HM)].H2O (10) 1601 1200 1184 1279, 848 550 430 1426,  726 
[Zn(phen)(HE)].H2O (11) 1601 1205 1121 1273, 845 554 421 1426,  726 
[Zn(phen)(HP)].H2O (12) 1603 1214 1171 1310, 800 503 - 1423,  726 
 
The appearance of new ν(Zn-N)  bands in the range of 421-426 cm-1 confirms the 
coordination through azomethine and polypyridine nitrogens. The presence of a new     
ν(Zn-O) band in the spectra of the complexes at 503-554  cm-1 is attributed to coordination 
of the phenolic oxygen (Latheef et al., 2007; Seena and Kurup, 2008).  
 
Electronic spectral assignments for the ligands and their zinc(II) complexes in DMF 
are presented in Table 3.8. All the ligands and the Zn(II) complexes have a ring (phenolic 
and diimine) π-π* band at around 37,593 cm-1 (West et al., 1995). No significant red shift is 
observed for these bands upon complexation (Swearingan and West, 2000). All the 
thiosemicarbazones also have two bands at around 32,985 cm-1 and 29,411 cm-1 due to n-π* 
transition of azomethine and thioamide function respectively. Upon complexation, the n-π* 
band of the thioamide function is shifted above 30,000 cm-1 due to thioenolization and 
merges with the azomethine  n-π* band at around 31,348 cm-1(Swearingan and West, 2000). 
  
128 
Thioenolization causes the weakening of the C=S bond.  A moderately intense band in the 
range 26,178-27,174 found only in the spectra of all the complexes is assigned to Zn(II)S 
metal to ligand charge transfer band (MLCT) (Latheef et al., 2007; Swearingan and West, 
2000). The MLCT band for Zn(II)O shows line broadening that runs into the visible part 
of the spectrum. However, the maxima of this band is not observed probably due to the 
overlapping with the low energy side of Zn(II)S transitions (Latheef et al., 2007; Seena 
and Kurup, 2008). The absence of bands below 22,000 cm-1 due to d-d transitions is in 
accordance with the d10 electron configuration of Zn(II) ion (Latheef et al., 2007; Seena and 
Kurup, 2008).  
Table 3.8 
Electronic spectral assignments (cm-1) for the ligands and their zinc(II) complexes in DMF . 
Compound π-π* n-π* MLCT 
H3T (1) 37593 33003, 29411  
H3M (2) 37593 33003, 29411  
H3E (3) 37593 32895, 29240  
H3P (4) 37453 32680, 28409  
[Zn(phen)(HT)].H2O (9) 37313 31646 26881 
[Zn(phen)(HM)].H2O (10) 37313 31348 27100 
[Zn(phen)(HE)].H2O (11) 37593 31348 27174 
[Zn(phen)(HP)].H2O (12) 37453 30769 26178 
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3.3.4 1H NMR spectra 
1H NMR spectral assignments for the ligands and their zinc(II) complexes in DMSO are 
presented in Table 3.9. The absence of the N(2)H signal in the spectra of all the complexes 
indicates the deprotonation of the hydrazinic proton and supports the coordination of sulfur 
in the thiolate form. The integration for phenolic protons decreases from two to one upon 
complexation suggesting deprotonation of one of the phenolic group and coordination of 
the oxygen atom to zinc. Coordination of the azomethine nitrogen is confirmed by the 
downfield shift of the -CH=N signal from 8.20-8.34 ppm in the free ligands to 8.35-8.52 
ppm in the spectra of the complexes due to a decrease in electron density around the proton 
of the azomethine linkage. Signal broadening resulted in inaccurate integration for these 
signals unlike those reported by Latheef et al. (2007) and observed by us in the bypyridine 
derivatives (chapter 2). However, the presence of the 1,10-phenanthroline moiety is 
supported by elemental analyses, IR spectroscopy and confirmed by the crystal structures 
of 9a and 11a. None of the complexes are sufficiently soluble in DMSO to record 
acceptable 13C spectra. 
 
Table 3.9 
1H NMR spectral assignments for the ligands and their zinc(II) complexes in DMSO 
Compound Chemical shifts, δ (ppm) 
 N(2)H OH N(4)H CH=N Aromatic Aliphatic 
H3T (1) 11.14 
(s, 1 H) 
9.74 (s, 2 H) 7.92 (s, 1 H) 
7.65 (s, 1 H) 
 
8.20 
( s, 1 H) 
 
7.62 (d, 1 H) 
6.25 (s, 1 H) 
6.22 ( d, 1 H) 
- 
H3M (2) 11.79 9.88 (s, 1 H) 8.24 (t, 1 H) 8.20 7.67 (d, 1 H) 2.95 (d, 3 H) 
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(s, 1 H) 9.74 (s, 1 H)  
 
( s, 1 H) 
 
6.26 (s, 1 H) 
6.24 ( d, 1 H) 
N-CH3 
H3E (3) 11.16 
(s, 1 H) 
9.76 (s, 2 H) 
 
8.31 (t, 1 H) 
 
 
8.26 
( s, 1 H) 
 
7.72 (d, 1 H) 
6.32 (s, 1 H) 
6.30 ( d, 1 H) 
3.57 (m, 2H) 
NCH2 
1.14 (t, 3H) 
NCH2CH3 
H3P (4) 11.54 
(s, 1 H) 
9.93 (s, 1 H) 
9.89 (s, 1 H) 
 
8.72 (s, 1 H) 
 
 
8.34 
( s, 1 H) 
 
7.82 (d, 1H) 
7.53 (d, 2H) 
7.33 (t, 2H) 
7.16 (t, 1H) 
 6.29 (s, 1H) 
 6.27 (d, 1H) 
- 
[Zn(phen)(HT)].H2O (9) Not sufficiently soluble in DMSO 
[Zn(phen)(HM)].H2O 
(10) 
- 9.04 (s, 1 H) 
 
6.21( s, 1 H) 
 
 
 
8.39 
(s, 1 H) 
 
8.89 (s, 2 H) 
8.78 (s, 2 H) 
8.15 (s, 2 H) 
8.02 (s, 2 H) 
6.95 (d, 1 H) 
5.66 (s, 1 H) 
5.88 ( d, 1 H) 
2.73 (d, 3 H) 
N-CH3 
Compound Chemical shifts, δ (ppm) 
 N(2)H OH N(4)H CH=N Aromatic Aliphatic 
[Zn(phen)(HE)].H2O 
(11) 
- 8.99 (s, 1 H) 
 
6.16 ( s, 1 H) 
 
 
8.35 
(s, 1 H) 
 
8.86 (s, 2 H) 
8.77 (s, 2 H) 
8.13 (s, 2 H) 
8.02(s, 2 H) 
6.92 (d, 1 H) 
5.62 (s, 1 H) 
5.85 ( d, 1 H) 
3.21 (m, 2H) 
NCH2 
1.01 (t, 3H) 
NCH2CH3 
[Zn(phen)(HP)].H2O 
(12) 
- 9.15 (s, 1 H) 8.56 (s, 1 H) 
 
8.52 
(s, 1 H) 
8.95 (s, 2 H) 
8.80 (s, 2 H) 
8.17 (s, 2 H) 
8.03(s, 2 H) 
- 
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7.81 (d, 2 H) 
7.18 (t, 2 H) 
7.04 (d, 1 H) 
6.82 (t, 1 H) 
5.91 (d, 1 H) 
5.67 ( s, 1 H) 
Table 3.9 continued 
 
3.3.5 DNA binding.   
3.3.5.1 Duplex DNA 
The interaction of complexes 10  and  11 with (i) duplex DNA of various specified 
nucleotide sequences, and (ii) quadruplex DNA of the 23-mer oligonucleotide 5’-
AG3(T2AG3)3-3’ and its corresponding duplex were investigated by using CD spectroscopy. 
Complexes 9 and 12 could not be studied due to limited solubility in DMF and buffer 
mixtures.   
 
Each of the CD spectra of all the duplex DNA show a negative band at ~250 nm 
due to DNA with right helicity and a positive band at ~275 nm due to base-pair stacking 
interaction, confirming the B-form conformation of these duplexes (Table 3.10). These 
bands are very useful in studying small molecules interacting with DNA because simple 
groove binding and electrostatic interaction of small molecules show less or no perturbation 
on the base-stacking and helicity bands, while intercalation enhances the intensities of both 
the bands due to stabilization of the right-handed B conformation of DNA (Maheswari and 
Palaniandavar, 2004). 
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 As in chapter 2, the first investigation was to find out the DNA binding preference 
for CG or AT sequences by zinc complexes 10 and 11 (Table 3.10). Complex 10 at a 
complex:duplex ratio of 1:8 causes a significant change to the CD spectrum of ds(AT)6. 
Complex 10 induces a decrease in the negative band and a drastic increase of the positive 
band accompanied by a red shift of 5 nm from 270 nm (Fig. 3.9). Similar changes with 
greater magnitude are observed for complex 11 with a red shift of the positive band from 
270 nm to 276 nm in the Cd spectrum of ds(AT)6 (Fig. 3.10). These changes are consistent 
with a change of confirmation from   B-like to A-like which is surprisingly not observed in 
its 2,2'-bipyridine analog (complexes 6 and 7) (Maheswari and Palaniandavar, 2004).  Since 
complexes 10 and 11 induced similar conformation changes to ds(AT)6, we can compare 
their binding strength to AT rich sequence based on the changes in intensity of the positive 
band in the CD spectra. The increase in intensity of the positive band for complex 11 (62%) 
is much greater compared to complex 10 (18%). This suggests that complex 11 binds more 
strongly to ds(AT)6. Seng et al. (2009) have studied the binding selectivity of bis(3-
methylpicolinato)(1,10-phenanthroline)-zinc(II), [Zn(3-Me-pic)2(phen)] towards 
ds(oligonucleotide) with different base sequences by using CD and ethidium bromide 
displacement assay (binding constant determination). The greater enhancement of positive 
band in the CD spectra seems to be directly proportional to the apparent binding constant 
obtained from ethidium bromide displacement assay for [Zn(3-Me-pic)2(phen)], towards 
different ds(oligonucleotide). 
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.  
Fig. 3.9 CD spectra of 15 μM of oligonucleotide in the absence and presence of 120 
μM of complex 10; (a) ds(AT)6 alone, (b) ds(AT)6 with complex 10, (c) ds(CG)6 alone and 
(d) ds(CG)6 with complex 10. 
 
 
Fig. 3.10 CD spectra of 15 μM of oligonucleotide in the absence and presence of 120 μM of 
complex 11; (a) ds(AT)6 alone, (b) ds(AT)6 with complex 11, (c) ds(CG)6 alone and (d) 
ds(CG)6 with complex 11 
 
On the other hand, complexes 10, Zn(phen)(HM), and 11, Zn(phen)(HE), show a 
significant decrease in the negative band (helixcity) of the CD spectrum of ds(CG)6 without 
appreciable changes to the positive band. Similar observations have been reported for 
complex 6, Zn(bipy)(HM). However, complex 7, Zn(bipy)(HE) does not induce such 
changes. The distinct differences in their interactions with DNA between complex 7, 
Zn(bipy)(HE) and complex 11, Zn(phen)(HE) derived from H3E suggest that the presence 
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of the 1,10-phenanthroline moiety can also alter mode of binding as well as the ability of a 
complex in recognizing different DNA sequences.  By comparing the changes of the 
positive and negative bands in the CD spectra of the CG and AT rich sequences, we can 
infer that complexes 10 and 11 can effectively differentiate CG from AT rich sequence base 
on their different mode of interaction with the DNA. Since three out of four zinc complexes 
in our study derived form alkyl substituted thiosemicarbazone induced similar unwinding 
of ds(CG)6, it is possible that the alkyl substituent at the N(4) position plays a key role in 
recognizing CG rich sequence.  
 
We next utilised oligonucleotides such as ds(CGCGAATTCGCG)2 (referred to as 
AATT sequence) and ds(CGCGATATCGCG)2 (referred to as ATAT sequence) to 
investigate any binding preferences in interactions with duplex DNA as the sequence on 
each chain is varied from non-alternating to alternating purine-pyrimidine bases in grooves 
of the duplex.  For the AATT sequence (Fig. 3.11), complex 10 causes a respective 
decrease and increase in the negative and positive bands of the CD spectra of the duplex 
which correspond to conformational change from B to ψ, which we mentioned earlier 
(Maheswari and Palaniandavar, 2004; Seng et al. 2008). This observation also suggests 
partial intercalation of complex 10 to the duplex. However, complex 11 shows a decrease in 
the negative band without significant changes to the positive band. This indicates that 
complex 11 binds to the AATT sequence and causes the unwinding of the DNA similar to 
its interaction with ds(CG)6 discussed earlier. For the interaction with ATAT rich sequence, 
complex 10 and 11 show an increase for both the positive and negative bands which is 
consistent with intercalation mode of binding to DNA (Maheswari and Palaniandavar, 
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2004; Seng et al. 2008).  Greater enhancement of the positive band by complex 11 suggests 
that it binds more strongly to the ATAT sequence compared with complex 10. Comparing 
the results for interactions with AATT and ATAT sequence, we can infer that complex 10 
and 11 can differentiate ATAT from AATT sequence (Seng et al. 2009). 
 
 Comparing the CD results of these four ds(oligos)2, we can conclude that complex 
10, Zn(phen)(HM) and 11, Zn(phen)(HE) can differentiate ds(oligonucleotide) with 
different base sequences. However, the order of selectivity for each ds(oligonucleotide) is 
not clear since the complex can induce different conformational changes to 
oligonucleotides with different base sequences.  In addition, we also noticed that complex 
11 always induces greater changes (%) to the CD spectra of the four ds(oligos)2 when 
compared with complex 10. This may be attributed to the higher hydrophobicity of 
complex 11 with an ethyl substituent. This observation again underscores the role of 
hydrophobicity in enhancing drug-DNA interactions (Talib et al. 2008; Maheswari et al. 
2006). 
 
We postulate that the observed DNA recognition is conferred by the ability of the 
complexes to form hydrogen bonds with the DNA through various hydrogen donor and 
acceptor groups on the thiosemicarbazone moiety. The different length of the alkyl group of 
the N(4)-substituent seems to be responsible in DNA recognition through hydrophobic 
interaction or grooves binding because each complex has substituent with different 
hydrophobicity. The size of the molecules and the orientation of different substituted bulky 
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group in space may affect their ability to bind into the groove (major or minor) with 
different cavity size or steric hindrance.  
 
Fig. 3.11 CD spectra of 10 μM of oligonucleotides in the absence and presence of 120 μM 
of complex 10; (a) ds(CGCGATATCGCG)2 alone, (b) ds(CGCGATATCGCG)2 with 
complex 10, (c) ds(CGCGAATTCGCG)2 alone, and (d) ds(CGCGAATTCGCG)2  with 
complex 10. 
 
Fig. 3.12 CD spectra of 10 μM of oligonucleotides in the absence and presence of 120 μM 
of complex 11; (a) ds(CGCGATATCGCG)2 alone, (b) ds(CGCGATATCGCG)2 with 
complex 11, (c) ds(CGCGAATTCGCG)2 alone, and (d) ds(CGCGAATTCGCG)2  with 
complex 11. 
 
3.3.5.2 G-quadruplex and guanine-rich duplex 
As mentioned in section 2.3.5, the guanine-rich region of DNA such as in human telomeric 
DNA, can be folded into higher-order DNA structure known as G-quadruplex under 
physiological (ionic) conditions (Burge et al. 2006). There is growing interest in complexes 
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that can induce or stabilize quadruplex structure due to the discovery that these complexes 
can lead to inhibition of telomerase (Neidle and Parkinson, 2002). Even though most of 
these initial studies involve the interaction of quadruplex with organic molecules having 
aromatic rings (Pivetta et al. 2008; White et al. 2007; Yamashita et al. 2005;  Nagesh and 
Krishnaiah, 2003), increasing interest regarding interaction with metal complexes has been 
observed in recent publications (Reed et al. 2009; Pierce et al. 2009; Arola and Vilar, 2008; 
Arola et al. 2008). A peculiar similarity among these complexes is most them involve metal 
complexes containing phenanthroline that may favour π-π stacking interactions with the 
guanine quartet (Reed et al. 2009 and 2007; Musetti et al. 2009; Talib et al. 2008; Shi et al. 
2008). We are curious whether interactions of metal complexes containing phenanthroline 
with G-quadruplex can be improved with the presence of a secondary ligand such as a 
thiosemicarbazone. 
 
The CD spectra of the 20 μM of the antiparallel G-quadruplex 5’-AG3(T2AG3)3-3’ 
with complexes of 10 and 11 (120 μM) were monitored.  The intensity of the positive band 
for G-quadruplex at 296 nm is greatly enhanced while the negative band at 265 nm also 
increases in intensity upon addition of complexes 10 and 11. A blue shift of 3 nm is 
observed for the negative band at 265 nm. Furthermore, an induced peak at 280 nm is 
observed for the interaction of both complexes with G-quadruplex. This induced peak may 
be attributed to presence of an additional chromophore on the chiral DNA backbone upon 
strong binding of the complex to DNA. The presence of an induced CD signal is commonly 
observed in binding of achiral porphyrins to chiral DNA (Yamashita et al. 2005).   The 
overall shape of the G-quadruplex remains unchanged, suggesting retention of the 
antiparallel structure (Fig. 3.13, Table 3.10).  
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Table 3.10 
CD spectral bands of duplex oligo or quadruplex + copper complex: wavelength, λ  
(molar  ellipcity) 
 λ/nm (molar ellipcity) 
(-) band (+) band 
15 µM ds(AT)6 248 (-472333) 270 (389404) 
15 µM ds(AT)6 + 120 µM complex 10 249 (-438211) 275 (458228) 
15 µM ds(AT)6 + 120 µM complex 11 250 (-366571) 276 (633852) 
15 µM ds(CG)6 253 (-346082) 278 (211135) 
15 µM ds(CG)6 + 120 µM complex 10 253 (-568230) 280 (203041) 
15 µM ds(CG)6 + 120 µM complex 11 253 (-335693) 276 (224090) 
10 µM ds(CGCGAATTCGCG)2 251 (-603665) 279 (215560) 
10 µM ds(CGCGAATTCGCG)2 + 120 
µM complex  10 
252 (-584490) 278 (230681) 
10 µM ds(CGCGAATTCGCG)2 + 120 
µM complex  11 
252 (-537811) 279 (213212) 
10 µM ds(CGCGATATCGCG)2 248 (-286559) 277 (174875) 
10 µM ds(CGCGATATCGCG)2 + 120 
µM complex 10 
251 (-349413) 276 (262921) 
10 µM ds(CGCGATATCGCG)2 + 120 
µM complex 11 
250 (-302377) 275 ( 310441) 
20 µM G-duplex 250 (-82682) 279 (283975) 
20 µM guanine-rich duplex+ 120 µM 
complex 10 
252 (-32694) 279 (175916) 
20 µM guanine-rich duplex+ 120 µM 
complex 11 
251 (-145729) 280 (603383) 
20 µM G-quadruplex 265 (-151753) 247 (75789)  
295 (161061) 
20 µM G-quadruplex + complex 10 262 (-232022) 245 ( 27533) 
280 (248906) 
295 (273842) 
20 µM G-quadruplex + complex 11 262 (-229848) 245 (45920) 
280 (333735) 
295 (309068) 
Guanine-rich duplex  =(5’-CCAGTTCGTAGTAGTAACCC-3’)·(3'-GGTCAAGCATCATCATTGGG-5’)  
 
The possibility of the formation of a mixture of parallel and antiparallel components 
or G-quadruplex structures is ruled out because the induced positive peak is at 280 nm and 
not at 272 nm which is characteristic of parallel structure. Furthermore, there is a 
significant increase in the negative band at 262 nm that disagreed with the formation of 
parallel structure. Therefore, it is very likely that the induced peak at 280 nm is from the 
strong absorbance of the complex at 267 nm (Shi et al. 2008).  
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Shi et al. (2008) have suggested that the induced CD signal that they observed at 272 nm 
may be induced through the strong absorbance of Ru2(obip)L4 (obip = 2-(2-
pyridyl)imidazo[4,5-f][1,10]-phenanthroline) at about 280 nm. 
 
The enhancement of the positive band at 296 nm due to G-G base stacking suggests 
partial intercalation of phenanthroline between G-tetrads by the zinc complex similar to 
enhancement of positive, base-base stacking band at ~270 nm attributed to intercalation of 
the B-form duplex DNA. This observation is in contrast to those observed for the 
interactions of acridine and bis-acridine with G-quadruplex where the decrease in the 
intensity of the positive band at 293 nm was interpreted as destabilization of the quadruplex 
structure (Nagesh et al. 2003). Thus, enhancement of the positive band of the CD spectrum 
of the present quadruplex suggests stabilization of the antiparallel quadruplex structure by 
our zinc complexes as suggested by Musseti et al. (2009). The greater enhancement of the 
positive band at 295 nm in contrast to its 2,2'-bipyridine analog (chapter 2) implies that the 
presence of an extended aromatic ring on the phenanthroline moiety enhances the ability of 
the complex to bind to the quadruplex structure through intercalation. The greater 
enhancement of the positive band for complex 11 compared with complex 10 suggests that 
complex 11 binds more strongly to the G-quadruplex. This may be attributed to the 
presence of a more hydrophobic ethyl group in complex 11 in contrast to the methyl group 
at the N(4) position in complex 10. 
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Fig. 3.13 CD spectra of  20 μM of G-quadruplex in the absence and presence of 120 μM of 
complex; (a) G-quadruplex alone, (b) G-quadruplex  with complex 10, (c) G-quadruplex  
with complex 11 
 
Talib et al. (2008) found that ruthenium(II) complexes with known intercalating 
ligands, viz. [Ru(phen)2(dpqC)]2+, [Ru(phen)2(dpq)]2+, [Ru(phen)2(dppz)]2+ and 
[Ru(phen)3]2+ complexes have higher binding affinity towards duplex DNA than towards 
quadruplex. This has prompted us to carry out preliminary investigation regarding the 
interaction of complexes 10 and 11 with guanine-rich duplex DNA annealed from two 
complementary 17 bp primers, 5’-CCAGTTCGTAGTAACCC-3’ and 3’-
GGTCAAGCATCATTGGG-5’. Complex 10 (Fig. 3.14, Table 3.10) induces a great 
decrease in both the positive and negative bands. This indicates that complex 10 binds to 
guanine-rich duplex and the binding leads to conformational change from B like to Z 
(Mahadevan and Palaniandavar, 1996). Complex 11 (Fig. 3.14, Table 3.10) shows drastic 
increase in both the positive and negative bands which indicates strong intercalation to the 
guanine-rich duplex (Maheswari and Palaniandavar, 2004). These observations again 
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illustrate the ability of the N(4) substituent in altering the interaction of the zinc complex 
with DNA. 
 
 
Fig. 3.14 CD spectra of  20 μM of guanine-rich duplex in the absence and presence of 120 
μM of complex; (a) guanine-rich duplex alone, (b) guanine-rich duplex with complex 10, 
(c) guanine-rich duplex with complex 11, (d) guanine-rich duplex with complex 18 and (e) 
guanine-rich duplex with complex 19 
 
By comparing the extent of changes induced in both the positive and negative bands 
of G-quadruplex and guanine-rich duplex when they interact with the complexes, we 
cannot conclude the selectivity of the complexes towards different DNA structures. This is 
attributed to the difference in conformational changes of quadruplex and duplex DNA upon 
binding to the complexes. The selectivity towards different DNA structures can be easily 
determined with CD if the complexes only bind to either duplex or quadruplex structure. 
The selectivity can also be determined if the complex induced similar conformational 
changes to quadruplex and duplex DNA. When the conformational changes are the same, 
the strength of binding to the DNA structure can be derived by comparing the percentage 
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changes in either the positive or negative band of the CD spectra. However, we can still 
conclude that complexes 10 and 11 can differentiate guanine-rich duplex structure from G-
quadruplex. 
 
3.3.6 Nucleolytic study 
As in chapter 2, we similarly examine the ability of complexes 10 and 11 to cleave 
pBR322 under hydrolytic conditions and in the presence of exogenous agents, sodium 
ascorbate and hydrogen peroxide, using gel electrophoresis. Complexes 9 and 12 could not 
be studied due to their limited solubility in DMF and other buffer mixtures. Incubating the 
zinc complexes with pBR322 at varying concentrations of the zinc complex (10 – 1000 
μM) for 24 h at 37 oC, slight DNA cleavage was observed for complexes 10 (Fig. 3.15, 
Lane L8 & L9)  and 11  (Fig. 3.16: Lane L5, L8 & L9).  Complexes 10 and 11 can cleave 
the DNA at 500 μM with the appearance of a nicked band with very low intensity. 
Interestingly, complex 11 started to show very weak cleavage at 10 μM (Fig. 3.16: Lane 
L5) that diminished at 50 and 200 μM. The exact nature of this cleavage at such low 
concentrations is not clear but it could be attributed to slight dissociation of the complex to 
another species.   
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Fig. 3.15 Electrophoresis results of incubating pBR322 (0.5 μg/μL) in the presence of 
complex 10 in TN buffer (5 mM Tris, 50 mM NaCl) pH 7.5 at 37 oC for 24 h.  L1 & L4, 
gene ruler 1 Kb DNA ladder; L2, DNA alone; L3, DNA + 1000 μM ZnCl2; DNA + various 
complex concentrations L5-L9: L5, 10 μM; L6, 50 μM; L7, 200 μM; L8, 500 μM; L9, 1000 
μM. 
 
 
Fig. 3.16 Electrophoresis results of incubating pBR322 (0.5 μg/μL) in the presence of 
complex 11 in TN buffer (5 mM Tris, 50 mM NaCl) pH 7.5 at 37 oC for 24 h.  L1 & L4, 
gene ruler 1 Kb DNA ladder; L2, DNA alone; L3, DNA + 1000 μM ZnCl2; DNA + various 
complex concentrations L5-L9: L5, 10 μM; L6, 50 μM; L7, 200 μM; L8, 500 μM; L9, 1000 
μM. 
 
When the DNA was incubated with 300 μM of zinc complex in the presence of 30 
μM sodium ascorbate or 30 μM hydrogen peroxide no activation of zinc complexes towards 
DNA cleavage by sodium ascorbate or hydrogen peroxide is observed as the gel pattern is 
the same as that for DNA alone (results not shown).  No cleavage was observed even when 
Complex 10 
Complex 11 
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the concentration of hydrogen peroxide was varied from 250 μM to 500 μM by maintaining 
the complex concentration at 300 μM (results not shown). 
 
3.3.7 Topoisomerase I inhibition assay 
Of the four complexes 9-12, only complexes 10 and complex 11 can be studied due 
to solubility problem (see previous section). As a preliminary investigation into the 
mechanism of action of topo I inhibition by 10 and 11, we used three variations of mixing 
the DNA, topo I and the zinc complexes (at 40 µM). When the three components are mixed 
simultaneously for complex 10, there is slight inhibiton of topo I as seen by the presence of 
various bands of DNA with different degree of relaxation between Form I and Form II (Fig. 
3.17, lane L5). Secondly, when complex 10 was incubated first with topo I before the 
addition of DNA; the intensity of the slowest moving band (Form II) was the lowest 
suggesting best inhibition of topo I (Fig. 3.17, lane L6). Further, when the DNA is first 
incubated with complex  10 for 30 minutes before adding the topo I (Fig. 3.17, lane L7), the 
fastest moving band (Form I) almost totally disappears. The intensity of Form II is slightly 
lower compared to lane L5 but slightly higher than lane L6. This implies that the degree of 
topoisomerase inhibition is intermediate between those observed for the first and second 
methods of mixing. Therefore the order of topoisomerase inhibition decreases with the 
following sequence of mixing; (b) > (c) > (a) (Fig. 3.17). 
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.  
Fig. 3.17 Effect of sequence of mixing for the human topoisomerase I inhibition assay of 
complex 10. Electrophoresis results of incubating human topoisomerase I (1 unit/21μL) 
with pBR322: Lane 1, 1 kb DNA ladder; Lane 2, Plasmid DNA pBR 322 (control); Lane 3, 
DNA + 40µM complex (control); Lane 4, DNA+ 1 unit Human Topoisomerase I (control); 
(a) All components mixed at the same time; Lane 5, DNA + 40µM complex + 1 unit 
Human Topoisomerase I ; (b) Complex + TopoI incubated for 30 minutes first before DNA 
is added; Lane 6, DNA + 40µM complex + 1 unit Human Topoisomerase I; (c) Complex + 
DNA incubated for 30 minutes first before TopoI is added; Lane 7, DNA + 40µM complex 
+ 1 unit Human Topoisomerase I 
 
When the experiment was repeated with complex 11, a similar order of inhibitions 
is seen. However, complex 11 (Fig. 3.18, lane L6) shows better topoisomerase I inhibition 
activity when compared with complex 10, (Fig. 3.17, lane L6) as seen from the greater 
intensity in the fastest moving band (Form I) and lower intensity in the slowest moving 
band (Form II). The disappearance of the fastest moving band (Form I) for complex 10, 
(Fig. 3.17, lane L6) further supports better inhibition of topoisomerase I by complex 11.  
Unlike complexes 10 and 11, its 2,2'-bipyridine analogs (complex 6 and 7) do not show any 
topoisomerase inhibition. This shows that incorporation of a 1,10-phenanthroline moiety in 
the ternary zinc complex has led to improvement in topoisomerase inhibition, most 
probably owing to its improved binding strength to AT rich sequence.  
 (a)   (b)  (c) 
 Form I 
 Form II 
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Fig. 3.18 Effect of sequence of mixing for the human topoisomerase I inhibition assay of 
complex 11. Electrophoresis results of incubating human topoisomerase I (1 unit/21μL) 
with pBR322: Lane 1, 1 kb DNA ladder; Lane 2, Plasmid DNA pBR 322 (control); Lane 3, 
DNA + 40µM complex (control); Lane 4, DNA+ 1 unit Human Topoisomerase I (control); 
(a) All components mixed at the same time; Lane 5, DNA + 40µM complex + 1 unit 
Human Topoisomerase I ; (b) Complex + TopoI incubated for 30 minutes first before DNA 
is added; Lane 6, DNA + 40µM complex + 1 unit Human Topoisomerase I; (c) Complex + 
DNA incubated for 30 minutes first before TopoI is added; Lane 7, DNA + 40µM complex 
+ 1 unit Human Topoisomerase I 
 
These observed differences in inhibition of topo I suggest initial binding of the zinc 
complex to either the topo I or the DNA give rise to differences in mode of action. 
Therefore, two pathways of toposisomerase inhibition are suggested, one involves the 
binding of complex to DNA while the other involves the binding to toposiomerase. By 
comparing lanes L6 and L7, we infer that since greater inhibition of topo I is observed 
when the complex is incubated with topo first, the inhibition process involving the binding 
of the complex to the topoisomerase enzyme may be a more dominant pathway. However, 
further investigation is crucial to confirm this. 
 
  (a)      (b)       (c) 
 Form I 
 Form II 
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3.3.8 Antibacterial and antifungal assays 
3.3.8.1 Antibacterial activity 
The antibacterial activity of the ligands and complexes 10 and 11 were assessed against two 
species of Gram positive bacteria and four species of Gram negative bacteria (Table 3.11).  
Complexes 9 and 12 could not be studied due to limited solubility in DMF and buffer 
mixture.  
Table 3.11. 
 Mean MIC value (µg/mL) towards microbes tested. 
Complex Bacteria 
 S. aureus B. cereus P. aeruginosa K.  pneumoniae E. coli  E. coli  
              
(penicillin- 
sensitive strain) 
(penicillin- 
resistant strain) 
1 62.50 62.50 62.50 62.50 62.50 62.50 
2 125 62.50 125.00 62.50 62.50 62.50 
3 62.50 62.50 62.50 62.50 62.50 62.50 
4 62.50 31.25 62.50 31.25 62.50 62.50 
10 62.50 31.25 52.08±18.04 31.25 62.50 62.50 
11 62.50 15.63 31.25 31.25 31.25 31.25 
ZnCl2 - - - - - - 
phen 62.50 15.63 15.63 15.63 15.63 15.63 
Drug 8.00 4.00 4.00 4.00 4.00 4.00 
 “ - ” : no activity . Drug used in antibacterial assay = Chloramphenicol     
  
All thiosemicarbazones ligands are less potent than 1,10-phenanthroline ligand 
since their MIC values are either two times or much higher than 1,10-phenanthroline alone. 
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Complex 10, Zn(phen)(HM) shows improved antibacterial activity towards B. cereus, P. 
aeruginosa and K.  pneumoniae compared with its free thiosemicarbazone ligand (H3E)( 
Table 3.11). On the other hand, complex 11, Zn(phen)(HE) shows improvement in 
antibacterial activity towards all the strains in our study except for S. aureus when 
compared to ligand 3, H3E. However, the MIC values for both complexes are higher than 
the free 1,10-phenanthroline ligand for all the bacteria except for complex 11 against B. 
cereus. This implies that the ternary complexes did not achieve the desired improvement in 
antibacterial activity because its potency did not surpass both Schiff base and 1,10-
phenanthroline ligands. However, complex 11 with a more hydrophobic ethyl chain still 
shows better antibacterial activity for most of the bacteria strains when compared with 
complex 10 with a methyl chain. Furthermore, complexes 10 and 11 also show better 
antibacterial activity than their 2,2'-bipyridine analog probably owing to the increase in 
hydrophobicity, stronger binding to AT rich sequences and topoisomerase I inhibition 
capability of these complexes that resulted from substitution of 2,2'-bipyridine with 1,10-
phenanthroline. Recently, Mazumder et al. (2004) have studied the antibacterial activity of 
some mononuclear ruthenium complexes with the general formula of [Ru(B)2L]Cl2 ( B = 
1,10-phenanthroline or 2,2'-bipyridine; L = aze = acetazolamide; r-tsc = 4-substituted 
thiosemicarbazides;  nmit = N-methyl-isatin-3-thiosemicarbazone and icpl = isatin-3-(4-
chlorophenyl) thiosemicarbazone). They found that 1,10-phenanthroline imparted greater 
biological activity to the complexes than their 2,2'-bipyridine containing analogs. In 
addtition, complexes bearing bulky ligands such as nmit and icpl were found to be more 
biologically active than complexes with aze. Thus, it seems that the antibacterial activity of 
the complexes is influenced by size and the substituent groups in the ligands as reported by 
us. 
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Since the site of action of thiosemicarbazone is ribonucleotide reductase (RR) 
(Finch et al. 1999), one of the possible mechanisms of the present compounds could be 
inhibition of DNA synthesis by controlling the inhibition of RR as suggested by Pandeya et 
al.  (1999). RR is responsible in catalyzing the reduction of the 2-carbon atoms of the D-
ribose portion of the ribonucleotide directly reduced to form the 2-deoxyribonucleotides 
derivative. Inactivation of RR in general leads to the reduction of intracellular pools of 
deoxyribonucleotides and that will affect the biosynthesis of DNA and thus the death of the 
bacteria. 
 
The antibacterial activity of both complexes 10 and 11 can be attributed to their 
ability to inhibit toposiomerase I. Toposiomerase I has been gaining popularity lately as a 
good target for the development of antibacterial drug (Tse-Dinh, 2009). This could be 
attributed to the success of the currently marketed inhibitors such as the quinolones 
dervatives (Bradbury and Pucci, 2008).  
 
3.3.8.2 Antifungal activity 
The antifungal activity of the ligands and complexes 10 and 11 were assessed against four 
species of fungi. Complexes 9 and 12 could not be studied due to limited solubility in DMF 
and buffer mixture. All ligands and complexes had some degree of inhibitory activity 
against the fungi tested (Table 3.12).   
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 Complex 10 only shows marked improvement in antifungal activity towards C. 
neoformans with MIC value of 7.81 µg/mL when compared with 1,10-phenanthroline and 
its free thiosemicarbazone ligand. Whereas, complex 11 shows improvement in antifungal 
properties towards C. neoformans and A. niger. In general, antifungal activity of complex 
11 is better than complex 10 towards C. parapsilosis and A.niger. This again shows that the 
presence of a longer alkyl chain in complex 11 makes it a better antifungal agent than 
complex 10 for C. parapsilosis and A. niger fungal strain. The ability of complexes 10 and 
11 in inhibiting A. niger is noteworthy since other ligands and complexes derived from 
salicylaldehyde thiosemicarbazones are inactive towards this strain (Valdes-Martinez et al. 
1996). Both complexes show very good antifungal property towards C. neoformans with 
MIC value of 7.81 µg/mL. Complexes 10 and 11 also have lower MIC value compared 
with their 2,2'-bipyridine analogs. This implies that the presence of the phenantroline 
moiety can also lead to improvement in antifungal activity. 
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Table 3.12. 
Mean MIC value (µg/mL) towards fungi tested. 
 Compound Fungi 
 C. albicans C. parapsilosis C. neoformans A.niger 
              
1 31.25 62.50 31.25 62.50 
2 31.25 31.25 31.25 62.50 
3 31.25 31.25 31.25 62.50 
4 31.25 62.50 7.81 31.25 
10 15.63 31.25 7.81 62.50 
11 15.63 15.63 7.81 7.81 
ZnCl2 - - - - 
phen 3.91 3.91 31.25 31.25 
Drug 1.00± 2.00 1.00 4.00 
 “ - ” : no activity . Drug used in antifungal assay = fluconazole  
 
3.4 Conclusion 
Spectroscopic and crystal data reveal that all the zinc complexes are five-coordinated with 
the doubly deprotonated thiosemicarbazones acting as a tridentate ligand that coordinated 
through one phenolic oxygen, azomethine nitrogen and thiolate sulfur atoms while the 1,10-
phenanthroline is coordinated as the N,N’-bidentate ligand. The coordination geometry 
around these zinc complexes is intermediate between trigonal bipyramidal and square 
pyramidal geometries and is better described as trigonal bipyramidal distorted square based 
pyramid (TBDSBP). The coordination geometry around zinc complexes with 2,2'-
bipyridine is retained when 2,2'-bipyridine is substituted by 1,10-phenanthroline. 
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Results from biological tests indicate that the N(4) substituent play crucial role in 
determining the selectivity and potency of zinc(II) complexes of 2,4-
dihydroxybenzaldehyde N(4)-substituted thiosemicarbazones and 1,10-phenanthroline. 
Only the biological properties for complexes 10 and 11 can be studied attributed to their 
better solubility in DMF and buffer mixtures. Complex 11 has better selectivity for AT rich 
sequence and binds stronger to most duplex DNA sequence than complex 10. In addition, 
complex 11 also has better antibacterial, antifungal and toposiomerase I inhibition activities 
compared with complex 10. Since the major difference between these two complexes is just 
the length of the alkyl chain at the N(4) substituent, we can infer that the difference in 
hydrophobicity can exert a great effect on the biological potency of thiosemicarbazones and 
its ternary zinc complexes. Complexes 10 and 11 have the potential to be developed as an 
anticancer agent because complexes that can inhibit topoisomerase I and most complexes 
that show good antifungal property are normally cytotoxic.  
 
 When the biological properties of complexes 10 and 11 were compared with their 
2,2'-bipyridine analogs, a drastic improvement in all assays is observed. This implies that 
the extended aromatic ring in the 1,10-phenanthroline moiety bestows a complex with 
better biological properties that can be attributed to enhanced hydrophobicity or 
intercalating capability which is known in extended polypyridine ligands like phen, dpq or 
dppz. Even though the 1,10-phenanthroline moiety has led to improvement of a wide 
spectrum of biological activities, but this strategy has it limitations. The enhanced 
hydrophobicity has led to a decrease in water solubility which is a major challenge in 
biological assays. Complex 12, which is the analog of complex 8 with good biological 
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properties could not be tested owing to solubility problems. Therefore, care must be taken 
in juggling between features that can enhance biological properties with those that can 
affect water solubility in the design of metal-based drugs. 
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Chapter 4 
Synthesis, characterization and biological properties of copper(II) complexes of       
2,4-dihydroxybenzaldehyde N4-substituted thiosemicarbazones and 2,2'-bipyridine 
4.1. Introduction   
The results in chapter 2 show that the N(4) substituents in zinc(II) complexes of 2,4-
dihydroxybenzaldehyde N(4)-substituted thiosemicarbazones and 2,2-bipyridine 
(Zb(bipy)L) can affect their biological activities, viz. DNA sequence recognition, 
quadruplex binding, topoisomerase I inhibition, antibacterial and antifungal properties. 
However, these zinc complexes are lacking in nucleolytic efficiency. Since the biological 
properties of metal complexes with similar ligands are known to vary with the central metal 
ion (Bal et al. 2000; Kong and Xie, 2000; Roy et al. 2007; Seng et al. 2008), we replaced 
the zinc(II) ion with copper(II) ion in an attempt to improve the biological activities of 
these complexes that we mentioned earlier.  Copper complexes containing heterocyclic 
base are well known for its ability to cleave DNA in the presence or absence of exogenous 
agents (Dhar et al. 2005; Patra et al. 2005 & 2007; Rao et al. 2007 & 2008). Previously, 
Seng et al. (2008) have shown that nucleolytic efficiency order  of M(phen)(edda) (in the 
presence of hydrogen peroxide) is Cu(phen)(edda) > Co(phen)(edda) >Zn(phen)(edda) > 
Ni(phen)(edda). Whereas in the presence of 1 μM ascorbic acid, the DNA cleavage of 50 
μM Cu(phen)(edda) was greatly enhanced as nearly all the supercoiled plasmid was 
converted to nicked and linear. The addition of this amount of ascorbic acid did not affect 
the nucleolytic efficiency of the other metal complexes.  Furthermore, copper(II) ion was 
chosen because its known to enhance the anticancer properties of thiosemicarbazones 
(West et al. 1993; Bindu et al. 1998; Wang and Guo, 2006). Cross comparison of the 
  
155 
chemical and biological properties of this series with the zinc(II) series in chapter 2 may 
help in understanding the effect of varying the metal ions in complexes with same ligand. 
 
Therefore in this chapter, we report the effect of varying the N(4) substituent of the 
thiosemicarbazone ligand, L from proton, methyl, ethyl to phenyl towards the chemical and 
biological properties (DNA binding, nucleolytic, topoisomerase I inhibition and 
antimicrobial) of Cu(bipy)L. 
 
4.2. Experimental 
4.2.1. Materials and solutions 
Similar materials were used as reported in chapter 2. 
 
4.2.2. Physical measurements 
Spectroscopic measurements and elemental analyses were similarly carried out as reported 
in chapter 2.  
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4.2.3. Syntheses 
4.2.3.1 Synthesis of (4-Hydroxy-2-oxidobenzaldehyde thiosemicarbazonato)-(2,2-
bipyridine)copper(II) monohydrate , [Cu(bipy)(HT)]H2O (13) 
Copper acetate dihydrate (0.22 g, 1 mmol) and 2,2-bipyridine (0.16 g, 1 mmol) were 
reacted with 2,4-dihydroxybenzaldehyde thiosemicarbazone (0.21 g, 1 mmol) as reported in 
chapter 2. 
(Yield: 0.23 g, 52 %). Anal. Calc. for C18H16N5O3SCu: C, 48.37; H, 3.83; N, 15.67. Found: 
C, 48.38; H, 3.40; N, 16.94 %. IR (KBr disc, cm-1): 3436 w, 3352 m, 3277 w, 3158 w, 3087 
w, , 1602 s, 1496 s, 1442 m, 1313 m, 1257 m, 1223 s, 1179s , 1123 m, 841 w, 762 m, 555 
w, 430 w (s, strong; m, medium; w, weak). 
 
4.2.3.2 Synthesis of (4-Hydroxy-2-oxidobenzaldehyde 4-methylthiosemicarbazonato)-(2,2-
bipyridine)copper(II) monohydrate, [Cu(bipy)(HM)]. H2O (14) 
Complex 14 was similarly prepared as complex 13 by using 2,4-dihydroxybenzaldehyde 4-
methylthiosemicarbazone (0.23 g, 1 mmol) as the Schiff base. 
(Yield: 0.35 g, 75 %). Anal. Calc. for C19H19N5O3SCu: C, 49.50; H, 4.15; N, 15.19. Found: 
C, 49.68; H, 3.76; N, 15.62 %. IR (KBr disc, cm-1): 3392 m (broad), 3069 w, 1603 s, 1444 
m, 1401 m, 1365 w, 1262 m, 1221 m, 1181 m, 841 w , 763 m, 652 w 554 w, 479 w  
(s, strong; m, medium; w, weak). 
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4.2.3.3 Synthesis of (4-Hydroxy-2-oxidobenzaldehyde 4-ethylthiosemicarbazonato)-(2,2-
bipyridine)copper(II) semihydrate, [Cu(bipy)(HE)].0.5H2O (15) 
Complex 15 was similarly prepared as complex 13 by using 2,4-dihydroxybenzaldehyde 
2,4-dihydroxybenzaldehyde 4-ethylthiosemicarbazone (0.24 g, 1 mmol) as the Schiff base. 
 (Yield: 0.36 g, 72 %). Anal. Calc. for C20H20N5O2.5SCu: C,51.55; H, 4.33; N, 15.03. 
Found: C, 50.93; H, 4.76; N, 15.33 %. IR (KBr disc, cm-1):  3422 (broad) m, 3224 m, 3059 
w, 2933 w, 1592 s, 1441 m, 1344 m, 1260 m, 1215 m, 1186 m, 842 m, 787 w, 765 m, 589 
w, 465 w,  432 w (s, strong; m, medium; w, weak). 
 
4.2.3.4 Synthesis of (4-Hydroxy-2-oxidobenzaldehyde 4-phenylthiosemicarbazonato)-(2,2-
bipyridine)copper(II) dihydrate, [Cu(bipy)(HP)].2 H2O (16) 
Complex 16 was similarly prepared as complex 13 by using 2,4-dihydroxybenzaldehyde 4-
phenylthiosemicarbazone (0.29 g, 1 mmol) as the Schiff base. 
(Yield: 0.43 g, 80 %). Anal. Calc. for C24H23N5O4SCu: C, 53.27; H, 4.28; N, 12.94. Found: 
C, 53.28; H, 4.57; N, 13.04 %. IR (KBr disc, cm-1): 3398 m, 3335 w, 3070 w, 1602 s, 1496 
s, 1431 s, 1311 m, 1219 s, 1172 m, 852 m, 755 w, 588 w,  505 w, 466 w, 426 w 
(s, strong; m, medium; w, weak). 
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4.2.4. X-ray crystallography 
Green crystal for complex 13a was recrystallised from dimethylformamide. Data collection 
was carried out as repoted in chapter 2. The structure was solved by direct-methods and 
refined by a full-matrix least-squares procedure on F2 with anisotropic displacement 
parameters for non-hydrogen atoms. Hydrogen atoms in their calculated positions were 
refined using a riding model. The hydroxy and amino H-atoms were located in a difference 
Fourier map.  
 
4.2.5 DNA binding 
DNA binding was carried out as reported in chapter 2. 
 
4.2.6 Nucleolytic study 
Agarose gel electrophoresis experiments were carried out on supercoiled plasmid 
DNA pBR322 (4.4 kb) using a horizontal gel system as described in chapters 2 and 3. 
 
4.2.7 Human Topoisomerase I inhibtion assay 
The human DNA topoisomerase I inhibitory activity was determined by using a horizontal 
gel system as outlined in chapters 2 and 3.  
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4.2.8 Antibacterial and antifungal assay 
The antibacterial and antifungal activities of the ligands and complexes were assessed 
against several strains of Gram-positive bacteria, Gram-negative bacteria, and fungi. A 
colorimetric broth microdilution method using p-iodonitrotetrazolium violet (INT) as the 
growth indicator was employed to quantify the minimum inhibitory concentration (MIC) 
value of the complexes in the assay. The test was performed as mentioned in chapter 2. 
 
4.3. Results and discussion 
4.3.1 Synthesis of the complexes 
The stoichiometries, color and partial elemental analyses of the Cu(bipy)L complexes are 
shown in Table 4.1. Proposed structures for all the complexes with IUPAC numbering 
scheme are shown in Fig. 4.1 (Shown here for convenience). 
 
13 R = H 14 R’ = -CH3 15 R = -C2H5 16 R = -C6H5 
Fig. 4.1 Proposed structure for all the complexes 
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Results from partial elemental analyses are in good agreement with the proposed 
formulation of Cu(bipy)L where bipy = 2,2-bipyridine and L represents each of the doubly 
deprotonated thiosemicarbazones. Complex 13 exists as a monohydrate, while its crystal 
(13a) that was recrystallised from DMF solution contains a solvated DMF molecule. 
Complex 14 exists as a monohydrate, while complex 15 as a semihydrate and complex 16 
as a dihydrate. All the complexes are green. The complexes were prepared in high yield by 
refluxing copper acetate dihydrate, 2,2'-bipyridine and the thiosemicarbazones in ethanol. 
Complexes 13-16 are insoluble in common polar and non-polar solvents but are soluble in 
DMF and DMSO.  The room temperature magnetic susceptibility of the complexes in the 
polycrystalline state fall in the range of 1.82-1.84 B.M which are very close to the spin only 
value of 1.73 B.M for d9 in Cu(II)  (Bindu et al. 1999). 
 
Table 4.1 
Stoichiometries, color and partial elemental analyses of the copper(II) complexes 
Complex Stoichiometries Color Anal. Calc. (Found )%  
µ 
effective 
   C H N (B.M) 
[Cu(bipy)(HT)].H2O 
(13) C18H16N5O3SCu Green 48.37(48.38) 3.83(3.40) 15.67(16.94) 1.82 
[Cu(bipy)(HT)].DMF 
(13a) C21H22N6O3SCu Green 50.24(50.55) 4.42(4.52) 16.74(16.43) 1.82 
[Cu(bipy)(HM)].H2O 
(14) C19H19N5O3SCu Green 49.50(49.68) 4.15(3.76) 15.19(15.62) 1.84 
[Cu(bipy)(HE)].0.5H2O 
(15) C20H20N5O2.5SCu Green 51.55(50.93) 4.33(4.76) 15.03(15.33) 1.84 
[Cu(bipy)(HP)].2H2O 
(16) C24H23N5O4SCu Green 53.27(53.28) 4.28(4.57) 12.94(13.04) 1.83 
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4.3.2 Crystal structure analysis 
4. 3.2.1 Crystal structures of [Cu(bipy)(HT)].DMF(13a) 
Complex 13a crystallised into a monoclinic lattice with space group symmetry P21. The 
perspective view of the complex with numbering scheme is shown in Fig. 4.2. Selected 
bond lengths and angles are presented in Table 4.3.  
 
 
Fig. 4.2 Thermal ellipsoid (Barbour, 2001) plot of 13a drawn at the 70% probability level. 
Hydrogen atoms are drawn as spheres of arbitrary radii. 
 
The complex is mononuclear and five coordinated with the doubly deprotonated 
thiosemicarbazone as a tridentate ligand coordinating through the phenolic oxygen, 
azomethine nitrogen and thiolate sulfur atoms while 2,2-bipyridine as the N,N’-bidentate 
ligand. The trigonality index τ of 0.03 for 13a indicates that the coordination geometry 
around copper is close to a perfect square pyramidal in contrast to the zinc analog, complex 
9 with τ of 0.49. Complex 9 is intermediate between trigonal bipyramidal and square 
pyramidal geometries and is better described as trigonal bipyramidal distorted square based 
pyramid (TBDSBP). The τ value of complex 13a is smaller compared to the τ value of 0.15 
  
162 
in [CuL2bipy] where H2L2 = salicylaldehyde 3-tetramethyleneiminyl thiosemicarbazone 
(Latheef and Kurup, 2008).  In the square pyramidal complex 13a, copper is displaced 
0.1537(3) Å above the N(1), N(4), O(1) and S(1) coordination plane and towards the 
elongated apical N(5) atom. 
 
The Cu –Nazomethine bond length of 1.960 (2) Å is shorter than the Cu-Nbipy bond 
lengths of 2.051(2) and 2.291(2) Å. This indicates that the azomethine nitrogen is 
coordinated more strongly to copper compared to the bipyridine nitrogen and the 
thiosemicarbazone moiety dominates equatorial bonding. The Cu–Nbipy bond lengths are 
similar to those reported for mononuclear copper(II) complexes (Seena and Kurup, 2007; 
Latheef and Kurup, 2008). The difference between the axial and equatorial Cu–Nbipy bond 
lengths may be due to the presence of Jahn-Teller effect in copper complex with d9 
electronic configuration. This is not seen in the zinc complexes with d10 electronic 
configuration in chapter 2 (complexes 5 and 8). The imine bond formation is evidenced 
from N1-C7 and N2-C8 distances of 1.296(3) Å and 1.308(3) Å respectively.  The N2-C8 
bond length of 1.308(3) Å and C-S bond length of 1.744 (2) is similar to those reported for 
coordination of thiosemicarbazone in the thiolate form (Seena and Kurup, 2007; Latheef 
and Kurup, 2008; Seena and Kurup, 2008; Bal-Demirci, 2008).  
 
Hydrogen bonding parameters are shown in Table 4.4 while hydrogen bonding 
interactions for complex 13 are shown in Fig. 4.3 and Fig. 4.4. A solvated 
dimethylformamide (DMF) molecule is linked to complex 13 through an O2—H2···O3 
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hydrogen bond. The N3—H32···O2 hydrogen bonds link the mononuclear molecules into 
an infinite linear chain motif parallel to c axis as shown in Fig. 4.3.  
 
Fig. 4.3 Linear chain formed from N3—H32···O2 hydrogen bonding interactions for 
complex 13a view down from b-axis. 
 
The molecules along this linear chain are further connected to the adjacent molecule 
through N3—H31···O1 hydrogen bonds to form another infinite linear zigzag chain along b- 
axis as shown in Fig. 4.4. Combinations of these hydrogen bonds lead to the formation on 
an infinite two dimensional array. The packing of the molecules is stabilized by hydrogen 
bonding interactions (Fig. 4.5). No π-π interactions are observed in this system. 
 
c 
a 
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Fig. 4.4 Zig-zag chain from N3—H31···O1 hydrogen bonding interactions for complex 13a 
view down from c axis. 
 
 
Fig. 4.5 Packing diagram of 13a along b-axis. 
a 
c 
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Table 4.2 
Crystal data and structure refinement parameters for complex 13a 
Complex [Cu(bipy)(HT)].DMF(13) 
Empirical formula  C21H22CuN6O3S 
Formula weight  502.05 
Crystal system  Monoclinic 
Space group  P21 
Unit cell dimensions  
a (Å)  11.8131 (3) 
b (Å) 8.40790 (10)  
c (Å) 12.2719 (3)  
β (°)  116.5900 (10) 
Volume, V (Å3)  1089.97 (4) 
Z  2 
F(0 0 0)  518 
Density (calculated), (mg m−3) 1.530  
Absorption coefficient, µ(mm−1) 1.13 
Wavelength, λ (Å) 0.71073  
Temperature, T (K) 118 (2) 
Crystal size (mm) 0.20 × 0.20 × 0.03 
Reflections collected  7639 
Independent reflections  4629 [R(int) = 0.020] 
Data/restraints/parameters  4629/4/303 
R[F2 > 2σ(F2)] 0.027 
wR(F2) 0.068 
S  1.05 
Largest difference  
peak and hole (e Å−3) 
0.27 and −0.23  
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Table 4.3 
Selected bond lengths (Å) and angles (˚) for [Cu(bipy)(HT)].DMF (13a) 
Bond lengths   Bond angles  
Cu1—O1 1.9562 (16) O1—Cu1—N1 92.21 (7) 
Cu1—N1 1.960 (2) O1—Cu1—N4 91.80 (7) 
Cu1—N4 2.051 (2) N1—Cu1—N4 171.57 (8) 
Cu1—S1 2.2856 (6) O1—Cu1—S1 169.65 (5) 
Cu1—N5 2.291 (2) N1—Cu1—S1 84.77 (6) 
S1—C8 1.744 (2) N4—Cu1—S1 89.99 (6) 
O1—C1 1.311 (3) O1—Cu1—N5 90.52 (7) 
O2—C3 1.362 (3) N1—Cu1—N5 111.97 (8) 
N1—C7 1.296 (3) N4—Cu1—N5 75.39 (8) 
N1—N2 1.390 (3) S1—Cu1—N5 99.80 (5) 
N2—C8 1.308 (3) C8—S1—Cu1 93.98 (8) 
N3—C8 1.353 (3) C1—O1—Cu1 124.89 (14) 
N4—C9 1.339 (3)   
N4—C13 1.346 (3)   
N5—C18 1.333 (3)   
N5—C14 1.340 (3)   
 
Table 4.4 
Hydrogen-bond geometry (Å, °) for [Cu(bipy)(HT)].DMF (13a) 
D—H···A D—H H···A D···A D—H···A 
O2—H2···O3 0.838 (10) 1.827 (11) 2.661 (3) 173 (3) 
N3—H31···O1i 0.886 (10) 2.089 (11) 2.968 (3) 172 (2) 
N3—H32···O2ii 0.868 (10) 2.138 (11) 3.003 (3) 174 (2) 
Symmetry codes: (i) − x+1, y+1/2, − z+2; (ii) x, y, z−1. Hydrogen atoms are placed at 
calculated positions. 
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4.3.3 Infrared and electronic spectra 
Important IR bands for the ligands and complexes are given in Table 4.5. IR spectra for all 
the complexes are shown in Fig. 4.6. Thiosemicarbazones are known to exhibit thione-thiol 
tautomerization (Fig. 4.7). The absence of any band around 2600-2800 cm-1 ν(S-H) 
indicates that in the solid form, all the ligands exist in the thione form (Bindu et al. 1999; 
Afrasiabi et al. 2005). Analysis of the IR spectra of the complexes revealed that the 
thiosemicarbazones are coordinating through the phenolic oxygen, azomethine nitrogen and 
thiolate sulfur atoms while 2,2-bipyridine as the N,N’-bidentate ligand as reported for the 
zinc complexes in chapters 2 and 3. 
 
The appearance of new ν(Cu-N)  bands in the range of 465-479 cm-1 confirms the 
coordination through azomethine and bipyridine  nitrogens.  Coordination through phenolic 
oxygen is confirmed by the presence of ν(Cu-O) band at around at around 426-430 cm-1 
(Bindu et al. 1999; Seena and Kurup, 2007; Latheef and Kurup, 2008). The mode of 
coordination for the ligands determined by IR spectra is in good agreement with the crystal 
structure of complex 13a. Complexes 13-16 have very similar IR spectra (Fig. 4.6), this 
indicates that they share the similar mode of coordination.  Since the ligands have the same 
ligating atoms and the only variation in the structure of these complex is at the N(4)-
substituent which is not involved in coordination to copper, it is reasonable to propose that 
the coordination geometry around copper for each of the complexes 13-16 is distorted 
square pyramidal. 
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Fig. 4.6 IR spectra of complexes 13-16 
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Fig. 4.7 Thione-thiol tautomerization for the ligands 
 
Table 4.5 
IR spectral assignments (cm-1) for the ligands and their copper(II) complexes 
Compound ν(C=N) ν(C-O) ν(N-N) ν (C=S) ν(Cu-O) ν(Cu-N) 
Bands due to  
bipyridine 
H3T (1) 1620 1239 1165 1379, 863 - - - 
H3M (2) 1625 1231 1166 1331,868 - - - 
H3E (3) 1626 1241 1166 1325, 867 - - - 
H3P (4) 1629 1264 1121 1323,838 - - - 
[[Cu(bipy)(HT)].H2O (13) 1603 1223 1179 1313, 841 430 471 1442,  762 
[Cu(bipy)(HM)].H2O (14) 1603 1221 1181 1314, 841 430 479 1444, 763 
[Cu(bipy)(HE)].0.5H2O (15) 1592 1215 1186 1314, 842 432 465 1441, 765 
[Cu(bipy)(HP)].2H2O (16) 1602 1219 1172 1311, 795 426 466 1431, 763 
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Electronic spectral assignments for the ligands and their copper(II) complexes in 
DMF are presented in Table 4.6. All the ligands and the Cu(II) complexes have a ring 
(phenolic and diimine) π-π* band at around 37,593 cm-1 (West et al. 1995). No significant 
red shift is observed for these bands upon complexation (Swearingan and West, 2000). All 
the thiosemicarbazones also have two bands at around 32,985 cm-1 and 29,411 cm-1 due to 
n-π* transition of azomethine and thioamide function, respectively. Upon complexation, the 
n-π* band of the thioamide function is shifted above 30,000 cm-1 due to thioenolization and 
merges with the azomethine n-π* band at around 31,348 cm-1(Swearingan and West, 2000). 
Thioenolization causes the weakening of the C=S bond. A moderately intense band in the 
range 25840-26666 cm-1 found only in the spectra of the complexes is assigned to 
Cu(II)S metal to ligand charge transfer band (MLCT) (Swearingan and West, 2000; 
Seena and Kurup, 2007). The MLCT band for Cu(II)O shows line broadening that runs 
into the visible part of the spectrum. However, the maxima of this band is not observed 
probably due to the overlapping with the low energy side of Cu(II)S transitions (Seena 
and Kurup, 2007). The copper complexes show a d-d band at 17153-17544 cm-1 due to 
dx2−y2 → dxz, dyz and dx2−y2 → dz2 transitions characteristic of five coordinate copper(II) 
complexes with square pyramidal geometry (Bindu et al., 1999; Seena and Kurup, 2007; 
Latheef and Kurup, 2008). 
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Table 4.6 
Electronic spectral assignments (cm-1) for the ligands and their copper(II) complexes in DMF . 
Complex π-π* n-π* MLCT d-d 
transition 
H3T (1) 37593 33003, 29411 - - 
H3M (2) 37593 33003, 29411 - - 
H3E (3) 37593 32895, 29240 - - 
H3P (4) 37453 32680, 28409 - - 
[[Cu(bipy)(HT)].H2O (13) 
37736 30769 26596 17483 
[Cu(bipy)(HM)].H2O (14) 
37594 30769 26666 17153 
[Cu(bipy)(HE)].0.5H2O (15) 37594 30769 26455 17544 
[Cu(bipy)(HP)].2H2O (16) 35211 30581 25840 17182 
 
4.3.4 DNA binding 
4.3.4.1 Duplex DNA 
The interaction of the complexes with (i) duplex oligonucleotides of various specified 
nucleotide sequences, and (ii) quadruplex DNA of the 23-mer oligonucleotide 5’-
AG3(T2AG3)3-3’ and its corresponding duplex were investigated with CD spectroscopy.  
 
As was routinely done in the work presented in chapters 2 and 3, the first 
investigation was to find out the DNA binding preference for CG or AT sequences by the 
copper complex. Complexes 13 (Fig. 4.8) and 14 (Fig. 4.9) at a complex:duplex ratio of 1:8 
induce a decrease in the intensity of  the positive and negative bands of the ds(AT)6, and 
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this suggests that binding of the complexes cause a change of conformation from B to Z-
like conformation similar to those observed in interaction of [Cu(5,6-dmp)2]2+ with calf 
thymus DNA (Mahadevan and Palaniandavar, 1996). On the other hand, complexes 15 (Fig. 
4.10) and 16 (Fig. 4.11) cause a decrease and increase of the negative and positive band, 
respectively. This type of changes is normally attributed to a change of conformation from 
B to A-like if accompanied by a shift in the peak maxima of the positive band (Ivanov et al. 
1973; Maheswari and Palaniandavar, 2004). However, no shift in the peak maxima of the 
positive band suggests that complex 15 and 16 bind to the DNA through partial 
intercalation and induce a slight unwinding of the helical twist of the ds(AT)6. Complex 16 
induces a greater increase (9.4 %) in the intensity of the positive band of the CD spectrum 
of ds(AT)6 compared with complex 15 (3.5 %). This implies that complex 16 binds more 
strongly to ds(AT)6 in contrast to complex 15. This is attributed to the higher 
hydrophobicity and surface area conferred to complex 16 by the phenyl substituent. 
However, other factors may be responsible for the increase in the positive band of ds(AT)6. 
 
We now look at the results for ds(CG)6. Complexes 13, Cu(bipy)(HT) and 14, 
Cu(bipy)(HM) only cause a slight increase (2-3.5 %) to the positive band of ds(CG)6 which 
is too weak to suggest intercalation. Both complexes cause a decrease to the negative band 
with the greatest decrease of  18.6 % observed in complex 14 indicating that complex 14 
causes more unwinding of DNA than complex 13. Interestingly, similar observation is seen 
in complex 6 which is the zinc analog of complex 14 with methyl substituent at N(4).  
Complex 15, Cu(bipy)(HE) causes a slight decrease in both the positive and negative bands 
of ds(CG)6 suggesting a very weak transition from B like to Z like conformation 
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(Mahadevan and Palaniandavar, 1996). No significant changes is observed for the 
interaction of complex 16, Cu(bipy)(HP)  with ds(CG)6. 
 
By comparing the changes induced by complexes 13-16 in both the positive and 
negative bands in the CD spectra of  ds(AT)6 and ds(CG)6, we can infer that complex 13-16 
can differentiate ds(AT)6 from ds(CG)6. Complexes that induce similar conformation 
change suggest similar binding mode to the ds(oligonucleotides) and vice-versa. These 
results show that the N(4) substituent play a role in determining the mode of binding of the 
complexes with ds(oligonucleotides) with a particular base sequence. The strength of 
binding is also affected by the N(4) substituent because complexes that induce similar 
conformation change to a particular ds(oligonucleotides) also show differences in 
percentage of changes in both the positive and negative bands in the CD spectra. At present, 
this explanation seems reasonable. No other alternative can account for the observed results. 
 
Fig. 4.8 CD spectra of 15 µM of oligonucleotide in the absence and presence of 120 µM of 
complex 13; (a) ds(AT)6 alone, (b) ds(AT)6 with complex 13, (c) ds(CG)6 alone and (d) 
ds(CG)6 with complex 13. 
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Fig. 4.9 CD spectra of 15 µM of oligonucleotide in the absence and presence of 120 µM of 
complex 14; (a) ds(AT)6 alone, (b) ds(AT)6 with complex 14, (c) ds(CG)6 alone and (d) 
ds(CG)6 with complex 14 
 
 
Fig. 4.10 CD spectra of 15 µM of oligonucleotide in the absence and presence of 120 µM 
of complex 15; (a) ds(AT)6 alone, (b) ds(AT)6 with complex 15, (c) ds(CG)6 alone and (d) 
ds(CG)6 with complex 15 
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Fig. 4.11 CD spectra of 15 µM of oligonucleotide in the absence and presence of 120 µM 
of complex 16; (a) ds(AT)6 alone, (b) ds(AT)6 with complex 16, (c) ds(CG)6 alone and (d) 
ds(CG)6 with complex 16. 
 
Next oligonucleotides such as ds(CGCGAATTCGCG)2 and 
ds(CGCGATATCGCG)2 were utilized in order to investigate any binding preferences in 
interactions with duplex DNA as the sequence on each chain is varied from non-alternating 
to alternating purine-pyrimidine bases in grooves of the two duplexes. To investigate the 
above factors, we assume that the complexes can bind in the DNA grooves. For the AATT 
sequence (Fig. 4.12-4.15), complexes 13-16 show decrease and increase in the negative and 
positive bands of the CD spectra of the duplex which is consistent with the conformational 
change from B to ψ (Maheswari and Palaniandavar, 2004; Seng et al. 2008).  The great 
enhancement of the positive band (≈ 20 %) for complexes 15 and 16 suggest partial 
intercalation of either the Schiff base or 2,2'-bipyridine to the duplex. Both the schiff base 
and 2,2'-bipyridine moieties have planar aromatic rings that favours intercalation. Greater 
enhancement of positive band for complexes 15 and 16 (≈ 20 %) compared to complexes 
13 and 14 (≈ 8 %) suggests that base stacking interaction for this particular AATT sequence 
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is favoured by higher hydrophobicity of the N(4) substituent (ethyl and phenyl). Greater 
enhancement of the negative band is observed for complexes 13 and 14, in contrast to their 
positive band, with the highest enhancement shown by complex 13. This observation 
suggests that the binding of the complex 13 that is the least hydrophobic to the AATT 
sequence will result in greater unwinding of the helical twist of the ds(oligonucleotides) 
than complexes 14-16. 
 
For the ATAT sequence, complexes 13 and 14 also show a decrease and increase in 
the negative and positive bands respectively. This is consistent to conformational change 
from B to ψ (Maheswari and Palaniandavar, 2004; Seng et al. 2008) which was similarly 
observed for the interaction of these two complexes with the AATT sequence earlier. 
However, complexes 15 and 16 show an increase in both the positive and negative bands 
which implies intercalation and stabilization of the B form DNA (Maheswari and 
Palaniandavar, 2004). This implies that complex 15 and 16 can effectively differentiate 
AATT from ATAT sequence based on their different mode of binding to these different 
ds(oligonucleotide).  
 
Comparing the CD results of these four ds(oligos)2, we can conclude that complexes  
13-16 can differentiate ds(AT)6 from ds(CG)6 whereas only complex 15 and 16 can 
effectively differentiate the AATT from ATAT sequence. Complexes 13 and 14 is less 
effective in differentiating AATT from ATAT sequence because both complexes induce 
same conformational change from B to ψ for these two duplexes. This implies that 
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complexes that are more hydrophobic can effectively differentiate more DNA base 
sequences. We think that one of the contributing factors in the observed DNA recognition 
is conferred by the ability of the complexes to form hydrogen bonds with the DNA through 
various hydrogen donor and acceptor groups on the thiosemicarbazone moiety. The N(4)-
substituent seems to be responsible in DNA recognition through hydrophobic interaction or 
grooves binding because each complex has a substituent with different hydrophobicity  and 
bulkiness (alkyl chain or aromatic ring). The size of the molecules and the orientation of 
different substituted bulky group in space may affect their ability to bind into the groove 
(major or minor) with different cavity size or steric hindrance.  
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Fig. 4.12 CD spectra of 10 µM of oligonucleotides in the absence and presence of 120 µM 
of complex 13; (a) ds(CGCGATATCGCG)2 alone, (b) ds(CGCGATATCGCG)2 with 
complex 13, (c) ds(CGCGAATTCGCG)2 alone and (d) ds(CGCGAATTCGCG)2  with 
complex 13. 
 
Fig. 4.13 CD spectra of 10 µM of oligonucleotides in the absence and presence of 120 µM 
of complex 14; (a) ds(CGCGATATCGCG)2 alone, (b) ds(CGCGATATCGCG)2 with 
complex 14, (c) ds(CGCGAATTCGCG)2 alone and (d) ds(CGCGAATTCGCG)2  with 
complex 14. 
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Fig. 4.14 CD spectra of 10 µM of oligonucleotides in the absence and presence of 120 µM 
of complex 15; (a) ds(CGCGATATCGCG)2 alone, (b) ds(CGCGATATCGCG)2 with 
complex 15, (c) ds(CGCGAATTCGCG)2 alone and (d) ds(CGCGAATTCGCG)2  with 
complex 15. 
 
 
Fig. 4.15 CD spectra of 10 µM of oligonucleotides in the absence and presence of 120 µM 
of complex 16; (a) ds(CGCGATATCGCG)2 alone, (b) ds(CGCGATATCGCG)2 with 
complex 16, (c) ds(CGCGAATTCGCG)2 alone and (d) ds(CGCGAATTCGCG)2  with 
complex 16. 
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Table 4.7 
CD spectral bands of duplex oligo or quadruplex + copper complex: wavelength, λ  
(molar  ellipcity) 
 λ/nm (molar ellipcity) 
(-) band (+) band 
15 µM ds(AT)6 248 (-419344) 270 (339753) 
15 µM ds(AT)6 + 120 µM complex 13 249 (-406033) 269 (307784) 
15 µM ds(AT)6 + 120 µM complex 14 249 (-390550) 270 (327403) 
15 µM ds(AT)6 + 120 µM complex 15 249 (-406640) 270 (352262) 
15 µM ds(AT)6 + 120 µM complex 16 249 (-398382) 270 (372043) 
15 µM ds(CG)6 252 (-585418) 278 (213799) 
15 µM ds(CG)6 + 120 µM complex 13 257 (-568230) 280 (221230) 
15 µM ds(CG)6 + 120 µM complex 14 253 (-475805) 279 (216996) 
15 µM ds(CG)6 + 120 µM complex 15 252 (-574558) 279 (195609) 
15 µM ds(CG)6 + 120 µM complex 16 253 (-581489) 280 (209792) 
10 µM ds(CGCGAATTCGCG)2 251 (-603665) 279 (215560) 
10 µM ds(CGCGAATTCGCG)2 + 120 
µM complex  13 
252 (-532365) 277 (226497) 
10 µM ds(CGCGAATTCGCG)2 + 120 
µM complex  14 
253 (-568922) 279 (219396) 
10 µM ds(CGCGAATTCGCG)2 + 120 
µM complex  15 
251 (-578551) 278 (259217) 
10 µM ds(CGCGAATTCGCG)2 + 120 
µM complex  16 
251 (-560689) 279 (255896) 
10 µM ds(CGCGATATCGCG)2 248 (-286559) 277 (174875) 
10 µM ds(CGCGATATCGCG)2 + 120 
µM complex  13 
249 (-278584) 277 (189419) 
10 µM ds(CGCGATATCGCG)2 + 120 
µM complex  14 
252 (-274954) 276 (198449) 
10 µM ds(CGCGATATCGCG)2 + 120 
µM complex 15 
249 (-299115) 277 (222815) 
10 µM ds(CGCGATATCGCG)2 + 120 
µM complex complex 16 
249 (-297319) 277 (213912) 
20 µM guanine-rich duplex 250 (-82682) 279 (283975) 
20 µM guanine-rich duplex + 120 µM 
complex 13 
249 (-69010) 276 (204189) 
20 µM guanine-rich duplex + 120 µM 
complex 14 
251 (-119879) 279 (373394) 
20 µM guanine-rich duplex + 120 µM 
complex 15 
250 (-213321) 279 (584026) 
20 µM guanine-rich duplex + 120 µM 
complex 16 
250 (-55187) 279 (129537) 
20 µM G-quadruplex 266 (-116489) 247 (106239)  
296 (180571) 
20 µM G-quadruplex + complex 13 265 (-97017) 248 (106105) 
296 (184718) 
20 µM G-quadruplex + complex 14 264 (-115677) 248 (89027) 
297 (178264) 
20 µM G-quadruplex + complex 15 264 (-100287) 246 (105507) 
296 (187905) 
20 µM G-quadruplex + complex 16 265 (-99265) 246 (124286) 
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296 (202926) 
guanine-rich duplex = (5’-CCAGTTCGTAGTAGTAACCC-3’)·(3'-GGTCAAGCATCATCATTGGG-5’)  
Table 4.7 Continued. 
 
4.3.4.2 G-quadruplex and guanine-rich duplex 
 The CD spectra of the 20 μM of the antiparallel G-quadruplex 5’-AG3(T2AG3)3-3’ 
with complexes 13-16 (120 μM) were monitored.  The intensity of the positive band for G-
quadruplex at 296 nm is enhanced while the negative band at 267 nm decreases upon 
addition of each of the complexes 13, 15 and 16. Complex 14 does not induce any 
significant change to the CD spectrum. The overall shape of G-quadruplex remains 
unchanged, suggesting retention of the antiparallel structure (Fig. 4.16, Table 4.7). The 
enhancement of the positive band at 296 nm due to G-G base stacking suggests partial 
intercalation between G-tetrads by the copper complex similar to enhancement of the 
positive, base-base stacking band at ~270 nm attributed to intercalation of B-form duplex 
DNA (Maheswari and Palaniandavar, 2004). This observation is in contrast to those 
observed for the interaction of acridine and bis-acridine with the G-quadruplex where the 
decrease in the intensity of the positive band at 293 nm was interpreted as destabilization of 
the quadruplex structure (Nagesh et al. 2003). Thus, enhancement of the positive band of 
the CD spectrum of the present quadruplex suggests stabilization of the antiparallel 
quadruplex structure by the copper complexes as suggested by Musseti et al. (2009).   
 
Based on the enhancement in the positive band (Fig. 4.16, Table 4.7), complex 16 
with a phenyl substituent is the most effective in stabilizing G-quadrupex while complex 14 
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is the least effective. Since complex 16 can bind strongly to AT-rich base sequence, there is 
a possibility that this complex binds to the TTA loop in G-quadrupex. Furthermore, 
complex 8, which is the zinc analog of complex 16, is known as the weakest quadruplex 
binder (chapter 2).  This implies the significant role of the metal ion in altering the binding 
strength of complexes with a general formulation of [M(bipy)(L)] where M = zinc or 
copper and L = 2,4-dihydroxybenzaldehyde N(4)-substituted thiosemicarbazone towards 
the quadruplex. This could be attributed to the difference in coordination geometry of the 
zinc and copper complexes. Results from X-ray crystallography for complexes (5, 8, 9, 11, 
12, 13 and 17) and literature survey (John et al. 2004; Thomas et al. 2004; Seena and 
Kurup, 2007 & 2008; Latheef and Kurup, 2008) for similar complexes show that a five 
coordinate copper complex with a bidentate N,N’-heterocycle and a tridentate ONS-schiff 
base tends to adopt a  distorted square pyramidal geometry with τ value less than 0.35 
whereas a similar zinc complex would have a greater distortion towards a trigonal 
bipyramidal geometry with τ value greater than 0.4.        
Fig. 4.16 CD spectra of  20 µM of G-quadruplex in the absence and presence of 120 µM of 
complex 13-16; (a) G-quadruplex alone, (b) G-quadruplex  with complex 
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The results from the interactions with guanine-rich duplex indicate that complexes 
13 and 16 show decrease in the intensity of both the negative and positive bands with a 
greater decrease in the latter. This is consistent with conformational change from B to Z- 
like conformation (Mahadevan and Palaniandavar, 1996). Meanwhile, complexes 14 and 15 
show a great increase in both the positive and negative CD spectral bands. This implies that 
complexes 14 and 15 intercalate strongly to the duplex and stabilize the B form of the 
guanine-rich duplex (Maheswari and Palaniandavar, 2004). The distinct difference in the 
conformational change induced by these two sets of complexes suggests different modes of 
binding towards guanine-rich duplex. This different mode of binding seems to be 
dependent on the N(4) substituent. It seems that complexes 13, Cu(bipy)(HT), and 16, 
Cu(bipy)(HP), without the alkyl substituent could induce conformational change from B to 
Z-like. Whereas, complexes 14 (methyl) and 15 (ethyl), that are alkyl substituted, will 
intercalate in between the guanine-rich duplex base pair. The magnitude of changes 
induced by these complexes towards the guanine-rich duplex is much higher compared to 
their zinc analogs (complexes 5-8). This show that besides altering the base sequence 
recognition, the change of metal ion may also alter the binding strength of a complex 
towards DNA.  
 
By comparing the extent of changes induced in both the positive and negative bands 
of the G-quadruplex and guanine-rich duplex, we can see that these complexes can possibly 
differentiate G-quadruplex from guanine-rich duplex. Since the complexes can bind to both 
structures and induced different conformational changes, it is not possible to determine 
their selectivity based on CD data alone. The feature that seems to favor stabilization of the 
G-quadruplex such as the presence of an alkyl substituent in the zinc series (chapter 2) does 
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not apply in this copper series.  However, the presence of alkyl substituent in the copper 
series seems to promote intercalation to the guanine-rich duplex that is not seen in the zinc 
series either. Interestingly, in this copper series [Cu(bipy)(L)], the complex that is most 
effective in stabilizing G-quadruplex has a phenyl substituent while the least effective has a 
methyl substituent but the reverse pattern is seen in the zinc series, [Zn(bipy)(L)]. These 
observations show that the mode of interactions of the metal complexes with guanine-rich 
duplex and G-quadruplex are greatly dependent to the central metal ion. This can be 
attributed to the different in coordination geometry between the zinc and copper complexes 
as shown in the crystallographic studies.  
 
 
Fig. 4.17 CD spectra of  20 µM of guanine-rich duplex in the absence and presence of 120 
µM of complex; (a) guanine-rich duplex alone, (b) guanine-rich duplex with complex 13, 
(c) guanine-rich duplex with complex 14, (d) guanine-rich duplex with complex 15 and (e) 
guanine-rich duplex with complex 16 
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4.3.5 Nucleolytic study 
In this study, we examine the ability of the complexes to cleave pBR322 under 
hydrolytic conditions and in the presence of exogenous agents, sodium ascorbate and 
hydrogen peroxide, using gel electrophoresis.  
 
In the absence of exogenous agent, no cleavage was observed (results not shown) 
when the copper complexes were incubated with pBR322 for 24 h at 37 oC with increasing 
concentrations of the copper complex (10 – 1000 μM). When the DNA was incubated with 
300 µM of copper complex in the presence of 30 μM sodium ascorbate, no activation of 
copper complexes towards DNA cleavage by sodium ascorbate is observed for complexes 
15 (Fig. 4.18, lane L13) and 14 (Fig. 4.18, lane L14). However, complexes 13 and 16 can 
cleave the DNA in the presence of sodium ascorbate, which is evidenced from the distinct 
increase in intensity of the nick band (Fig. 4.18). These results imply that the presence of an 
electron donating alkyl group as the N(4) substituent in complexes 14 and 15 can actually 
stabilize the Cu(II) oxidation state whereas the presence of an electron withdrawing phenyl 
group in complex 16 will destabilize the 2+ oxidation state, making the complex more 
susceptible to reduction by sodium ascorbate. Similar observation in stabilisation of the 
higher oxidation state by electron donating groups has been reported by Velusamy et al. 
(2004) in their study of iron(III) complexes of sterically hindered tetradentate 
monophenolate ligands. 
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Fig. 4.18 Electrophoresis results of incubating pBR322 (0.5 μg/μL) with CuCl2 or 
complex 13-16 in TN buffer (5 mM Tris, 50 mM NaCl) pH 7.5 at 37 oC for 2 h in the 
absence and presence of exogenous agents: Lane 1, 5, 11, 17 gene ruler 1 Kb DNA ladder; 
Lane 2, DNA alone (0.5 µg/µL) control; Lane 3, DNA + 30μM sodium ascorbate; Lane 4, 
DNA + 30μM H2O2;  Lane 6, DNA + 300μM CuCl2; Lane 7, DNA + 300μM 15; Lane 8, 
DNA + 300μM 14; Lane 9, DNA + 300μM 16; Lane 10, DNA + 300μM 13; Lane 12, 
DNA + 300μM CuCl2 + 30μM sodium ascorbate; Lane 13, DNA + 300μM 15 + 30μM 
sodium ascorbate; Lane 14, DNA + 300μM 14 + 30μM sodium ascorbate;  Lane 15, DNA 
+ 300μM 16 + 30μM sodium ascorbate; Lane 16, DNA + 300μM 13 + 30μM sodium 
ascorbate; Lane 18, DNA + 300μM CuCl2 + 30μM H2O2; Lane 19, DNA + 300μM 15 + 
30μM H2O2; Lane 20, DNA + 300μM 14 + 30μM H2O2; Lane 21, DNA + 300μM 16 + 
30μM H2O2; Lane 22, DNA + 300μM 13 + 30μM H2O2 
 
Further, complex 16 (Fig. 4.18, lane L15) is more efficient in cleaving the DNA 
compared with complex 13 (Fig. 4.18, lane L16) based on the greater intensity of the 
observed nick band. If our previous assumption that an electron withdrawing group could 
destabilize the Cu(II) oxidation state is true, then the higher activity of complex 16 can be 
accounted for since it has a phenyl substituent which is more electron withdrawing 
compared to the two protons at N(4) in complex 13.  Another possibility is complex 16 may 
bind more strongly to DNA in contrast to complex 13 resulting in greater DNA cleavage. 
This possibility is supported by the greater enhancement of the positive band (Table 4.7) in 
the CD spectra for most of the tested ds(oligonucleotides) upon binding to complex 16. The 
greater enhancement of the positive bands attributed to base stacking interactions suggest a 
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stronger mode of binding through intercalation or partial intercalation. Previously, Thomas 
et al. (2004) have studied the DNA binding and cleavage properties of ternary copper(II) 
complexes of formulation [Cu(Ph-tsc)phen] and [Cu(Me-tsc)phen] (H2Ph-tsc = 
salicylaldehyde N(4)-phenylthiosemicarbazone and H2ME-tsc = salicylaldehyde N(4)-
ethylthiosemicarbazone). The cleavage efficiency of [Cu(Ph-tsc)phen] is greater compared 
with [Cu(Me-tsc)phen] which is consistent with their DNA binding strength obtained from 
ethidium bromide displacement assay. 
 
When the DNA was incubated with 300 µM of copper complex in the presence of 
30 μM hydrogen peroxide no activation of copper complexes towards DNA was observed 
for the complexes except for complex 16 (Fig. 4.18, lane L21).  To determine whether all 
the complexes can be activated by hydrogen peroxide, the concentration of hydrogen 
peroxide was varied from 250 μM to 500 μM by maintaining the complex concentration at 
300 µM. DNA cleavage is observed for complex 16 (Fig. 4.19, lane L15) in the presence of 
250 μM hydrogen peroxide with the appearance of a nick band with very high intensity. 
When the concentration of hydrogen peroxide was further increased to 500 μM, complex 
16 (Fig. 4.19, lane L21) converted almost all the supercoiled DNA to the nick form. 
Complexes 15, 14 and 13 (Fig. 4.19, lane L19, L20 and L22) also start to cleave DNA at 
this hydrogen peroxide concentration based on the appearance of nick bands with similar 
intensity. This indicates that the copper complexes can be activated by hydrogen peroxide 
at high concentration and complex 16 posses the best nucleolytic efficiency in the presence 
of hydrogen peroxide. The zinc analog of this series cannot be activated by hydrogen 
peroxide. The nucleolytic efficiency of CuCl2 in the presence of sodium ascorbate (Fig. 
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4.18, Lane L12) or hydrogen peroxide (Fig. 4.19, Lane L12) is greater compared with the 
ternary copper complexes. The reduced nucleolytic property of Cu(II) can be attributed to 
the stabilization of the 2+ oxidation state upon coordination to bipyridine and 
thiosemicarbazones. 
 
Fig. 4.19 Electrophoresis results of incubating pBR322 (0.5 μg/μL) with CuCl2 or complex 
13-16 in TN buffer (5 mM Tris, 50 mM NaCl) pH 7.5 at 37 oC for 2 h in the absence and 
presence of increasing hydrogen peroxide concentrations: Lane 1, 5, 11 and  17, gene ruler 
1 Kb DNA ladder; Lane 2, DNA alone (0.5 µg/µL) control; Lane 3, DNA + 250μM H2O2; 
Lane 4, DNA + 500μM H2O2; Lane 6, DNA + 300μM CuCl2; Lane 7, DNA + 300μM 15; 
Lane 8, DNA + 300μM 14; Lane 9, DNA + 300μM 16; Lane 10, DNA + 300μM 13; Lane 
12, DNA + 300μM CuCl2 + 250μM H2O2; Lane 13, DNA + 300μM 15 + 250μM H2O2; 
Lane 14, DNA + 300μM 14 + 250μM H2O2; Lane 15, DNA + 300μM 16 + 250μM H2O2; 
Lane 16, DNA + 300μM 13 + 250μM H2O2; Lane 18, DNA + 300μM CuCl2 + 500μM 
H2O2; Lane 19, DNA + 300μM 15 + 500μM H2O2; Lane 20, DNA + 300μM 14 + 500μM 
H2O2; Lane 21, DNA + 300μM 16 + 500μM H2O2; Lane 22, DNA + 300μM 13 + 500μM 
H2O2; 
 
Since complex 16 has the greatest nucleolytic efficency, further tests were carried 
out to elucidate the cleavage mechanism. Complex 16 was incubated with neocuprione 
(Cu(I) ion chelator), thiourea (·OH radical-specific scavenger), sodium azide (a singlet 
oxygen radical scavenger) and Tiron (a superoxide anion radical scavenger) in the presence 
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of exogenous agent. When sodium ascorbate was used as an activating agent, addition of 
sodium azide (Fig. 4.20, Lane L5) leads to almost total inhibition of DNA degradation. 
This indicates the involvement of singlet oxygen in the cleavage mechanism. No inhibition 
of DNA cleavage is observed when neocuproine (Fig. 4.20, Lane L6) was added, this ruled 
out the involvement of oxidation of Cu(I) to Cu(II) in the generation of reactive oxygen 
species.  
 
 
 
Fig. 4.20 Electrophoresis results of incubating pBR322 (0.5 μg/μL) with complex 16 in TN 
buffer (5 mM Tris, 50 mM NaCl) pH 7.5 at 37 oC for 2 h in the presence of sodium 
ascorbate and scavenging agents: Lane 1, plasmid DNA pBR322  (0.25µg/µl); Lane 2, 
DNA + 30 µM sodium ascorbate; Lane 3, 1kb DNA ladder; Lane 4, DNA + 300 µM 
complex + 30 µM sodium ascorbate (control); Lane 5, DNA + 300 µM complex + 2mM 
sodium azide + 30 µM sodium ascorbate; Lane 6, DNA + 300 µM complex + 2mM 
Neocuproine + 30 µM sodium ascorbate; Lane 7, DNA + 300 µM complex + 2mM Tiron+ 
30 µM sodium ascorbate; Lane 8, DNA + 300 µM complex + 2mM Thiourea + 30 µM 
sodium ascorbate; 
 
Tiron can also block the DNA cleavage (Fig. 4.20, Lane L7), this indicates the 
formation of superoxide radical in the cleavage mechanism.  Hydroxyl radical scavengers 
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like thiourea can also inhibit the DNA cleavage (Fig. 4.20, Lane L8), this suggests the 
involvement of diffusible hydroxyl radicals in the DNA cleavage. The inhibition of DNA 
cleavage decreases with the following scavengers: sodium azide > Tiron >  thiourea. This 
indicates that the major pathway in the DNA cleavage involves singlet oxygen.  
 
Thomas et al. (2004) have studied the oxidative DNA cleavage activity of the some ternary 
copper(II) complexes with formulation of [Cu(L)B] (B = 1,10-phenanthroline, phen; 
dipyridoquinoxaline, dpq; dipyridophenazine, dppz; L = Ph-H2tsc,     salicylaldehyde-N(4)-
phenylthiosemicarbazone) and Me-H2tsc, salicylaldehyde-(4)-methylthiosemicarbazone) by 
gel electrophoresis using supercoiled (SC) pUC19 DNA in Tris–HCl buffer (pH, 7.2) in the 
presence of a reducing agent like mercaptopropionic acid (MPA). The complexes show 
significant cleavage of DNA in the dark in the presence of MPA. Mechanistic study using 
DMSO as hydroxyl radical scavenger revealed that the reaction pathway also involves a 
hydroxyl radical that can be inhibited by DMSO.  In addition, Thomas et al. (2004)  also 
studied light induced DNA cleavage by these complexes. Their result shows that the 
complexes are cleavage inactive under argon atmosphere. However, under aerobic 
conditions, sodium azide shows significant inhibition. The cleavage activity is also 
enhanced in D2O. The results suggest the involvement of singlet oxygen (1O2) as a reactive 
species.  
 
When hydrogen peroxide was used as an activating agent for the reaction with 
complex 16, addition of sodium azide (Fig. 4.21, Lane L5) leads to a slight inhibition of 
DNA degradation. This indicates the involvement of singlet oxygen in the cleavage 
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mechanism. No inhibition of DNA cleavage is observed when neocuproine (Fig. 4.21, Lane 
L6) was added, this ruled out the involvement of oxidation of Cu(I) to Cu(II) in the 
generation of reactive oxygen species. Tiron shows the greatest inhibitions in the DNA 
cleavage, suggesting the formation of superoxide radical as the key mechanism in DNA 
cleavage (Fig. 4.21, lane L7).  No involvement of diffusible hydroxyl radicals in the DNA 
cleavage is observed (Fig. 4.21, Lane L8).  
 
Fig. 4.21 Electrophoresis results of incubating pBR322 (0.5 μg/μL) with complex 16 in TN 
buffer (5 mM Tris, 50 mM NaCl) pH 7.5 at 37 oC for 2 h in the presence of hydrogen 
peroxide and scavenging agents: Lane 1, plasmid DNA pBR322  (0.25µg/µl); Lane 2, DNA 
+ 30 µM hydrogen peroxide; Lane 3, 1kb DNA ladder; Lane 4, DNA + 300 µM complex + 
30 µM hydrogen peroxide (control); Lane 5, DNA + 300 µM complex + 2mM sodium 
azide + 30 µM hydrogen peroxide; Lane 6, DNA + 300 µM complex + 2mM Neocuproine 
+ 30 µM hydrogen peroxide; Lane 7, DNA + 300 µM complex + 2mM Tiron+ 30 µM 
hydrogen peroxide; Lane 8, DNA + 300 µM complex + 2mM Thiourea + 30 µM hydrogen 
peroxide; 
 
4.3.6 Topoisomerase I inhibition assay 
Topoisomerases are gaining prominence as a target for anticancer drugs owing to clinical 
successes of the camptothecin derivatives that target these enzymes. Despite the successful 
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approach of  inhibiting DNA topoisomerase I (Topo I) in the design of anticancer agents, a 
significant need for less toxic and more chemically stable Topoisomerase I inhibitors still 
persists  (Dexheimer & Pommier, 2008). However, very few metal complexes have been 
reported to inhibit topoisomerases (Kikuta et al. 2000; Chuang et al. 1996). Previously, we 
learnt that some of our ternary zinc complexes derived from N(4)-substituted 
thiosemicarbazone and heterocyclic base such as 2,2'-bipyridine or 1,10-phenanthroline 
(chapters 2 and 3) can inhibit topoisomerase I with the right combinations of ligands. 
Continuing our efforts to develop more ternary complexes that can inhibit topoisomerase I, 
the effect of varying the metal of these complexes from zinc to copper is studied. 
 
In our DNA relaxation assay, one unit of human topoisomerase I can completely 
convert all the supercoiled plasmid pBR322 (4.4 kb) to fully relaxed topoisomer, which is 
the completely unwound covalently bonded closed circular DNA (Fig. 4.22, lane L7). This 
is found in the slowest moving DNA band (labelled Form II) which contains the fully 
relaxed closed circular pBR322 and the originally present, small amount of nicked DNA. 
No cleavage or unwinding of the DNA was observed when pBR322 was incubated with 40 
μM of complexes 13-16 alone (Fig. 4.22, lane L2-L5). As can be seen from Fig. 4.22 (lane 
L10 and L11), complexes 16 and 13 are capable of inhibiting topo I. The topoisomerase 
inhibition property of complex 16 (Table 4.7) could be attributed to its ability to bind 
strongly to AT-rich sequence (Kikuta et al. 2000).  Minor groove binders, such as 
distamycin A and 4,6-diamidino-2-phenylindole (DAPI) can suppress Topo I-linked DNA 
breaks.  These minor groove binders, recognize AT-rich regions of DNA mainly by 
hydrogen bondings. However, the ability of complex 13 in inhibiting topoisomerase I is not 
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clear since it does not show significantly stronger binding to the AT-rich sequence 
compared with complexes 12 and 14. Interestingly, the zinc analog of complex 13 cannot 
inhibit topoisomerase I indicating the importance of copper. This could be attributed to the 
different in coordination geometry between zinc and copper for our ternary complexes as 
shown by crystallography data. 
 
Fig. 4.22 Human topoisomerase I inhibition assay by gel electrophoresis. 
Electrophoresis results of incubating human topoisomerase I (1 unit/21μL) with pBR322 in 
the absence or presence of 40 μM  of complex:  Lane 1 & 6, gene ruler 1 Kb DNA ladder; 
Lane 2, DNA + 40µM 15 (control);Lane 3, DNA + 40µM 14 (control); Lane 4, DNA + 
40µM 16(control); Lane 5, DNA + 40µM 13(control); Lane 7, DNA+ 1unit Human 
Topoisomerase I (control); Lane 8, DNA + 40µM 15+ 1unit Human Topoisomerase I; Lane 
9, DNA + 40µM 14 + 1unit Human Topoisomerase I; Lane 10, DNA + 40µM 16 + 1unit 
Human Topoisomerase I; Lane 11,  DNA + 40µM  13 + 1unit Human Topoisomerase I 
 
As a preliminary investigation into the mechanism of action of the above 
topoisomerase I inhibition, we used three variations of mixing the DNA, topoisomerase I 
and the copper complexes (at 40 µM) for the inhibition assay. When the three components 
Form I 
Form II 
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were mixed simultaneously, there is slight inhibiton of topoisomerase Iby complexes 13 
and 16 as seen by the presence of the fastest moving band with low intensity (Form I) 
which consists of supercoiled DNA and poorly relaxed DNA (Fig. 4.23, lane L5). The 
bands of topoisomers with different degree of relaxation can also be seen in between Form 
I and Form II. Secondly, when the complex was incubated first with topoisomerase I before 
the addition of DNA; the intensity of the fastest moving band is the highest for complexes 
13 and 16 with almost total disappearance of the slowest moving band (Form II), 
suggesting almost total inhibition of topoisomerase I (Fig. 4.23, lane  L6). The inhibition of 
complex 16 is slightly better compared with complex 13 with this sequence of addition 
based on the intensity of the fastest moving band (form I). 
 
 Finally, when the DNA was first incubated with copper complex for 30 minutes 
before the addition of topoisomerase I (Fig. 4.23, lane L7), the fastest moving band (Form 
I) almost disappears completely for complex 13 whereas the fastest moving band can still 
be seen in complex 16. This again indicates that complex 16 is a better topoisomerase I 
inhibitor. The intensity of Form I is lower for both complexes in contrast to the second 
method of mixing. These observed differences in inhibition of topoisomerase I suggest 
initial binding of the copper complex to either the topoisomerase I or the DNA give rise to 
differences in mode of action. By comparing lanes L6 and L7, we infer that since greater 
inhibition of topoisomerase I is observed when the complex is incubated with topo first, the 
main pathway in inhibition process most likely involves the binding of complex to the 
enzyme. However, further investigation is required to confirm this.  
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.      
Fig. 4.23 Effect of sequence of mixing for the human topoisomerase I inhibition assay of 
complex 13 and 16. Electrophoresis results of incubating human topoisomerase I (1 
unit/21μL) with pBR322: Lane 1, 1 kb DNA ladder; Lane 2, Plasmid DNA pBR 322 
(control); Lane 3, DNA + 40µM complex (control); Lane 4, DNA+ 1unit Human 
Topoisomerase I (control); (a) All components mixed at the same time; Lane 5, DNA + 
40µM complex + 1unit Human Topoisomerase I ; (b) Complex + TopoI incubated for 30 
minutes first before DNA is added; Lane 6, DNA + 40µM complex + 1unit Human 
Topoisomerase I; (c) Complex + DNA incubated for 30 minutes first before TopoI is 
added; Lane 7, DNA + 40µM complex + 1unit Human Topoisomerase I 
 
4.3.7 Antibacterial and antifungal assay 
4.3.7.1 Antibacterial activity 
As seen in section 3.3.8.1, the antibacterial activity of ligands and complexes were assessed 
against the same six species. All ligands and complexes had some degree of inhibitory 
activity against the bacteria tested (Table 4.8). Among the four thiosemicarbazones ligands 
tested, ligand 4 shows the highest inhibition against B. cereus and K. pneumonia with MIC 
value 31.25 µg/ml.  
 
(a)  (b)   (c)  (a)      (b)       (c)    
Complex 16  Complex 13 
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Table 4.8. 
 Mean MIC value (µg/ml) towards microbes tested. 
Compound Bacteria 
 S. aureus B. cereus P. aeruginosa K. pneumonia E. coli  E. coli  
              
(penicillin- 
sensitive strain) 
(penicillin- 
resistant strain) 
1 62.50 62.50 62.50 62.50 62.50 62.50 
2 125.00 62.50 125.00 62.50 62.50 62.50 
3 62.50 62.50 62.50 62.50 62.50 62.50 
4 62.50 31.25 62.50 31.25 62.50 62.50 
13 62.50 62.50 104.17 62.50 62.50 62.50 
14 31.25 31.25 31.25 250.00 62.50 62.50 
15 15.63 15.63 15.63 31.25 62.50 62.50 
16 31.25 26.04±9.02 62.50 62.50 62.50 62.50 
CuCl2 - - - - - - 
bipy 125 62.50 62.50 62.50 62.50 62.50 
Drug 8.00 4.00 4.00 4.00 4.00 4.00 
 “ - ” : no activity     
Drug used in antibacterial assay = Chloramphenicol   
  
 Upon complexation, improvement of antibacterial activity towards S. aureus, B. 
cereus, P. aeruginosa and K. pneumonia are seen for complexes 14-16 compared with the 
free thiosemicarbazones or bipyridine ligands. However, a few exceptions are seen for the 
K. pneumoniae strain. The antibacterial property of complexes 14 and 16 towards K. 
pneumonia was less in contrast to the free ligands.  However, no improvement is seen for 
complex 13 and the antibacterial activity towards P. aeruginosa even decreases to 104.17 
µg/ml. None of the complexes showed improvement in efficacy towards E.coli  compared 
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with their corresponding thiosemicarbazones ligands.  Complex 14 shows good 
antibacterial activity towards S. aureus, B. cereus and P. aeruginosa with MIC value of 
31.25 µg/ml. Complex 15 is twice as effective as complex 14 with MIC values of 15.63 
µg/ml towards these three strains of bacteria. This suggests that elongation of alkyl chain in 
complex 15 helps to improve its antibacterial activity correlated with increasing 
hydrophobicity. Similar improvement in antibacterial activity with the increase in the 
length of alkyl chain has been reported by Kim et al. (1997) in their study of chitosan 
derivatives with quaternary ammonium salts. This increased activity has been ascribed to 
the contribution of the increased hydrophobic properties of the derivatives. 
 
Complex 15, [Cu(bipy)(HE)], with an ethyl substituent at the N(4) atom, is the most 
potent antibacterial complex in this copper series with the lowest MIC value towards   S. 
aureus, B. cereus, K. pneumonia  and P. aeruginosa. However, for a similar system with 
zinc , complex 8, [Zn(bipy)(HP)],  with a phenyl substituent is the most active. This shows 
that the trend in antibacterial activity for metal complexes with the same series of ligands 
will differ with the change in central metal ion. Copper complexes (14 and 15) derived 
from ligands 2 and 3 also show better antibacterial activity compared with their zinc 
analogs (complex 6 and 7). The antibacterial activity of complex 15, [Cu(bipy)(HE)], is not 
compatible with topoisomerase I inhibition unlike complex 8 from the zinc series. 
Toposiomerase I has been implicated as a good target for the development of antibacterial 
drug (Tse-Dinh, 2009). This could be attributed to the success of the currently marketed 
inhibitors such as the quinolones dervatives (Bradbury and Pucci, 2008). This suggests that 
the mode of action for the antibacterial activity of copper complexes may not be similar to 
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zinc. Recently, Rodríguez-Argüelles et al. (2009) have studied the antibacterial activity of 
metal complexes of 2-acetyl-butyrolactone and 2-furancarbaldehyde thiosemicarbazones. 
Their results show that the activity of the copper complexes is always better compared with 
their zinc analogs and they suggest that the observed biological activity for copper may 
involve redox processes. This argument seems reasonable given that copper complexes are 
usually redox active whereas zinc complexes are usually inert.  
 
4.3.7.2 Antifungal activity 
In the previous section, the antibacterial property of the copper complexes was discussed. 
This section presents the results and discussion of their antifungal property. All complexes 
had some degree of inhibitory activity against the fungi tested (Table 4.9).   
 
Most of the tested complexes do not show better antifungal properties than the free 
2,2'-bipyridine ligand even though their antifungal properties are mostly better than the free 
thiosemicarbazones ligands. This implies that formation of ternary complexes does not lead 
to much improvement in antifungal properties. The antifungal property for complexes 13 
and 16 is the same as the ligand for C. albicans. The same is observed for complex 15 
towards C. parapsilosis and C. neoformans. Complex 14 is the only complex that shows 
better antifungal property towards both C. neoformans and A.niger when compared with its 
free ligands (2 and 2,2'-bipyridine). Complex 14 possesses the lowest MIC value of 7.81 
µg/ml towards C. neoformans. This makes it the most active antifungal agent in our assay. 
Complexes 13 and 16 show better antifungal properties towards C. neoformans and A.niger 
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respectively in contrast to their free ligands (thiosemicarbazones and 2,2'-bipyridine). Both 
complexes have MIC value of of 15.63 µg/ml.  Generally, most of the copper complexes in 
this series posses better antifungal property than their zinc analogs (chapter 2).  Similar 
trends have been reported by Rodríguez-Argüelles et al. (2009) for metal complexes of 2-
acetyl-butyrolactone and 2-furancarbaldehyde thiosemicarbazones. 
 
Table 4.9 
Mean MIC value (µg/ml) towards fungi tested. 
 Compound Fungi 
 C. albicans C. parapsilosis C. neoformans A.niger 
              
1 31.25 62.50 31.25 62.50 
2 31.25 31.25 31.25 62.50 
3 31.25 31.25 31.25 62.50 
4 31.25 62.50 7.81 31.25 
13 31.25 31.25 15.63 31.25 
14 15.63 15.63 7.81 15.63 
15 15.63 31.25 31.25 31.25 
16 31.25 31.25 15.63 15.63 
CuCl2 - - - - 
Bipy 15.63 15.63 31.25 31.25 
Drug 1.00 2.00 1.00 4.00 
All values are expressed as mean ± standard deviation of three replicates  
“ - ” : no activity. Drug used in antifungal assay = fluconazole  
 
 
 
  
200 
4.4 Conclusion 
Four new copper complexes with the formulation Cu(bipy)L where bipy = 2,2'-bipyridine 
and L are the doubly deprotonated thiosemicarbazones have been successfully synthesized 
and characterized. All copper complexes are five-coordinated with the doubly deprotonated 
thiosemicarbazones ligands behaving as a tridentate ligand coordinating through one 
phenolic oxygen, azomethine nitrogen and thiolate sulfur while the 2,2'-bipyridine is 
coordinated as the N,N’-bidentate ligand. However, the coordination geometry around the 
copper complexes is square pyramidal in contrast to their zinc analogs (Zn(bipy)L) that 
adopt trigonal bipyramidal distorted square based pyramid (TBDSBP) geometry. 
 
Complexation of the ligands with copper lead to formation of a series of ternary 
complexes Cu(bipy)L with better biological properties compared with their zinc analogs. 
Complex 14, Cu(bipy)(HM), which is the copper analog for complex 6, Zn(bipy)(HM),  
retains its ability to effectively recognize CG rich sequence in DNA. The modes of binding 
towards base sequences for complexes 13, 14, 15 and 16 are quite different from those 
observed for their zinc analogs. The greatest difference is observed in binding towards the 
G-quadruplex. This again underscores that the synergistic effect of metal and ligand could 
be an underlying factor in molecular recognition of a DNA sequence or structure since a 
slight variation in the central metal ion for complexes with same ligands could lead to such 
diverse modes and strengths of binding. Unlike their zinc analogs, the copper complexes 
can be activated by sodium ascorbate or hydrogen peroxide to induce DNA cleavage. The 
nucleolytic efficiency is enhanced with the presence of an electron withdrawing group    
(phenyl) as the N(4) substituent. The mechanism for topoisomerase I inhibition most likely 
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involved the binding of the complex to topoisomerase I as the main pathway. Most of the 
copper complexes exhibit wider spectrum of antibacterial and antifungal properties with 
better MIC values compared to their zinc analogs. Complex 16, Cu(bipy)(HP),  has a good 
potential to be developed as a drug or DNA probe owing to its strong binding towards the 
AT-rich region in DNA, topoisomerase I inhibition activity and nucleolytic efficiency. It is 
noteworthy that complex 8, Zn(bipy)(HP)  which is the zinc analog for complex 16, also 
possesses topoisomerase I inhibition activity, the best antibacterial and antifungal 
properties in  the zinc series. This further substantiate the role of the phenyl group at the 
N(4) position in bestowing desirable biological activities to a complex regardless of its 
metal centre.  
  
202 
Chapter 5 
Synthesis, characterization and biological properties of copper(II) complexes of 2,4-
dihydroxybenzaldehyde N4-substituted thiosemicarbazones and 1,10-phenanthroline 
5.1. Introduction   
In an earlier chapter (chapter 2), we showed that the N(4) substituents play a role in 
determining the selectivity and potency of zinc(II) complexes of 2,4-
dihydroxybenzaldehyde N(4)-substituted thiosemicarbazones and 2,2'-bipyridine with the 
general formulation of Zn(bipy)(L). These complexes exhibit interesting biological 
activities from DNA sequence recognition, quadruplex binding, topoisomerase I inhibition, 
antibacterial to antifungal property. However, these zinc complexes are lacking in 
nucleolytic efficiency. When the zinc(II) ion was replaced with copper(II) ion we  observed 
some improvements in biological activities of these complexes, Cu(bipy)(L) particularly 
their nucleolytic efficiency (chapter 4). These encouraging results have spurred us to 
introduce further modifications to these complexes by replacing 2,2'-bipyridine with 1,10-
phenanthroline. We hope that this modification will result in complexes that can bind more 
strongly to DNA and hence wth better nucleolytic property as mentioned earlier. 
(Ramakrishnan and Palaniandavar, 2008; Roy et al. 2007; Patra et al. 2005; Dhar et al. 
2005; Thomas et al. 2003).  
 
Therefore, continuing our interest in improving the biological properties of these 
complexes, we report the effect of varying the N(4) substituent from proton, methyl, ethyl 
to phenyl upon the chemical and biological properties (DNA binding, nucleolytic, 
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topoisomerase I inhibition and antimicrobial) of ternary Cu(II) complexes containing 1,10-
phenanthroline as the heterocyclic base. Cross comparison of the chemical and biological 
properties of this series (Cu(phen)(L)) with the zinc(II) series (Zn(phen)(L))  in chapter 3 
will be carried out to study the effect of varying the metal ions in same ligand environment 
whereas comparison with its 2,2'-bipyridine analogs (Cu(bipy)(L))  in chapter 4 could help 
us in studying the effect of  varying  the polypyridyl ligand. 
 
5.2. Experimental 
5.2.1. Materials and solutions 
Similar materials were used as reported in chapter 2. 
 
5.2.2. Physical measurements 
Spectroscopic measurements and elemental analyses were similarly carried out as reported 
in chapter 2.  
 
5.2.3 Syntheses 
5.2.3.1 Synthesis of (4-Hydroxy-2-oxidobenzaldehyde thiosemicarbazonato)-(1,10-
phenanthroline)copper(II)monohydrate [Cu(phen)(HT)].H2O (17) 
Copper acetate dihydrate (0.22 g, 1 mmol) and 1,10-phenanthroline (0.20 g, 1 mmol) were 
heated in ethanol (20 ml) for 1 hour followed by addition of 2,4-dihydroxybenzaldehyde 
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thiosemicarbazone (0.21 g, 1 mmol) in hot ethanol (20 ml). The mixture was refluxed for 
another 3 hours.  
(Yield: 0.33 g, 80%). Anal. Calc. for C20H17N5O3SCu: C, 51.00; H, 3.64; N, 14.87. Found: 
C, 50.88; H, 3.60; N, 14.68%. IR (KBr disc, cm-1): 3450 w, 3350m, 3277 w, 3170 w, 
3058w, 1602 s, 1491 s, 1425 m, 1318 m, 1222 s, 1184 m, 1122 m, 842 m, 726 m, 595 w, 
553w, 473 w (s, strong; m, medium; w, weak). 
 
5.2.3.2 Synthesis of (4-Hydroxy-2-oxidobenzaldehyde 4-methylthiosemicarbazonato)-
(1,10-phenanthroline)copper(II) monohydrate, [Cu(phen)(HM)]. H2O (18) 
Complex 18 was similarly prepared as complex 17 by using 2,4-dihydroxybenzaldehyde 4-
methylthiosemicarbazone (0.23 g, 1 mmol) as the Schiff base. 
 (Yield: 0.39 g, 80%). Anal. Calc. for C21H19N5O3SCu: C, 52.00; H, 3.95; N, 14.44. Found: 
C, 51.82; H, 3.73; N, 14.25%. IR (KBr disc, cm-1): 3422 (broad), 3329 m, 3058 w, 1598 s, 
1524s, 1426 w, 1404 m, 1327 m, 1267 m, 1216 s, 1279 w, 1182 m, 1122 m, 843 m, 727 m, 
593 w, 553w, 471 w, (s, strong; m, medium; w, weak). 
 
5.2.3.3 Synthesis of (4-Hydroxy-2-oxidobenzaldehyde 4-ethylthiosemicarbazonato)-(1,10-
phenanthroline)copper(II) monohydrate, [Cu(phen)(HE)].H2O (19) 
Complex 19 was similarly prepared as complex 17 by using 2,4-dihydroxybenzaldehyde 4-
ethylthiosemicarbazone (0.24 g, 1 mmol) as the Schiff base. 
(Yield: 0.39 g, 78%). Anal. Calc. for C22H21N5O3SCu: C, 52.95; H, 4.24; N, 14.03. Found: 
C, 52.45; H, 4.24; N, 13.70%. IR (KBr disc, cm-1):  3457 m, 2964 m,  1602 s, 1490s, 1425 s, 
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1342 m , 1280 m m, 1209 s, 1123 m, 841 m, 726 m, 554 m, 462 w,  420 w  (s, strong; m, 
medium; w, weak). 
 
5.2.3.4 Synthesis of (4-Hydroxy-2-oxidobenzaldehyde 4-ethylthiosemicarbazonato)-(1,10-
phenanthroline)copper(II) monohydrate, [Cu(phen)(HP)]. H2O (20) 
Complex 20 was similarly prepared as complex 17 by using 2,4-dihydroxybenzaldehyde 4-
phenylthiosemicarbazone (0.29 g, 1 mmol) as the Schiff base ligand.  
 (Yield: 0.44 g, 83%). Anal. Calc. for C26H19N5O3SCu: C, 59.02; H, 3.62; N, 13.24. Found: 
C, 58.81; H, 3.39; N, 13.65%. IR (KBr disc, cm-1): 3398 m, 3058 w, 1601 s, 1541 m, 1499 
s, 1430 s, 1313 m, 1220 m, 1179 m, 845 m, 726 m, 695 w, 588 w,  506 w, 420 w (s, strong; 
m, medium; w, weak). 
 
5.2.4 X-ray crystallography 
Greenish crystal for complex 18a was recrystallised from DMSO. The unit cell parameters 
and the intensity data were collected on a Bruker SMART APEX CCD diffractometer, 
equipped with Mo Kα X-ray source (λ=0.71073 Å). Data collection, structure solution and 
refinement for complex 18a were carried out as mentioned in chapter 2. 
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5.2.5 DNA binding 
DNA binding was studied by using circular dichroism as reported in chapter 2. 
 
5.2.6 Nucleolytic study 
Agarose gel electrophoresis experiments were carried out on supercoiled plasmid 
DNA pBR322 (4.4 kb) using a horizontal gel system as described in chapter 2. 
 
5.2.7 Human Topoisomerase I inhibtion assay 
The human DNA topoisomerase I inhibitory activity was determined by measuring the 
relaxation of supercoiled plasmid DNA pBR322 as described in chapter 2.  
 
5.2.8 Antibacterial and antifungal assay 
For this series of Cu(phen)(L) complexes, the antibacterial and antifungal activities of the 
complexes were investigated as previously mentioned in chapter 2. 
 
5.3 Results and discussions 
5.3.1 Synthesis of the complexes 
The stoichiometries, color and partial elemental analyses of the ligands and copper(II) 
complexes are shown in Table 5.1. All the complexes are prepared in high yield by 
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refluxing copper acetate dihydrate, 1,10-phenanthroline and the thiosemicarbazones in 
ethanol. Proposed structures for all the complexes with IUPAC numbering scheme are 
shown in Fig. 5.1. Results from partial elemental analyses are in good agreement with the 
proposed formulation of Cu(phen)L where phen = 1,10-phenanthroline and L are the 
doubly deprotonated thiosemicarbazones. The complexes exist as a monohydrate and are 
greenish in colour. Complex 18a has additionally a DMSO in its lattice structure.. These 
complexes are insoluble in common polar and non-polar solvents but are soluble in DMF 
and DMSO. Magnetic susceptibility measurements indicates that the complexes are very 
close to the spin-only value of 1.73 B.M in accordance to d9 configuration of copper(II) 
(Bindu et al., 1999) 
 
17 R = H 18 R = -CH3 19 R = -C2H5 20 R = -C6H5 
Fig. 5.1 Proposed structure for all the complexes 
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Table 5.1 
Stoichiometries, color and partial elemental analyses of the copper(II) complexes 
Complex Stoichiometries Color 
Anal. 
Calc. (Found )%  
µ 
effective 
   C H N  (B.M) 
[Cu(phen)(HT)] .H2O (17) C20H17N5O3SCu Green 
51.00 
(50.88) 
3.64 
(3.60) 
14.87 
(14.68) 1.82 
[Cu(phen)(HM)].H2O (18) C21H19N5O3SCu Green 
52.00 
(51.82) 
3.95 
(3.73) 
14.44 
(14.25) 1.84 
[Cu(phen)(HM)].H2O .DMSO 
(18a) 
C23H25CuN5O4S2 Green 
49.05 
(49.36) 
4.47 
(4.26) 
12.44 
(12.85) 
1.84 
[Cu(phen)(HE)].H2O (19) C22H21N5O3SCu Green 
52.95 
(52.45) 
4.24 
(4.44) 
14.03 
(13.70) 1.83 
[Cu(phen)(HP)].H2O (20) C26H19N5O3SCu Green 
59.02 
(58.81) 
3.62 
(3.39) 
13.24 
(13.65) 1.84 
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5.3.2 Crystal structure analysis 
5.3.2.1 Crystal structures of [Cu(phen)(HM)].H2O.DMSO (18a) 
The complex is mononuclear and five coordinated with the doubly deprotonated 
thiosemicarbazone as a tridentate ligand coordinating through the phenolic oxygen, 
azomethine nitrogen and thiolate sulfur atoms. and with 1,10-phenanthroline as the N,N’-
bidentate ligand (Fig. 5.2). This complex is isomorphous with complex 11a. Calculation of 
the trigonality index τ, gives a value 0.30 for 18a. This indicates that the coordination 
geometry around copper is distorted square pyramidal.  
 
 
.      
 
 
 
 
Fig. 5.2 Thermal ellipsoid (Barbour, 2001) plot of 18a drawn at the 70% probability level. 
Hydrogen atoms are drawn as spheres of arbitrary radii. 
 
Selected bond lengths and angles are presented in Table 5.3. The variation in Cu–N 
bond distances, Cu(1)–N(1), 1.944(4), Cu(1)–N(4), 2.040(4) and Cu(1)–N(5), 2.230(4) Å 
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indicate differences in the strengths of the bonds formed by each of the coordinating 
nitrogen atoms. The Cu–N bond lengths for N1 and N5 are shorter than those reported in 
mononuclear copper(II) complex, [Cu(Ph-tsc)phen] (Ph-H2tsc = salicylaldehyde-N(4)-
phenylthiosemicarbazone)  by Thomas et al. (2004). The Cu–S bond length of 2.281(1) Å 
is also slightly shorter than those reported by Thomas et al. (2004). The imine bond 
formation is evidenced from N2-C8 and N1-C7 distances of 1.290(7) and 1.295(6) Å. Upon 
complexation, the C8-N2 bond length of 1.354(4) decreases to 1.290(7) and C8-S1 
increases from 1.699(3) to 1.757(5) Å. The changes in bond length are attributed to partial 
loss and gain of double bond character in accordance to coordination of thiosemicarbazone 
in the thiolate form.  
 
Hydrogen bonding parameters are shown in Table 5.4. Two mononuclear molecules 
are linked through two water molecules across a center-of-inversion. The 4-hydroxy group 
of the thiosemicarbazone ligand forms a hydrogen bond to the disordered DMSO solvate 
molecule as shown in Fig. 5.3. Formation of a hydrogen bond with DMSO hampers the 
formation of two or three dimensional network as seen for other complexes earlier where 
the hydroxyl group link the complex to adjacent mononuclear molecule through direct 
hydrogen bonding or through another water molecule. The packing of the molecules is 
stabilized by combination of hydrogen bonding and π-π interactions between aromatic rings 
as shown in Fig. 5.4.  
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Fig. 5.3 Hydrogen bonding interactions for complex 18a 
 
Fig. 5.4 Unit cell packing diagram of 18a view in between c and a axis. 
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Table 5.2 Crystal data and structure refinement parameters for complex 18a  
Complex [Cu(phen)(HM)].H2O.DMSO (18a) 
Empirical formula  C23H25CuN5O4S2 
Formula weight  563.14 
Crystal system  Monoclinic 
Space group  P21/c 
Unit cell dimensions  
a (Å) 9.6205(2) Å 
b (Å)  25.9915(5) Å 
c (Å) 9.7074(2) Å 
α (°) 93.544(2)° 
Volume, V (Å3)  2422.71(8) 
Z  4 
F(0 0 0) 1164 
Density (calculated), (mg m−3) 1.544 
Absorption coefficient, µ(mm−1) 1.12 
Temperature, T (K) 100 (2) 
Crystal size (mm) 0.28 × 0.08 × 0.04 
Reflections collected  24973 
Independent reflections  5569  [R(int) = 0.085] 
Data/restraints/parameters  5569/10/346 
R[F2 > 2σ(F2)] 0.059 
wR(F2) 0.182 
S  1.10 
Largest difference peak and hole (e Å−3) 0.63 and −0.82 
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Table 5.3 
Selected bond lengths (Å) and angles (˚) for [Cu(phen)(HM)].H2O.DMSO (18a)  
Bond lengths   Bond angles  
Cu1—N1 1.944 (4) N1—Cu1—N4 172.1 (2) 
Cu1—N4 2.040 (4) N1—Cu1—N5 94.2 (2) 
Cu1—N5 2.230 (4) N1—Cu1—O1 93.3 (2) 
Cu1—O1 1.965 (3) N1—Cu1—S1 84.8 (1) 
Cu1—S1 2.281 (1) N4—Cu1—O1 90.9 (2) 
S1—C8 1.757 (5) N4—Cu1—N5 78.4 (2) 
O1—C1 1.313 (6) N4—Cu1—S1 94.4 (1) 
O2—C3 1.366 (6) N5—Cu1—O1 101.8 (2) 
N1—C7 1.295 (6) N5—Cu1—S1 104.0 (1) 
N1—N2 1.409 (5) O1—Cu1—S1 154.2 (1) 
N2—C8 1.290 (7)   
N3—C8 1.369 (6)   
N3—C9 1.453 (7)   
N4—C10 1.322 (7)   
 
Table 5.4 
Hydrogen-bond geometry (Å, °) for [Cu(phen)(HM)].H2O.DMSO (1a) 
D—H···A D—H H···A D···A D—H···A 
O2—H2o···O3 0.84 (1) 1.84 (2) 2.681 (8) 173 (8) 
O2—H2o···O3' 0.84 (1) 1.82 (4) 2.61 (1) 155 (8) 
O1w—H1w1···O1i 0.85 (1) 2.06 (4) 2.878 (6) 160 (9) 
O1w—H1w2···O2 0.85 (1) 2.23 (3) 3.054 (7) 163 (9) 
Symmetry codes: (i) −x+1, −y+1, −z+1. 
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5.3.3 Infrared and electronic spectra 
IR spectra for all the complexes are shown in Fig. 5.5. Important IR bands for the ligands 
and complexes are given in Table 5.5. Thiosemicarbazones are known to exhibit thione-
thiol tautomerization (Fig. 5.6). The absence of any band around 2600-2800 cm-1 ν(S-H) 
indicates that in the solid form, all the ligands exist in the thione form (Bindu et al. 1999; 
Afrasiabi et al. 2005). The IR spectra for the complexes are similar to their 2,2'-bipyridine 
derivatives discussed in chapter 2. Therefore, the mode of binding of the ligands should be 
the same.    
 
 
Fig. 5.6 Thione-thiol tautomerization for the ligands 
(Depicted again for easy reference) 
 
The appearance of new ν(Cu-N)  bands in the range of 450-479 cm-1 confirms the 
coordination through azomethine and polypyridyl nitrogens.  Coordination through 
phenolic oxygen is confirmed by the presence of ν(Cu-O) band at around at around 426-
430 cm-1 (Bindu et al. 1999; Seena and Kurup, 2007; Latheef and Kurup, 2008). 
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Fig. 5.5 IR spectra of all the complexes 
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The mode of coordination for the ligands determined by IR spectra is in good 
agreement with the crystal structure of complex 18a. Complexes 17-20 have very similar 
IR spectra (Fig. 5.5), this indicates that they share the similar mode of coordination. 
Therefore, it is reasonable to propose that the coordination geometry around copper for 
complex 17-20 is distorted square pyramid. 
Table 5.5 
IR spectral assignments (cm-1) for the ligands and their copper(II) complexes 
Complex ν(C=N) ν(C-O) ν(N-N) 
ν (C=S)/  
ν (C-S) 
ν(Cu-O) ν(Cu-N) 
Bands due to  
phenanthroline 
H3T (1) 1620 1239 1165 1379, 863 - - - 
H3M (2) 1625 1231 1166 1331,868 - - - 
H3E (3) 1626 1241 1166 1325, 867 - - - 
H3P (4) 1629 1264 1121 1323,838 - - - 
[Cu(phen)(HT)] (17) 1602 1222 1184 1318, 842 426 473 1425,  726 
[Cu(phen)(HM)].H2O (18) 1598 1216 1182 1327, 843 430 471 1426,  727 
[Cu(phen)(HE)].H2O (19) 1602 1209 1187 1280, 841 422 460 1425,  726 
[Cu(phen)(HP)].H2O (20) 1601 1220 1179 1313, 845 420 450 1430,  726 
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Electronic spectral assignments for the ligands and their copper(II) complexes in 
DMF are presented in Table 5.6. All the ligands and the Cu(II) complexes have a ring 
(phenolic and diimine) π-π* band at around 37,593 cm-1 (West et al. 1995). No significant 
red shift is observed for these bands upon complexation (Swearingan and West, 2000). All 
the thiosemicarbazones also have two bands at around 32,985 cm-1 and 29,411 cm-1 due to 
n-π* transition of azomethine and thioamide function respectively. Upon complexation, the 
n-π* band of the thioamide function is shifted above 30,000 cm-1 due to thioenolization and 
merges with the azomethine n-π* band at around 31,348 cm-1  (Swearingan and West, 2000). 
Thioenolization causes the weakening of the C=S bond. A moderately intense band in the 
range 26110-27100 cm-1 found only in the spectra of all the complexes is assigned to 
Cu(II)S metal to ligand charge transfer band (MLCT) (Swearingan and West, 2000; 
Seena and Kurup, 2007). The MLCT band for Cu(II)O shows line broadening that runs 
into the visible part of the spectrum. However, the maxima of these band are not observed 
probably due to the overlapping with the low energy side of Cu(II)S transitions (Seena 
and Kurup, 2007). The copper complexes show a d-d band at 17422-17825 cm-1 due to 
dx2−y2 → dxz, dyz and dx2−y2 → dz2 transitions characteristic of five coordinate copper(II) 
complexes with square pyramidal geometry (Bindu et al., 1999; Seena and Kurup, 2007; 
Latheef and Kurup, 2008). 
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Table 5.6 
Electronic spectral assignments (cm-1) for the ligands and their copper(II) complexes in DMF  
Complex π-π* n-π* MLCT d-d 
H3T (1) 37593 33003, 29411   
H3M (2) 37593 33003, 29411   
H3E (3) 37593 32895, 29240   
H3P (4) 37453 32680, 28409   
[Cu(phen)(HT)] (17) 35714 31545 27100, 26042 17422 
[Cu(phen)(HM)].H2O (18) 36764 32051 26525 17452 
[Cu(phen)(HE)].H2O (19) 36764 31348 26667 17422 
[Cu(phen)(HP)].H2O (20) 37453 30488 26110 17825 
 
5.3.4 DNA binding  
5.3.4.1 Duplex DNA 
The interaction of  more soluble 18 and 19 with (i) duplex oligonucleotides of 
various specified nucleotide sequences, and (ii) quadruplex DNA of the 23-mer 
oligonucleotide 5’-AG3(T2AG3)3-3’ and its corresponding duplex could be investigated 
with CD spectroscopy. Complexes 17 and 20 could not be studied due to limited solubility 
in DMF and buffer mixture. 
 
Similar to what was done in other chapters, the first investigation was to find out the 
DNA binding preference for CG or AT sequences by interaction with ds(CG)6 and ds(AT)6 
duplexes by the complexes 18 and 19. Complex 18 (Fig. 5.7) at a complex:duplex ratio of 
1:8 shows decrease and increase in the positive and negative bands of the CD spectrum of  
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ds(AT)6 which shows some resemblance to conformational change from B to C-like 
(Ivanov et al. 1973). However, complex 19 (Fig. 5.8) does not cause significant changes to 
CD spectrum of ds(AT)6. Complex 18 shows a great decrease in intensity of the positive 
band of the CD spectrum of ds(CG)6 without noticeable changes to the negative band which 
is consistent with conformational change from B to C (Ivanov et al. 1973). Complex 19 
shows slight increase of the positive band of ds(CG)6 without appreciable changes to the 
negative band suggesting partial intercalation of the complex to DNA. By comparing the 
changes induced by complexes 18 and 19 in both the positive and negative bands in the CD 
spectra of  ds(AT)6 and ds(CG)6, we can infer that complex 18 binds more strongly to 
ds(AT)6 and ds(CG)6 compared with complex 19 (Table 5.7). Similar correlation between 
the degree of enhancement or decrease in intensity of CD bands with binding strength has 
been reported by Seng et al. (2009). Their results obtained from CD data are in good 
agreement with data from the ethidium bromide displacement assay and docking study. 
 
We next utilised oligonucleotides such as ds(CGCGAATTCGCG)2 and 
ds(CGCGATATCGCG)2 to investigate further whether there is any binding preferences in 
interactions with duplex DNA as the sequence on each chain is varied from non-alternating 
to alternating purine-pyrimidine bases in the groove of the duplex.  For the AATT sequence 
(Fig. 5.9-5.10, Table 5.7), complexes 18 and 19 show a decrease and increase in the 
negative and positive bands of the CD spectra of the duplex which is consistent to 
conformational change from B to ψ (Maheswari and Palaniandavar, 2004; Seng et al. 2008).   
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Fig. 5.7 CD spectra of 15 μM of oligonucleotide in the absence and presence of 120 μM of 
complex 18; (a) ds(AT)6 alone, (b) ds(AT)6 with complex 18, (c) ds(CG)6 alone and (d) 
ds(CG)6 with complex 18. 
 
 
Fig. 5.8 CD spectra of 15 μM of oligonucleotide in the absence and presence of 120 μM of 
complex 19; (a) ds(AT)6 alone, (b) ds(AT)6 with complex 19, (c) ds(CG)6 alone and (d) 
ds(CG)6 with complex 19 
 
For the ATAT sequence (Fig. 5.9-5.10), complex 18 shows an increase in the 
positive bands of the CD spectra of the duplex without significant changes to the negative 
band. This suggests partial intercalation of the complex to DNA (Maheswari and 
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Palaniandavar, 2004; Seng et al. 2008). However, complex 19 shows an increase in both 
the positive and negative bands of the CD spectra which is consistent with intercalation 
mode of binding (Maheswari and Palaniandavar, 2004; Seng et al. 2008). Comparing the 
results for interaction with DNA with AATT and ATAT sequence, we found that 
complexes 18 and 19 can differentiate between the ATAT sequence from AATT because 
they induce different conformational changes to ds(oligonucleotide) with different base 
sequence.  We also noticed that complex 18 can bind strongly to all four 
ds(oligonucleotides). However, complex 19 only binds strongly to AATT and ATAT 
sequences. This suggest that complex 19 is more selective towards these two sequence than 
ds(AT)6 and ds(CG)6. This again implies that the N(4) substituent plays an important role in 
recognizing base sequences, determining type of binding and strength of binding to DNA. 
Shape and hydrophobicity are factors long known to govern the binding of small molecules 
to DNA (Pyle et al. 1989). 
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Fig. 5.9 CD spectra of 10 μM of oligonucleotides in the absence and presence of 120 μM of 
complex 18; (a) ds(CGCGATATCGCG)2 alone, (b) ds(CGCGATATCGCG)2 with 
complex 18, (c) ds(CGCGAATTCGCG)2 alone and (d) ds(CGCGAATTCGCG)2  with 
complex 18. 
 
Fig. 5.10 CD spectra of 10 μM of oligonucleotides in the absence and presence of 120 μM 
of complex 19; (a) ds(CGCGATATCGCG)2 alone, (b) ds(CGCGATATCGCG)2 with 
complex 19, (c) ds(CGCGAATTCGCG)2 alone and (d) ds(CGCGAATTCGCG)2  with 
complex 19. 
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Table 5.7 
CD spectral bands of duplex oligo or quadruplex + copper complex: wavelength, λ  
(molar  ellipcity) 
 λ/nm (molar ellipcity) 
(-) band (+) band 
15 µM ds(AT)6 249 (-162440) 270 (98825) 
15 µM ds(AT)6 + 120 µM complex 18 249 (182082) 271 (70206) 
15 µM ds(AT)6 + 120 µM complex 19 250 (-172342) 271 (105235) 
15 µM ds(CG)6 252 (-395802) 281 (96919) 
15 µM ds(CG)6 + 120 µM complex 18 253 (-392286) 281 (64133) 
15 µM ds(CG)6 + 120 µM complex 19 252 (-398281) 282 (117130) 
10 µM ds(CGCGAATTCGCG)2 251 (-603665) 279 (215560) 
10 µM ds(CGCGAATTCGCG)2 + 120 
µM complex  18 
250 (-546507) 279 (277015) 
10 µM ds(CGCGAATTCGCG)2 + 120 
µM complex  19 
250 (-540857) 278 (279740) 
10 µM ds(CGCGATATCGCG)2 248 (-286559) 277 (174875) 
10 µM ds(CGCGATATCGCG)2 + 120 
µM complex complex 18 
250 (-281243) 277 (294148) 
10 µM ds(CGCGATATCGCG)2 + 120 
µM complex complex 19 
250 (-300704) 275 (241960) 
 
20 µM G-duplex 250 (-82682) 279 (283975) 
20 µM guanine-rich duplex+ 120 µM 
complex 18 
251 (-198287) 280 (564705) 
20 µM guanine-rich duplex+ 120 µM 
complex 19 
249 (-250491) 278 (701158) 
20 µM G-quadruplex 265 (-151753) 247 (75789)  
295 (161061) 
20 µM G-quadruplex + complex 18 264 (-147796) 245 (72833) 
295 (188283) 
20 µM G-quadruplex + complex 19 262 (-146047) 248 (81789) 
295 (180655) 
Guanine-rich duplex=(5’-CCAGTTCGTAGTAGTAACCC-3’)·(3'-
GGTCAAGCATCATCATTGGG-5’)  
 
5.3.4.2 G-quadruplex and guanine-rich duplex 
As discussed in chapter 3, the interaction of this series of copper(II) complexes 18 and 19 
(abbreviated as (Cu(phen)(L)) with G-quadruplex were similarly carried out to search for a 
complex that can stabilize G-quadruplex. Stabilizer of G-quadruplex can be a potential 
anticancer agent which functions by inhibiting telomerase. 
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 The CD spectra of the 20 μM of the antiparallel G-quadruplex 5’-
AG3(T2AG3)3-3’ with the two different complexes (120 μM) were obtained.  The intensity 
of the positive band for G-quadruplex at 296 nm is enhanced but no significant changes to 
the negative band at 267 nm are observed upon separate addition of complex 18, 
Cu(phen)(HM) and 19, Cu(phen)(HE). The overall shape of G-quadruplex remains 
unchanged, suggesting retention of the antiparallel structure (Fig. 5.11, Table 5.7).  
 
Fig. 5.11 CD spectra of  20 μM of G-quadruplex in the absence and presence of 120 μM of 
complex 18 and 19; (a) G-quadruplex alone, (b) G-quadruplex  with complex 18 , (c) G-
quadruplex  with complex 19  
 
The enhancement of the positive band at 296 nm due to G-G base stacking suggests 
partial intercalation between G-tetrads by the copper complex similar to enhancement of 
positive, base-base stacking band at ~270 nm attributed to intercalation of the B-form 
duplex DNA (Seng et al. 2009). Since the decrease in the intensity of the positive band at 
293 nm was interpreted as destabilization of the quadruplex structure for the interaction of 
acridine and bis-acridine with G-quadruplex (Nagesh et al. 2003), the enhancement of the 
positive band of the CD spectrum of the present quadruplex suggests stabilization of the 
  
225 
antiparallel quadruplex as reported by Musseti et al. (2009) and Seng et al. (2009). Based 
on the enhancement in the positive band (Fig. 5.11, Table 5.7) complex 19 probably binds 
stronger to G-quadrupex compared with complex 18.   
 
Results from the study of the interaction with guanine-rich duplex indicate that 
complexes 18, Cu(phen)(HM) and 19, Cu(phen)(HE) intercalate strongly to guanine-rich 
duplex (Fig. 5.12, Table 5.7) based on the drastic increase in both the negative and positive 
bands (Maheswari and Palaniandavar, 2004). The percentage of enhancement of the 
positive band in the CD spectra is much higher (99-146 %) compared with their 2,2'-
bipyridine analogs (31-106 %). This indicates that the 1,10-phenanthroline moiety 
promotes stronger binding of the complexes to guanine-rich duplex through intercalation. 
Complexes with phenanthroline moiety are known to bind more strongly to DNA through 
intercalation in contrast to those with 2,2'-bipyridine moiety (Dhar et al. 2002; Patra et al. 
2005). This is attributed to the extended aromatic ring in the 1,10-phenanthroline moiety 
that favors π stacking interaction with nucleobase.  Comparisons between the spectra for 
interaction with the guanine-rich duplex and G-quadruplex show that this series of 
complexes can differentiate the guanine-rich duplex from G-quadruplex. In addition, CD 
data also suggest that these complexes bind more strongly to the guanine-rich duplex than 
to the G-quadruplex. This is because the enhancement of the positive band in guanine-rich 
duplex(99-146 %) is greater compared with G-quadruplex (12-18 %). Similar observations 
were seen with their bipyridine analogs which implies that ternary copper complexes in our 
study most probably bind more strongly to guanine-rich duplex. Further, the binding of 
complexes 18 and 19 towards G-quadruplex are also weaker compared with their zinc 
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analogs (complexes 10, Zn(phen)(HM),  and 11, Zn(phen)(HE)). This again implies that the 
central metal ion also play a role in determining the binding strength of a particular 
complex towards DNA. The difference in binding strength caused by the change from 
copper to zinc may be attributed to the change in coordination geometry since all these 
complexes are neutral in charge.  
 
Fig. 5.12 CD spectra of  20 μM of guanine-rich duplex in the absence and presence of 120 
μM of complex; (a) guanine-rich duplex alone, (b) guanine-rich duplex with complex 10, 
(c) guanine-rich duplex with complex 11, (d) guanine-rich duplex with complex 18 and (e) 
guanine-rich duplex with complex 19 
 
5.3.5 Nucleolytic study 
In this study, we examine the ability of copper(II) complexes 18, Cu(phen)(HM) 
and 19, Cu(phen)(HE)  to cleave pBR322 under hydrolytic conditions and in the presence 
of exogenous agents, sodium ascorbate and hydrogen peroxide, using gel electrophoresis. 
The other copper(II) complexes in the series of Cu(phen)(L) such as 17 and 20 could not be 
studied due to limited solubility in DMF and buffer mixture (TN buffer and DMF).  
 
In the absence of any exogenous agent, cleavage was observed when the above two 
copper complexes were incubated with pBR322 for 24 h at 37 oC with increasing 
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concentrations of each copper complex (10 – 1000 μM). Complex 18 started to cleave 
DNA at a concentration of only 10 μM (Fig. 5.13, Lane L5). The amount of cleavage 
increases with increasing concentration of the complex from 200 μM onwards. (Fig. 5.13, 
Lane L7-L9) as shown by the increase in the intensity of the nicked band (Form II). At 
1000 μM, total degradation of the DNA was observed through the appearance of a smeared 
band (Fig. 5.13, Lane L9). This implies that the amount of cleavage due to complex 18 is 
concentration dependent. 
 
Fig. 5.13 Electrophoresis results of incubating pBR322 (0.5 μg/μL) in the presence of 
complex 18 in TN buffer (5 mM Tris, 50 mM NaCl) pH 7.5 at 37 oC for 24 h.  L1 & L4, 
gene ruler 1 Kb DNA ladder; L2, DNA alone; L3, DNA + 1000 μM CuCl2; DNA + various 
complex concentrations L5-L9: L5, 10 μM; L6, 50 μM; L7, 200 μM; L8, 500 μM; L9, 1000 
μM. 
 
On the other hand, complex 19 only started to show cleavage of the DNA at a 
concentration of 50 μM (Fig. 5.14, Lane L6). The amount of cleavage also increases with 
increase in complex concentration. (Fig. 5.14, Lane L6-L9) as shown by the increase in the 
intensity of the nicked band (Form II). In contrast to complex 18, complex 19 did not cause 
smearing of the DNA at 1000 μM. Complex 19 converted all the supercoiled DNA (Form I) 
to nicked DNA (Form II) instead. This observation could imply two possibilities. The first 
is that, complex 18 has higher nucleolytic efficiency in the absence of exogenous agents 
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compared with complex 19. However, the absence of smearing of the DNA band at very 
high concentration may also imply that the cleavage induced by complex 19 could be site 
specific.  
 
Fig. 5.14 Electrophoresis results of incubating pBR322 (0.5 μg/μL) in the presence of 
complex 19 in TN buffer (5 mM Tris, 50 mM NaCl) pH 7.5 at 37 oC for 24 h.  L1 & L4, 
gene ruler 1 Kb DNA ladder; L2, DNA alone; L3, DNA + 1000 μM CuCl2; DNA + various 
complex concentrations L5-L9: L5, 10 μM; L6, 50 μM; L7, 200 μM; L8, 500 μM; L9, 1000 
μM. 
 
 Interestingly, the zinc analogs (Zn(phen)(HM) and Zn(phen)HE)) of complexes 18 
and 19 can only induce mild cleavage at concentration as high as 500 μM whereas the 2,2'-
bipyridine analogs (Cu(bipy)(HM) and Cu(bipy)HE))  cannot cleave the DNA in absence of 
exogenous agents. These results imply that double substitution of zinc with copper and 2,2'-
bipyridine with 1,10-phenanthroline respectively can lead to improvement in nucleolytic 
efficiency in these ternary complexes. There are two possible reasons. The first is copper is 
redox active and the second is 1,10-phenanthroline is known to be a better intercalating 
ligand than 2,2'-bipyridine (Pyle et al. 1989). Previously, Seng et al. (2008) have shown 
that the DNA cleavage effieciency of Cu(phen)(edda) is better than Zn(phen)(edda) in the 
presence of hydrogen peroxide. Whereas, Thomas et al. (2004) have shown that the 
cleavage efficiency of ternary copper(II) complexes of N(4)-substituted salicylaldehyde 
thiosemicarbazone increase with the increase in binding strength to calf thymus DNA. This 
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increase in binding strength is attributed to the increase in extended aromatic ring of the 
intercalating ligands which escalate with the following order: phen < dpq < dppz. 
 
To elucidate the cleavage mechanism, complexes 18 and 19 were incubated for 72 
hours with DNA, neocuprione (Cu(I) ion chelator), thiourea (·OH radical-specific 
scavenger), sodium azide (a singlet oxygen radical scavenger) and Tiron (a superoxide 
anion radical scavenger) in the absence of exogenous agent. Lane L3 (Fig. 5.15) contains 
DNA and 500 µM complex 18 as the control. At this concentration, complex 18 can 
convert supercoiled DNA to the nicked and linear forms. The addition of sodium azide (Fig. 
5.15, Lane L4) to complex 18 causes a lowering in DNA degradation. This indicates the 
involvement of singlet oxygen in the cleavage mechanism. No inhibition of DNA cleavage 
is observed when neocuproine (Fig. 5.15, Lane L5) was added. This ruled out the 
involvement of oxidation of Cu(I) to Cu(II) in the generation of reactive oxygen species. 
Neocuproine is known for its ability in stabilizing the +1 oxidation state of copper. If the 
mechanism in the generation of reactive oxygen species involves the oxidation of of Cu(I) 
to Cu(II), addition of neucuproine will lead to the decrease of Cu(I) species that can be 
oxidized back to Cu(II). Thus, leading to the decrease in reactive oxygen species and DNA 
cleavage. Very weak DNA cleavage inhibition is observed with the addition of Tiron (Fig. 
5.15, Lane L6) and thiourea (Fig. 5.15, Lane L7) which indicates minor involvement of 
superoxide radical and hydroxyl radicals in the cleavage mechanism. The inhibition of 
DNA cleavage decreases with the following scavengers: sodium azide > thiourea > Tiron. 
From the above discussion, it can be concluded that the major pathway in the DNA 
cleavage involves singlet oxygen for this complex. 
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Fig. 5.15  Electrophoresis results of incubating pBR322 (0.5 μg/μL) with complex 18 in TN 
buffer (5 mM Tris, 50 mM NaCl) pH 7.5 at 37 oC for 72 h in the presence of scavenging 
agents: Lane 1, 1kb DNA ladder; Lane 2, plasmid DNA pBR322  (0.25µg/µl); Lane 3, 
DNA + 500 µM complex (control); Lane 4, DNA + 500 µM complex + 2mM sodium azide; 
Lane 5, DNA + 500 µM complex + 2mM Neocuproine; Lane 6, DNA + 500 µM complex + 
2mM Tiron; Lane 7, DNA + 500 µM complex + 2mM Thiourea 
 
As for complex 19, addition of sodium azide (Fig. 5.16, Lane L4) causes a slight inhibition 
in DNA cleavage. This indicates the involvement of singlet oxygen in the cleavage 
mechanism. No inhibition of DNA cleavage is observed when neocuproine (Fig. 5.16, Lane 
L5) was added and this ruled out the involvement of oxidation of Cu(I) to Cu(II) in the 
generation of reactive oxygen species. The same was observed with the addition of Tiron 
(Fig. 5.16, Lane L6) which rules out the involvement of superoxide radical. Better DNA 
cleavage was observed with the addition of thiourea (Fig. 5.16, Lane L7) compared with 
sodium azide. This indicates that the role of singlet oxygen is more dominant in the 
cleavage mechanism. However, no total inhibition of DNA cleavage was observed with the 
addition of scavengers. Therefore, the possibility of DNA cleavage involving hydrolysis 
could not be ruled out. Even though the structure of complexes 18 and 19 is very similar, 
however it is noteworthy that the presence of an additional carbon atom at the N(4) position 
(ethyl) for complex 19 could results in slightly different cleavage mechanism. The major 
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pathway in the DNA cleavage for both complexes involves singlet oxygen. Further, there is 
a minor involvement of hydroxyl radical in both their cleavage mechanism. However, 
minor involvement of superoxide radical is only seen in complex 18 but not in complex 19. 
This implies that the N(4) substituent not only affect the nucleolytic efficiency of these two 
complexes but also the way they induce DNA cleavage. Further study is required in order 
to understand this phenomenon. The difference in cleavage mechanism pathway attributed 
to the change in alkyl substituent of a ligand was similarly observed by Hirohama et al. 
(2005). They have studied the DNA binding properties and nuclease activity of a series of 
copper(II) complexes of the type [Cu(L)]2+, where L = N,N0–dialkyl-1,10-phenanthroline-
2,9-dimethanamine and R = methyl (L1), n-propyl (L2), isopropyl (L3), sec-butyl (L4), or 
tert-butyl (L5) group. Mechanistic study revealed that cleavage reaction of [Cu(L1)]2+ can 
be inhibited by radical scavengers such as SOD, DMSO, and NaN3 inhibit the to the same 
extent. However, the reaction with [Cu(L5)]2+  was the most inhibited by DMSO but SOD 
and NaN3 fail to inhibit the cleavage under the experimental conditions employed in the 
pathway study. These results suggest that the cleavage reaction with [Cu(L1)]2+ involves 
various oxygen species whereas that with [Cu(L5)]2+ progresses mainly with the hydroxyl 
radical. 
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Fig. 5.16  Electrophoresis results of incubating pBR322 (0.5 μg/μL) with complex 19 in TN 
buffer (5 mM Tris, 50 mM NaC) pH 7.5 at 37 oC for 72 h in the presence of scavenging 
agents: Lane 1, 1kb DNA ladder; Lane 2, plasmid DNA pBR322  (0.25µg/µl); Lane 3, 
DNA + 500 µM complex (control); Lane 4, DNA + 500 µM complex + 2mM sodium azide; 
Lane 5, DNA + 500 µM complex + 2mM Neocuproine; Lane 6, DNA + 500 µM complex + 
2mM Tiron; Lane 7, DNA + 500 µM complex + 2mM Thiourea 
 
When the DNA was incubated with 300 µM of copper complex in the presence of 
30 μM NaAsc, activation of copper complexes towards DNA cleavage by sodium ascorbate 
is observed for complexes 18 (Fig. 5.17, lane L14) and 19 (Fig. 5.17, lane L16). The DNA 
cleavage is evidenced from the increase in intensity of the nicked band. Further, complex 
18 (Fig. 5.17, lane L14) is more efficient in cleaving the DNA compared with complex 19 
(Fig. 5.17, lane L16) based on the total conversion of supercoiled DNA to the nicked form 
(Form II). For complex 19, the band attributed to supercoil DNA can still be seen. If our 
previous assumption that an electron donating group could stabilize the Cu(II) oxidation 
state is true, then the lower activity of complex 19 can be accounted for since it has an ethyl 
substituent which is more electron donating compared with the methyl substituent in 
complex 18. No DNA cleavage was observed for its zinc analogs (Fig. 5.17, lane L15 and 
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17) and its 2,2'-bipyridine analogs (chapter 4). This implies that the cleavage efficiency of 
ternary copper(II) complexes is improved with the presence of 1,10-phenanthroline moiety 
that enhances DNA binding.  
 
When the DNA was incubated with 300 μM of copper complex in the presence of 
30 μM hydrogen peroxide, DNA cleavage was observed for complexes 18, Cu(phen)(HM), 
and 19, Cu(phen)(HE),  (Fig. 5.17, lane L21 and 23).  However, a reversal in cleavage 
efficiency is seen for complex 19 in contrast to its cleavage efficiency with sodium 
ascorbate. Complex 19 converted (Fig. 5.17, lane L23) all the supercoiled DNA to nicked 
DNA and the appearance of linear DNA can also be seen. However, no linear band is seen 
with complex 18. Therefore, complex 19 is a better nuclease compared with complex 18 in 
the presence of hydrogen peroxide. The reversal in cleavage efficiency can be attributed to 
the presence of a more electron donating ethyl group in complex 19. The more electron 
donating ethyl group bestows the copper centre of 19 with higher electron density through 
inductive effect. Therefore,  higher electron density led to the easier removal of electron 
from copper (oxidation) in complex 19 thus the increase in cleavage efficiency. 
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Fig. 5.17 Electrophoresis results of incubating pBR322 (0.5 μg/μL) with CuCl2 or 
complex 10, 11, 18 and 19 in TN buffer (5 mM Tris, 50 mM NaC) pH 7.5 at 37 oC for 2 h 
in the absence and presence of exogenous agents: Lane 1, 11 and 18 gene ruler 1 Kb DNA 
ladder; Lane 2, DNA alone (0.5 µg/µL) control; Lane 3, DNA+ 30μM sodium ascorbate; 
Lane 4, DNA + 30μM H2O2; Lane 5, DNA + 300μM CuCl2;  Lane 6, DNA + 300μM ZnCl2; 
Lane 7, DNA + 300μM of 18; Lane 8, DNA + 300μM of 10; Lane 9, DNA + 300μM of 19; 
Lane 10, DNA + 300μM of 11; Lane 12, DNA + 300μM CuCl2 + 30μM sodium ascorbate; 
Lane 13, DNA + 300μM ZnCl2 + 30μM sodium ascorbate; Lane 14,  DNA + 300μM 
of 18 + 30μM sodium ascorbate; Lane 15, DNA + 300μM of 10 + 30μM sodium ascorbate; 
Lane 16, DNA + 300μM of 19 + 30μM sodium ascorbate;  Lane 17, DNA + 300μM of 11 + 
30μM sodium ascorbate; Lane 19, DNA + 300μM CuCl2 + 30μM H2O2; Lane 20, 
DNA+300μM ZnCl2 + 30μM H2O2; Lane 21, DNA + 300μM of 18 + 30μM H2O2; Lane 22, 
DNA + 300μM of 10 + 30μM H2O2; Lane 23, DNA + 300μM of 19 + 30μM H2O2; Lane 24, 
DNA + 300μM of 11 + 30μM H2O2 
 
To determine whether the complexes can be activated by hydrogen peroxide, the 
concentration of hydrogen peroxide was varied from 250 μM to 500 μM while maintaining 
the complex concentration at 300 μM. DNA cleavage was observed for complexes 18 and 
19 (Fig. 5.18, lane L14 and 16) in the presence of 250 μM hydrogen peroxide. Appearance 
of a nicked band with very high intensity and a linear band with low intensity is seen for 
complex 18 whereas smearing of the DNA band is seen for complex 19 (Fig. 5.18, lane L21 
and 23). This is consistent with our earlier result that complex 19 is a better DNA cleaving 
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agent than complex 18 in the presence of hydrogen peroxide. No cleavage is seen for their 
zinc analogs (Fig. 5.18, lane L15, 17, 22 and 24).  
 
Fig. 5.18 Electrophoresis results of incubating pBR322 (0.5 μg/μL) with CuCl2 or complex 
(10, 11, 18 or 19) in TN buffer (5 mM Tris, 50 mM NaCl) pH 7.5 at 37 oC for 2 h in the 
absence and presence of increasing hydrogen peroxide concentrations: Lane 1, 11 and 18 
gene ruler 1 Kb DNA ladder; Lane 2, DNA alone (0.5 µg/µL) control; Lane 3, DNA + 
250μM H2O2; Lane 4, DNA + 500μM H2O2; Lane 5, DNA + 300μM CuCl2; Lane 6, DNA 
+ 300μM ZnCl2; Lane 7, DNA + 300μM of 18; Lane 8, DNA + 300μM of 10; Lane 9, 
DNA + 300μM of 19; Lane 10, DNA + 300μM of 11; Lane 12, DNA + 300μM CuCl2 + 
250μM H2O2; Lane 13, DNA + 300μM ZnCl2 + 250μM H2O2; Lane 14, DNA + 300μM of 
18 + 250μM H2O2; Lane 15, DNA + 300μM of 10 + 250μM H2O2; Lane 16, DNA + 
300μM  of 19 + 250μM H2O2; Lane 17, DNA + 300μM of 11 + 250μM H2O2; Lane 19, 
DNA + 300μM CuCl2 + 500μM H2O2; Lane 20, DNA + 300μM ZnCl2 + 500μM H2O2; Lane 
21, DNA + 300μM of 18 + 500μM H2O2; Lane 22, DNA + 300μM of 10 + 500μM H2O2; 
Lane 23, DNA + 300μM of 19 + 500μM H2O2; Lane 24, DNA + 300μM of 11 + 500μM 
H2O2. 
 
In order to elucidate the cleavage mechanism with exogenous agents, complexes 18 
and 19 were incubated for 2 hours with DNA in the presence of the exogenous agent and 
scavenging agents such as neocuprione (Cu(I) ion chelator), thiourea (·OH radical-specific 
scavenger), sodium azide (a singlet oxygen radical scavenger) and Tiron (a superoxide 
anion radical scavenger) in the presence of exogenous agent. 
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When sodium ascorbate was used as an activating agent, addition of sodium azide 
(Fig. 5.19, Lane L5) and thiourea (Fig. 5.19, Lane L8) to complex 18 showed no effect on 
inhibition of DNA degradation. This rules out the involvement of either singlet oxygen and 
hydroxyl radical in the cleavage mechanism. Slight inhibition of DNA cleavage is observed 
when neocuproine (Fig. 5.19, Lane L6) was added, this indicates the involvement of 
oxidation of Cu(I) to Cu(II) in the generation of reactive oxygen species. Tiron also showed 
mild inhibition of DNA cleavage (Fig. 5.20, Lane L7), this indicates that the cleavage 
mechanism also involves the formation of superoxide radical. On the other hand, for 
complex 19 only thiourea showed slight inhibition to its cleavage activity (Fig. 5.20, Lane 
L8). This indicates that the cleavage mechanism involves hydroxyl radical but not singlet 
oxygen, superoxide radical and the oxidation of Cu(I) to Cu(II) in the generation of reactive 
oxygen species. When hydrogen peroxide was used as an activating agent, the cleavage by 
complex 18 can only be inhibited by sodium azide and Tiron (Fig. 5.21, L5 and 7). This 
indicates the involvement of singlet oxygen and superoxide radical in the cleavage 
mechanism. Greatest inhibition is seen with Tiron which implies that the superoxide anion 
dominates in the cleavage mechanism. A similar observation was encountered in complex 
19 (Fig. 5.22, L4 and 6).   
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Fig. 5.19 Electrophoresis results of incubating pBR322 (0.5 μg/μL) with complex 18 in TN 
buffer (5 mM Tris, 50 mM NaC) pH 7.5 at 37 oC for 2 h in the presence of exogenous agent 
and scavenging agents: Lane 1, plasmid DNA pBR322  (0.25µg/µl); Lane 2, DNA + 30 µM 
sodium ascorbate; Lane 3, 1kb DNA ladder; Lane 4, DNA + 300 µM complex + 30 µM 
sodium ascorbate (control); Lane 5, DNA + 300 µM complex + 2mM sodium azide + 30 
µM sodium ascorbate; Lane 6, DNA + 300 µM complex + 2mM Neocuproine + 30 µM 
sodium ascorbate; Lane 7, DNA + 300 µM complex + 2mM Tiron+ 30 µM sodium 
ascorbate; Lane 8, DNA + 300 µM complex + 2mM Thiourea + 30 µM sodium ascorbate 
L1       L2       L3       L4      L5       L6       L7      L8 
 
 
 
 
 
 
 
Fig. 5.20 Electrophoresis results of incubating pBR322 (0.5 μg/μL) with complex 19 in TN 
buffer (5 mM Tris, 50 mM NaCl) pH 7.5 at 37 oC for 2 h in the presence of exogenous 
agent and scavenging agents: Lane 1, plasmid DNA pBR322  (0.25µg/µl); Lane 2, DNA + 
30 µM sodium ascorbate; Lane 3, 1kb DNA ladder; Lane 4, DNA + 300 µM complex + 30 
µM sodium ascorbate (control); Lane 5, DNA + 300 µM complex + 2mM sodium azide + 
30 µM sodium ascorbate; Lane 6, DNA + 300 µM complex + 2mM Neocuproine + 30 µM 
sodium ascorbate; Lane 7, DNA + 300 µM complex + 2mM Tiron+ 30 µM sodium 
ascorbate; Lane 8, DNA + 300 µM complex + 2mM Thiourea + 30 µM sodium ascorbate 
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          L1      L2        L3       L4       L5        L6       L7       L8 
 
 
 
 
 
 
 
Fig. 5.21 Electrophoresis results of incubating pBR322 (0.5 μg/μL) with complex 18 in TN 
buffer (5 mM Tris, 50 mM NaC) pH 7.5 at 37 oC for 2 h in the presence of hydrogen 
peroxide and scavenging agents: Lane 1, plasmid DNA pBR322  (0.25µg/µl); Lane 2, DNA 
+ 30 µM hydrogen peroxide; Lane 3, 1kb DNA ladder; Lane 4, DNA + 300 µM complex + 
30 µM hydrogen peroxide (control); Lane 5, DNA + 300 µM complex + 2mM sodium 
azide + 30 µM hydrogen peroxide; Lane 6, DNA + 300 µM complex + 2mM Neocuproine 
+ 30 µM hydrogen peroxide; Lane 7, DNA + 300 µM complex + 2mM Tiron+ 30 µM 
hydrogen peroxide; Lane 8, DNA + 300 µM complex + 2mM Thiourea + 30 µM hydrogen 
peroxide; 
L1         L2        L3        L4       L5         L6       L7 
 
 
 
 
 
 
 
Fig. 5.22 Electrophoresis results of incubating pBR322 (0.5 μg/μL) with complex 19 in TN 
buffer (5 mM Tris, 50 mM NaC) pH 7.5 at 37 oC for 2 h in the presence of hydrogen 
peroxide and scavenging agents: Lane 1, plasmid DNA pBR322  (0.25µg/µl); Lane 2, 1kb 
DNA ladder; Lane 3, DNA + 300 µM complex + 30 µM hydrogen peroxide (control); Lane 
4, DNA + 300 µM complex + 2mM sodium azide + 30 µM hydrogen peroxide; Lane 5, 
DNA + 300 µM complex + 2mM Neocuproine + 30 µM hydrogen peroxide; Lane 6, DNA 
+ 300 µM complex + 2mM Tiron+ 30 µM hydrogen peroxide; Lane 7, DNA + 300 µM 
complex + 2mM Thiourea + 30 µM hydrogen peroxide 
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5.3.6 Topoisomerase I inhibition assay 
The objective of topoisomerase I inhibition assay by complexes 18 and 19 is similar 
to that mentioned in previous chapters (Chapters 2, 3 and 4). 
 
 As can be seen from Fig. 5.23 (lanes L10 and L11), complex 19, Cu(phen)(HE), is 
capable of almost total inhibition of topo I. The inhibition activity is better than the zinc 
complexes used as a comparison. Interestingly, complex 18, Cu(phen)(HM), does not 
inhibit topo I in contrast to its zinc analog (complex 10). This implies that inhibition of topo 
I in ternary complexes is very dependent on the combinations of ligands and metal. A slight 
variation in geometry and hydrophobicity can lead to total alterations of its potency. 
      L1     L2      L3      L4     L5      L6      L7      L8     L9     L10    L11 
 
 
 
 
 
Fig. 5.23 Human topoisomerase I inhibition assay by gel electrophoresis. 
Electrophoresis results of incubating human topoisomerase I (1 unit/21μL) with pBR322 in 
the absence or presence of 40 μM  of complex:  Lane 1 & 6, gene ruler 1 Kb DNA ladder; 
Lane 2, DNA + 40µM 18(control);Lane 3, DNA + 40µM 10(control); Lane 4, DNA + 
40µM 19(control); Lane 5, DNA + 40µM 11(control); Lane 7, DNA+ 1 unit Human 
Topoisomerase I (control); Lane 8, DNA + 40µM 18+ 1 unit Human Topoisomerase I; 
Lane 9, DNA + 40µM 10 + 1 unit Human Topoisomerase I; Lane 10, DNA + 40µM 19 + 1 
unit Human Topoisomerase I; Lane 11,  DNA + 40µM  11 + 1 unit Human 
Topoisomerase I 
Form I 
Form II 
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5.3.7 Antibacterial and antifungal assays 
5.3.7.1 Antibacterial activity 
As a routine test in this research project, the antibacterial activity of ligands and complexes 
Cu(phen)(L) were screened against Gram positive bacteria Gram negative bacteria as was 
carried out for the other complexes. All ligands and complexes had some degree of 
inhibitory activity against the bacteria tested (Table 5.8). Complexes 17 and 20 could not be 
studied due to limited solubility in DMF and the buffer mixture therefore the antibacterial 
activity of complexes 18 and 19 are compared with their zinc analogs (complexes 10 and 
11) to study the effect of varying metal ions. All the thiosemicarbazones ligands are less 
potent compared with the 1,10-phenanthroline ligand. 
 
Upon complexation of copper(II) with 1,10-phenanthroline and the 
thiosemicarbazones ligands (2 and 3), enhanced antibacterial activity is observed for 
complexes 18 and 19 towards S. aureus and B. cereus compared with 1,10-phenanthroline 
and their free thiosemicarbazones. On top of that, complex 19 also showed improved 
antibacterial activity towards K. pneumonia and P. aeruginosa. Since the MIC values of 
these complexes are lower than their free ligands, the improved antibacterial activity can be 
attributed to synergistic effect of metal and ligands in the complexes. The antibacterial 
properties of thiosemicarbazones ligands are known to improve upon complexation and this 
is attributed to enhance liphophilicity (Bindu et al. 1998; Joseph et al. 2006). However, a 
right combination of metals and ligands is essential to achieve the desired results since 
complexation does not always resulting in improved biological properties. 
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For the copper complexes in this research project, the ethyl derivative is always 
more active compared to the methyl derivative. Higher lipophilicity of a complex can help 
in permeation through the hydrophobic membrane of bacteria, thus enhancing their 
antibacterial activity (Kikuta et al., 2000, Kasuga et al., 2003).       
 
Another important observation is that under the same ligand environment, the 
copper complexes will always have better antimicrobial activity compared to the zinc 
complexes. This may be due to the ability of the copper complexes in inducing DNA 
damage in the presence or absence of exogenous agent in contrast to the zinc complexes 
that are cleavage inactive as observed in the nucleolytic experiments.  
 
The antimicrobial activity of the complexes in decreasing order for majority of the 
strains tested is 19 > 18 > 11 > 10. A few exceptions are seen in S. aureus, K. pneumoniae 
and the E.Coli strains. Of the complexes tested, complex 19 showed the highest 
antibacterial activity. It is noteworthy that complex 19 inhibited S. aureus with a MIC value 
(7.81 µg/mL) even lower than the antibacterial drug, Chloramphenicol, used for 
comparison. The highest antimicrobial activity for complex 19 is understandable because 
19 has an ethyl substituent which is more hydrophobic than the methyl group and it consists 
of a copper centre that is redox active.  
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Table 5.8. 
 Mean MIC value (µg/mL) towards microbes tested. 
Complex Bacteria 
 S. aureus B. cereus P. aeruginosa K. pneumoniae E. coli  E. coli  
              
(penicillin- 
sensitive strain) 
(penicillin- 
resistant strain) 
1 62.50 62.50 62.50 62.50 62.50 62.50 
2 125.00 62.50 125 62.50 62.50 62.50 
3 62.50 62.50 62.50 62.50 62.50 62.50 
4 62.50 31.25 62.50 31.25 62.50 62.50 
10 62.50 31.25 52.08 31.25 62.50 62.50 
11 62.50 15.63 31.25 31.25 31.25 31.25 
18 15.63 7.81 15.63 15.63 31.25 31.25 
19 7.81 6.51±2.25 7.81 6.51 15.63 15.63 
CuCl2 - - - - - - 
phen 62.50 15.63 15.63 15.63 15.63 15.63 
Drug 8.00 4.00 4.00 4.00 4.00 4.00 
 “ - ” : no activity. Drug used in antibacterial assay = Chloramphenicol   
  
5.3.7.2 Antifungal activity 
The antifungal activity of ligands and their complexes were assessed against four species of 
fungi. All ligands and complexes had some degree of inhibitory activity against the fungi 
tested (Table 5.9).  All the thiosemicarbazones ligands are less potent compared with 1,10-
phenanthroline. 
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The antifungal trends of the complexes are dependent on the strain of the fungi. 
However a general trend that can still be observed is that the copper complexes are 
generally more active than their zinc counterpart. The complexes are most active towards 
C. neoformans with a MIC value of 7.81 µg/mL (complexes 19, 11 and 10) and 15.63 
µg/mL (complex 18). All four copper complexes benefited from the synergistic effect of 
complexation between metal with the 1,10-phenanthroline and their thiosemicarbazones 
ligands towards C. neoformans strains. These complexes have lower MIC value compared 
with 1,10-phenanthroline and their respective thiosemicarbazone ligands.  A.niger showed 
very high resistant towards complex 18 and complex 10 suggesting that the membrane of 
this particular fungus is harder to permeate with shorter alkyl chain compared to other 
strains. Drastic improvement is observed for complex 19 and complex 11 towards A.niger 
with both showing MIC value of 7.81 ug/ml when the methyl group in complex 18 and 
complex 10 is replaced with an ethyl group. This example once again demonstrates the 
importance of lipophilicity in antifungal property as observed for antibacterial activity. 
Complex 19 showed the highest inhibitory activity of 7.81 ug/ml for all the fungi tested 
when compared with all of the complexes in this assay. However, its MIC value is higher 
than 1,10-phenanthroline (3.91 ug/ml)  towards C. albicans and C. parapsilosis. This 
implies that antifungal properties of 1,10-phenanthroline towards these two fungi most 
likely attributed to its ability to chelate metal ions required for the survival of the fungi. 
Complexation removes the chelation ability of 1,10-phenanthroline hence resulted in 
decrease antifungal property towards these fungi.  
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Table 5.9 
Mean MIC value (µg/mL) towards fungi tested. 
 Complex 
Fungi 
C. albicans C. parapsilosis C. neoformans A.niger 
      
1 31.25 62.50 31.25 62.50 
2 31.25 31.25 31.25 62.50 
3 31.25 31.25 31.25 62.50 
4 31.25 62.50 7.81 31.25 
10 15.63 31.25 7.81 62.50 
11 15.63 15.63 7.81 7.81 
18 15.63 7.81 15.63 31.25 
19 7.81 7.81 7.81 7.81 
CuCl2 
 
- - - - 
phen 
 
3.91 3.91 31.25 31.25 
Drug 
 
1.00 2.00 1.00 4.00 
All values are expressed as mean ± standard deviation of three replicates  
“ - ” : no activity     
Drug used in antifungal assay = fluconazole  
   
5.4 Conclusion 
Spectroscopic and crystal data reveal that all the copper complexes are five-coordinated 
with the doubly deprotonated thiosemicarbazones acting as a tridentate ligand that 
coordinated through one phenolic oxygen, azomethine nitrogen and thiolate sulfur atoms 
while the 1,10-phenanthroline is coordinated as a N,N’-bidentate ligand. The coordination 
geometry around these copper complexes is distorted square pyramidal similar to their 2,2'-
bipyridine analogs Cu(bipy)(L). 
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Complexation of the ligands with copper lead to formation of a series of ternary complexes 
with better biological activities compared with their zinc analogs. Complex 18 
Cu(phen)(HM) which is the copper analog for complexes 6, Zn(bipy)(HM), 10, 
Zn(phen)(HM),  and 14, Cu(bipy)(HM),  retains its ability in recognizing CG rich sequence 
in DNA. The mode of binding towards DNA for complexes 18 and 19 is quite different 
from those observed in their zinc analog Zn(phen)L. The same is true for its bipyridine 
analogs Zn(bipy)L. However, greater enhancement in binding strengths is observed by 
substitution of bipyridine with 1,10-phenanthroline. This can be attributed to increase 
lipophilicity and intercalation of the 1,10-phenanthroline ligand.  
 
 Unlike their zinc analogs, Zn(phen)L, the Cu(phen)L complexes can be activated by 
sodium ascorbate or hydrogen peroxide to induce DNA cleavage. In addition, these copper 
complexes also have better nucleolytic efficiency than their 2,2'-bipyridine analogs 
Cu(bipy)L, because they can cleave DNA without any exogenous agents and the cleavage 
efficiency is much higher in the presence of exogenous agent. Topoisomerase I inhibition 
by complex 19, Cu(phen)(HE), is also better than its zinc analog (complex 11 
Zn(phen)(HE)).  Most of the copper complexes exhibit a wider spectrum of antibacterial 
and antifungal properties with better MIC value compared to their zinc analog. Complex 19 
has a good potential to be developed as a drug or DNA probe owing to its highest 
nucleolytic efficiency, topoisomerase I inhibition, antibacterial and antifungal activities. 
These results further substantiate the role of hydrophobicity in bestowing desirable 
biological activities to a complex regardless of its metal centre.  
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Chapter 6 
Conclusion 
6.1 Syntheses and characterizations of the ligands and complexes  
Four thiosemicarbazones ligands (H3T(1), H3M(2), H3E(3) H3P(4)) have been prepared in 
good yield by refluxing 2,4-dihydroxybenzaldehyde with thiosemicarbazide or N(4)-
substituted thiosemicarbazide in ethanol or methanol. From these four ligands, four new 
sets of ternary metal complexes (Zn(bipy)L (5-8); Zn(phen)L (9-12); Cu(bipy)L (13-16) 
and Cu(phen)L (17-20) with the general formulation of M(B)L have been prepared from 
the reactions of metal acetates  with 2,4-dihydroxybenzaldehyde N(4)-substituted 
thiosemicarbazone in the presence of N,N-heterocyclic base (M2+ = Zn2+ or Cu2+; B = 2,2'-
bipyridine, (bipy); 1,10-phenanthroline, (phen); L2- = doubly deprotonated 
thiosemicarbazone =                          2,4-dihydroxybenzaldehyde thiosemicarbazonato, 
(HT); 2,4-dihydroxybenzaldehyde                4-methylthiosemicarbazonato, (HM); 2,4-
dihydroxybenzaldehyde 4-ethylthiosemicarbazonato, (HE) and 2,4-dihydroxybenzaldehyde 
4-phenylthiosemicarbazonato, (HP)). These compounds have been characterized by 
elemental analyses, IR, UV, NMR, magnetic susceptibility. The structures for some of the 
ligands (2, 3) and some of the complexes (5, 8, 9, 11, 13 and 18) have been solved by 
single crystal X-ray crystallography.* Results from spectroscopic data and crystal structure 
analysis show that all of the free ligands exist in the thione form. The complexes are 
mononuclear and five coordinated with the doubly deprotonated thiosemicarbazone as a 
tridentate ligand coordinating through the phenolic oxygen, azomethine nitrogen and 
thiolate sulfur atoms with 2,2'-bipyridine or 1,10-phenanthroline as the N,N’-bidentate 
ligand. The coordination geometries vary from distorted square pyramidal to trigonal 
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bipyramidal distorted square based pyramid (TBDSBP). Five coordinated complexes can 
adopt either one of the coordination geometry and are known to interconvert through a 
process known as pseudo-Berry rotation. Results from our crystallography study and 
literature review show that the copper complexes tend to adopt distorted square pyramidal 
geometry while zinc complexes tend to adopt a trigonal bipyramidal distorted square based 
pyramid (TBDSBP).   The preferred coordination geometry is conferred by several 
restrictions such as the strength of the ligand field, rigidity and denticity of the ligand as 
well as the electronic configuration of the metal ions. The combinations of these factors 
will dictate the possible hybridization of the metal’s orbitals and hence the preferred 
coordination geometry. Since the copper and zinc complexes are analogs with similar 
ligands, the effects from the ligands such as the strength of the ligand field, rigidity and 
denticity should not be the driving force in dictating the final coordination geometry. Hence, 
the deciding factor should lie with the metal ions used in our study. Copper complexes tend 
to adopt a distorted square pyramidal geometry while zinc complexes tend to adopt a 
geometry  towards trigonal bipyramidal.  This could be attributed to the difference in 
electron configurations for copper and zinc that leads to the stabilization of particular 
coordination geometry since the energy difference between square pyramidal and trigonal 
bipyramidal is quite small. For copper with a d9 electronic configuration, the energy 
difference is 0.25 βσЅσ
2. The zinc(II) ion with d10 electronic configuration is not subjected 
to tetragonal distortion of its coordination geometry due to Jahn-Teller effect unlike copper 
with a d9 electronic configurations. The presence of Jahn-Teller effect in the copper 
complexes is confirmed by the elongation of the apical Cu-N bond lengths. The copper 
complexes show two different sets of Cu-N(heterocycle) bond length with one being 
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slightly longer than the other. As for the zinc complexes, similar Zn-N(heterocycle) bond 
lengths are observed. 
* Structures for the following compounds have been published: 2, 3, 5 and 9 (Appendix) 
 
6.2 Biological activities 
The effect of varying (i) the N(4) substituent from methyl, ethyl to phenyl, (ii) metal 
ions and (iii) polpyridyl ligand towards the chemical and biological properties (DNA 
binding, nucleolytic, topoisomerase I inhibition and antimicrobial) have been studied. By 
comparing the results of 12 complexes in each type of screening that span over four 
chapters, some generalizations can be made on the role of metal ions, type of N(4) 
substituent and type of polypyridyl ligand in determining the ability to recognize different 
DNA base sequence and potency of a particular complex towards a particular biological 
property or activity.  
 
6.2.1 DNA binding 
Results from CD experiments show that the mode of binding and recognizing 
capability of the complexes to different DNA sequences or structures are dependent on the 
N(4) substituent because the variation of the substituent would change the hydrophobicity, 
surface area, shape, size and steric effect of a particular complex. The ability of a complex 
to differentiate base sequences and DNA structure (e.g.s quadruplex) is found to be 
dependent on the N(4) substituent. The mode of binding strength as well as the binding 
strength of a complex is also dependent on the N(4) substituent. Besides the N(4) 
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substituent, recognition capability of a complex is also dependent on polypyridyl ligands or 
metal ions. The shape of a complex and how that shape matches the DNA is known as the 
most critical factor in determining binding affinity (Pyle et al. 1989).  
 
As for the effect of varying polypyridyl ligand, incorporation of a 1,10-
phenanthroline moiety in place of a 2,2'-bipyridine moiety in Zn(bipy)L led to formation of 
Zn(phen)L that show higher selectivity for the ds(AT)6 sequence for the N(4) alkyl 
substituted thiosemicarbazones. The non-substituted thiosemicarbazones complexes 
containing phenanthroline could not be studied owing to solubility problem. This also 
implies that though the phenanthroline moiety can promote DNA binding with its better 
intercalating capability, it can also pose a problem in biological testing of neutral 
complexes. The increased hydrophobicity in a neutral complex owing to the presence of 
extended aromatic ring can render it insoluble in water. Our study also shows that most of 
the complexes that are more hydrophobic (containing phenyl as N(4) substituent or 
phenanthroline) normally bind more strongly to the various duplex structures. Our results 
also show that most zinc complexes (Zn(bipy)L and Zn(phen)L) induce a greater increase 
in the positive band of the CD spectra of G-quadruplex compared with their copper analogs 
(Cu(bipy)L and Cu(phen)L). This suggests that zinc complexes are better in stabilizing the 
G-quadruplex structure. Since the major difference between the zinc and the copper 
complexes is their coordination geometry, the shape of the complex with same ligand may 
be important in determining its ability to bind to G-quadruplex. 
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6.2.2 Nucleolytic study 
Results from nucleolytic experiments show that the zinc complexes are very weak 
DNA cleaving agents that only show mild cleavage of the DNA at very high concentration 
in the absence of exogenous agents. Not much difference is observed in the cleavage 
efficiency between the 2,2’-bipyridine  and 1,10-phenanthroline derivatives of zinc. None 
of the complexes can be activated to induce DNA cleavage by the exogenous agents. 
Interestingly, when zinc in the Zn(bipy)L series was replaced by copper to form Cu(bipy)L, 
drastic improvement is seen in the cleavage efficiency in the presence of exogenous agents 
used. The copper complex with unsubstituted thiosemicarbazone and N(4)-
phenylthiosemicarbazone can induce DNA cleavage in the presence of sodium ascorbate. 
The copper complexes with alkyl substituted thiosemicarbazones (Cu(bipy)(HM) and 
Cu(bipy)(HE)) are incapable of DNA degradation most probably owing to its ability to 
stabilize the Cu(II) oxidation state from reduction by sodium ascorbate. All copper 
complexes can be activated to induce DNA scission in the presence of hydrogen peroxide. 
Cleavage efficiency for complex 16 Cu(bipy)(HP) is the highest in the presence of an 
exogenous agent most probably owing to its ability to intercalate to DNA with its hanging 
phenyl substituent. None of the copper complexes Cu(bipy)L show hydrolytic cleavage of 
DNA. When the 2,2’-bipyridine  moiety in complex 14, Cu(bipy)(HM), and 15, 
Cu(bipy)(HE)  was substituted with a 1,10-phenanthroline moiety, great improvement in 
cleavage efficiency is seen. This could be attributed to stronger binding of the complexes to 
DNA. The resultant 1,10-phenanthroline derivatives (complex 18, Cu(phen)(HM),  and 19, 
Cu(phen)(HE)) can cleave DNA in the absence of exogenous agents. Complex 18 has better 
cleavage efficiency in the absence of exogenous agent. Radical scavenging experiments for 
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complex 18 show that the cleavage mechanism involves a combination of reactive oxygen 
species such as singlet oxygen, superoxide anion and hydroxyl radical. However, no total 
inhibition was observed with the addition of scavengers. Therefore, the possibilities of 
DNA cleavage involving hydrolysis can not be ruled out. Complexes (18 and 19) can also 
be activated by hydrogen peroxide and sodium ascorbate. The mechanism of cleavage is 
different in the presence of different exogenous agents as seen from the scavenging 
experiments. Complex 18 shows better cleavage efficiency in the presence of sodium 
ascorbate whereas complex 19 shows better cleavage efficiency in the presence of 
hydrogen peroxide. These results imply that the best way of elevating cleavage efficiency 
for these complexes is to use a redox active metal such as copper and a better intercalating 
ligand such as phenanthroline. The incorporation of ligands such as dpq or dppz may 
further enhance its cleavage efficiency. However, solubility problem may arise from higher 
hydrophobicity.  
 
6.2.3 Topoisomerase I inhibition assay  
Results from topoisomerase I inhibitions show that six (Zn(bipy)(HP) (8), 
Zn(phen)(HM) (10), Zn(phen)(HE) (11), Cu(bipy)(HT) (13), Cu(bipy)(HP) (16), 
Cu(phen)(HE) (19)) out of twelve of the complexes tested can inhibit the enzyme. The 
ability of these complexes to inhibit the enzyme may be attributed to (i) their ability to bind 
to DNA and cause various conformational changes to the DNA or (ii) blocking the binding 
site of the enzyme. However, the preliminary mechanistic study suggests that the main 
pathway in inhibition of the enzymes is likely attributed to the binding of the complexes to 
the enzymes since greater inhibition was observed when the complexes were incubated 
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with topoisomerase I first before the addition of DNA. Both pathways seem to be occurring 
simultaneously. Similar to results from DNA binding, the factors that favor topoisomerase I 
inhibition is not straight forward.  However, in the absence of the 1,10-phenanthroline 
moiety, two of the complexes that inhibited the enzymes contain a thiosemicarbazone 
moiety with phenyl substituent that favors intercalation to DNA. The third complex is a 
copper complex with unsubstituted thiosemicarbazone. Another implication that maybe 
derived from this observation is none of them are alkyl substituted. This suggests that alkyl 
substitution disfavor topoisomerase I inhibition in 2,2’-bipyridine  derivatives. 
 
 However, a very contradicting observation is seen in the 1,10-phenanthroline 
analog of these alkyl substituted complexes. Three out of four of these complexes 
(Zn(phen)(HM) (10), Zn(phen)(HE) (11) and Cu(phen)(HE) (19)) can inhibit 
topoisomerase I. This suggests that the 1,10-phenanthroline moiety can bestow the 
following inactive complexes (Zn(bipy)(HM)(6), Zn(bipy)(HE)(7) and Cu(bipy)(HM)(14)) 
with topoisomerase inhibiton activity by substituting the 2,2’-bipyridine  moiety. The exact 
nature of this improvement is not fully understood. However, such improvement may be 
attributed to better binding to DNA or topoisomerase I with the presence of 1,10-
phenanthroline moiety with higher hydrophobicity and intercalating capability. 
 
6.2.4 Antibacterial and antifungal activity 
The antibacterial and antifungal activity of the free thiosemicarbazones ligands are 
very dependent on the N(4) substituent. Greater degree of substitution or presence of a 
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more hydrophobic substituent led to an increase in inhibitory activity. Drastic enhancement 
is seen in overall inhibitory activity of the complexes compared with their free 
thiosemicarbazones ligands. However, most of these complexes have MIC values either 
higher or similar to the polypyridyl ligands. This implies that the inhibitory activities of 
these complexes are most likely conferred by the polypyridyl ligands. Most complexes that 
show good antibacterial activity in our study are also topoisomerase I inhibitor. Better 
activity is seen in complexes with more hydrophobic substituent group (ethyl and phenyl). 
All the 1,10-phenanthroline derivatives possess better activity than their 2,2’-bipyridine  
analogs. Another important observation is that under the same ligand environment, the 
copper complexes will always have better antimicrobial activity compared to the zinc 
complexes. This may be due to the ability of the copper complexes in inducing DNA 
cleavage in the presence or absence of exogenous agent in contrast to the zinc complexes 
that are cleavage inactive as observed in the nucleolytic experiments. The good antifungal 
and antibacterial activity of complex 19 can be attributed to its redox active copper metal 
center and the presence of an ethyl susbstituent and 1,10-phenanthroline moiety. The ethyl 
substituent and 1,10-phenanthroline moiety can increase the permeability of the complex 
across the membrane of the microbes by elevating its hydrophobicity. In addition, the 1,10-
phenanthroline moiety can also help to promote the binding of the complex to DNA in the 
cell.   Complex 19 is the most active complex with the lowest MIC value of 7.81 µg/mL 
towards S. aureus which is even lower than the antibacterial drug, Chloramphenicol, used 
in the assay. Antibacterial and antifungal activities of complex 19 are good examples of the 
role of synergistic effect in elevating biological properties. This is attributed to the greater 
enhancement in biological activity of the complex in contrast to its free ion and both its free 
ligands (H3E and phenanthroline). 
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6.3 Suggestions  
Among the zinc complexes studied, complexes Zn(bipy)(HP) (8), Zn(phen)(HM) 
(10) and Zn(phen)(HE) (11) deserve further study owing to their good topoisomerase I 
inhibition, antibacterial and antifungal activities. Though these complexes are not efficient 
DNA cleavage agents, their ability to differentiate DNA sequences and induce various 
conformational change upon DNA binding make them good candidate as potential 
anticancer agent that does not cause oxidative cleavage to DNA. Complexes 10 and 11 that 
can bind strongly to the G-quadruplex also warrants further study as they can shed light on 
the requirements of zinc complexes that can stabilize G-quadruplex. As for the copper 
complexes, the most promising candidates are complexes Cu(bipy)(HP) (16), 
Cu(phen)(HE) (19) owing to their high nucleolytic efficiency, topoisomerase I inhibition, 
antibacterial and antifungal activities. Based on the selection of the most active complexes 
in each series that we have tested, (Zn(bipy)(HP)(8), Zn(phen)(HE)(11), Cu(bipy)(HP)(16), 
and Cu(phen)(HE)(19)) we can conclude that phenyl and alkyl substituted 
thiosemicarbazone complexes are always better than the non-substituted derivatives in the 
same series and the choice of polypyridyl ligands is crucial in determining the biological 
properties and water solubility of a particular complex. Further, the biological activities of 
the complexes seems to be cooperative since most complexes that are selective DNA 
binders are also good nuclease, topoisomerase I inhibitors, antibacterial and antifungal 
agents. Further, tests such as cytotoxicity assays can be carried out to evaluate the potential 
anticancer properties of the complexes that can inhibit topoisomerase I and bind strongly to 
G-quadruplex. Docking studies with computer simulation can also help to shed light on the 
mode of binding of the complexes to duplex and G-quadruplex DNA. 
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